0001903596-23-000879.txt : 20231114 0001903596-23-000879.hdr.sgml : 20231114 20231114122715 ACCESSION NUMBER: 0001903596-23-000879 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: American Cannabis Company, Inc. CENTRAL INDEX KEY: 0000945617 STANDARD INDUSTRIAL CLASSIFICATION: TELEVISION BROADCASTING STATIONS [4833] IRS NUMBER: 901116625 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-26108 FILM NUMBER: 231403192 BUSINESS ADDRESS: STREET 1: 200 UNION ST. STREET 2: SUITE 200 CITY: LAKEWOOD STATE: CO ZIP: 80228 BUSINESS PHONE: 303-974-4770 MAIL ADDRESS: STREET 1: 200 UNION ST. STREET 2: SUITE 200 CITY: LAKEWOOD STATE: CO ZIP: 80228 FORMER COMPANY: FORMER CONFORMED NAME: Brazil Interactive Media, Inc. DATE OF NAME CHANGE: 20130617 FORMER COMPANY: FORMER CONFORMED NAME: NATUREWELL INC DATE OF NAME CHANGE: 20000731 FORMER COMPANY: FORMER CONFORMED NAME: LA JOLLA DIAGNOSTICS INC DATE OF NAME CHANGE: 19950523 10-Q 1 ammj_10q.htm
0000945617 false Q3 --12-31 2023 0000945617 2023-01-01 2023-09-30 0000945617 2023-11-14 0000945617 2023-09-30 0000945617 2022-12-31 0000945617 2023-07-01 2023-09-30 0000945617 2022-07-01 2022-09-30 0000945617 2022-01-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2022-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000945617 ammj:SubscriptionReceivableMember 2022-06-30 0000945617 us-gaap:RetainedEarningsMember 2022-06-30 0000945617 2022-06-30 0000945617 us-gaap:CommonStockMember 2023-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000945617 ammj:SubscriptionReceivableMember 2023-06-30 0000945617 us-gaap:RetainedEarningsMember 2023-06-30 0000945617 2023-06-30 0000945617 us-gaap:CommonStockMember 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000945617 ammj:SubscriptionReceivableMember 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-12-31 0000945617 2021-12-31 0000945617 us-gaap:CommonStockMember 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000945617 ammj:SubscriptionReceivableMember 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-12-31 0000945617 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-07-01 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-07-01 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000945617 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-01-01 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-01-01 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000945617 us-gaap:CommonStockMember 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-09-30 0000945617 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-09-30 0000945617 2022-01-01 2022-12-31 0000945617 us-gaap:OfficeEquipmentMember 2023-09-30 0000945617 us-gaap:OfficeEquipmentMember 2022-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2023-09-30 0000945617 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2023-09-30 0000945617 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2023-09-30 0000945617 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000945617 us-gaap:LicenseMember 2023-09-30 0000945617 us-gaap:LicenseMember 2023-01-01 2023-09-30 0000945617 ammj:BrandMember 2023-09-30 0000945617 ammj:BrandMember 2023-01-01 2023-09-30 0000945617 us-gaap:PatentsMember 2023-09-30 0000945617 us-gaap:LicenseMember 2022-12-31 0000945617 us-gaap:LicenseMember 2022-01-01 2022-12-31 0000945617 ammj:BrandMember 2022-12-31 0000945617 ammj:BrandMember 2022-01-01 2022-12-31 0000945617 ammj:May2022ToApril2023Member 2023-01-01 2023-09-30 0000945617 ammj:May2023ToApril2024Member 2023-01-01 2023-09-30 0000945617 ammj:May2024ToApril2025Member 2023-01-01 2023-09-30 0000945617 ammj:May2025ToApril2026Member 2023-01-01 2023-09-30 0000945617 ammj:May2026ToApril2027Member 2023-01-01 2023-09-30 0000945617 ammj:January2023Member 2023-01-01 2023-09-30 0000945617 ammj:January2024Member 2023-01-01 2023-09-30 0000945617 ammj:January2025Member 2023-01-01 2023-09-30 0000945617 ammj:January2026Member 2023-01-01 2023-09-30 0000945617 ammj:January2027Member 2023-01-01 2023-09-30 0000945617 ammj:June2022ToJune2023Member 2023-01-01 2023-09-30 0000945617 ammj:June2023ToJune2024Member 2023-01-01 2023-09-30 0000945617 ammj:June2024ToJune2025Member 2023-01-01 2023-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

UNITED STATES

 

SECURITIES AND EXCHANGE COMMISSION 

 

Washington, D.C. 20549 

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2023

   

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

   

For the transition period from ______ to ______.  

 

Commission File Number 000-26108

 

 

AMERICAN CANNABIS COMPANY, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware   90-1116625
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

200 Union Street, Ste. 200

   
Lakewood, Colorado   80228
(Address of principal executive offices)   (Zip Code)

 

(303) 974-4770 

(Registrant’s telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer   Accelerated filer  ☐
Non-accelerated filer   Smaller reporting company  
Emerging growth company      

   

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). ☐

  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ☐   No ☒

  

At September 30, 2023, and November 14, 2023, 171,402,938 shares of common stock were outstanding, respectively. 

 
 

   
TABLE OF CONTENTS

 

    Page
PART I. FINANCIAL INFORMATION  
     
Item 1. FINANCIAL STATEMENTS:  
     
  CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2023 (UNAUDITED) AND DECEMBER 31, 2022 3
     
  CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023, AND 2022 (UNAUDITED). 4
     
  CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023, AND 2022 (UNAUDITED) 5
     
  CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023, AND 2022 (UNAUDITED). 6
     
  NOTES TO THE UNAUDITED CONDENSEND CONSOLIDATED FINANCIAL STATEMENTS.  7
     
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 30
     
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 35
     
Item 4. CONTROLS AND PROCEDURES 35
     
PART II. OTHER INFORMATION   
   
Item 1. LEGAL PROCEEDINGS 37
     
Item 1A. RISK FACTORS 37
     
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 37
     
Item 3. DEFAULTS UPON SENIOR SECURITIES 38
     
Item 4.   MINE SAFETY DISCLOSURES 38
     
Item 5. OTHER INFORMATION 38
     
Item 6. EXHIBITS 38
   
SIGNATURES 39

 

 

2
 

 

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS  

(UNAUDITED)

 

   Sept. 30,  December 31,
   2023  2022
ASSETS          
Current Assets          
Cash and Equivalents  $8,889   $117,547 
Accounts Receivable, Net   202,487    469,111 
Deposits   9,595    9,595 
Inventory   518,288    352,971 
Prepaid Expenses and Other Current Assets   64,059    73,933 
Total Current Assets   803,318    1,023,157 
           
Property and Equipment - Net   424,155    427,669 
           
Other Assets          
Intangible Assets, net amortization   1,084,242    1,223,242 
Goodwill   1,332,113    1,332,113 
Right of Use Assets - Operating Leases, net   519,244    604,020 
Long Term Deposits   6,000    6,000 
Total Other Assets   2,941,599    3,165,375 
TOTAL ASSETS  $4,169,072   $4,616,201 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY          
Current Liabilities          
Accounts Payable  $934,978   $679,163 
Advances from Clients   55,267    280,705 
Accrued and Other Current Liabilities   491,715    233,348 
Stock payable   17,021    74,343 
Right of Use Liabilities, current   191,539    181,661 
Litigation Settlement, current   75,000    100,000 
Note payables, current   300,000    550,000 
Total Current Liabilities   2,065,520    2,099,220 
           
LONG TERM LIABILITIES          
Litigation Settlement         75,000 
Right of Use Liabilities – LT   327,705    422,359 
LTD Note Payable   410,198    150,000 
Total Long-Term Liabilities   737,903    647,359 
TOTAL LIABILITIES   2,803,423    2,746,579 
           
Shareholders’ Equity          
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively            
Common stock, $0.00001 par value; 500,000,000 shares authorized; 171,402,938 and 92,152,938 shares issued and outstanding at September 30, 2023, and December 31, 2022, respectively   1,715    922 
Additional paid-in capital   12,022,958    11,949,409 
Accumulated deficit   (10,659,024)   (10,080,709)
Total Shareholders’ Equity   1,365,649    1,869,622 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY  $4,169,072   $4,616,201 

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

3
 

 

  

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 

(UNAUDITED)

 

                           
   Three Months Ended  Nine Months Ended
   Sept. 30,  Sept. 30,  Sept. 30,  Sept. 30,
   2023  2022  2023  2022
Revenues            
Consulting Services  $168,528    66,824   $637,028   $308,872 
Product & Equipment   218,242    1,866,725    986,000    6,540,558 
Cannabis Products   213,120    190,067    571,976    638,316 
Total Revenues   599,890    2,123,616    2,195,004    7,487,746 
                     
Cost of Revenues                    
Cost of Consulting Services   12,000    19,500    115,085    67,422 
Cost of Products and Equipment   187,818    1,664,235    695,464    5,628,432 
Cost of Cannabis Products   151,335    180,701    462,823    724,529 
Total Cost of Revenues   351,154    1,864,436    1,273,373    6,420,383 
Gross Profit   248,717    259,180    921,631    1,067,363 
                     
Operating Expenses                    
General and Administrative   326,429    617,270    1,408,209    1,951,008 
Selling and Marketing   51,675    64,017    169,059    165,544 
Stock Based Compensation Expense         56,170    17,021    121,479 
Total Operating Expenses   378,104    737,457    1,594,109    2,238,031 
Loss from Operations   (129,367)   (478,277)   (672,477)   (1,170,668)
                     
Other Income (Expense)                    
Interest (expense)   (28,690)   77,381    (93,054)   (32,024)
Debt Forgiveness                        
Other income   900    3,246    187,216    48,016 
Total Other (Expense) Income   (27,791)   80,627    94,162    80,040 
Net Loss   11,844    (170,803)   (451,156)   (692,978)
Income Tax Expense                        
NET LOSS  $(157,158)  $(397,650)  $(578,316)  $(1,090,628)
Basic net loss per common share  $(0)  $(0)  $(0.01)  $(0.01)
Basic and diluted weighted average common shares outstanding   85,727,938    85,727,938    84,795,246    84,795,246 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

4
 

 

  

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY

 

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

                        
   Common Stock  Additional
Paid-In
  Subscription  Accumulated  Total
Shareholders’
   Shares  Amount  Capital  Receivable  Deficit  Equity
Balance, June 30, 2022   85,727,938   $857   $11,794,476   $0   $(10,140,495)  $1,654,838 
Subscription Receivable Paid   0    0    0    0    0    0 
Stock based compensation third party   0    0    0    0    0    65,000 
Net Loss   —                        (397,650)   (397,650)
Balance, Sept. 30, 2022   85,727,938   $857   $11,794,476   $     $(10,538,145)  $1,257,188 

 

 

   Common Stock  Additional
Paid-In
  Subscription  Accumulated  Total
Shareholders’
   Shares  Amount  Capital  Receivable  Deficit  Equity
Balance, June 30, 2023   92,152,938   $922   $12,023,751   $0   $(10,543,709)  $1,480,694 
Subscription Receivable Issued   0    0    0                0 
Stock based compensation issued to employees   0    0    0                0 
Stock issued for cash   0    0    0                0 
Net Loss   —                        (157,158)   (157,158)
Balance, Sept. 30, 2023   92,152,938   $922   $12,023,751   $     $(10,700,867)  $1,323,806 

 

 

    FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

 

   Common Stock  Additional
Paid-In
  Subscription  Accumulated  Total
Shareholders’
   Shares  Amount  Capital  Receivable  Deficit  Equity
Balance, December 31, 2021   81,902,938   $819   $11,565,679   $     $(9,447,517)  $2,118,981 
Stock based compensation to employees   325,000    3    46,204                46,207 
Stock issued to service provider   1,000,000    10    64,990                65,000 
Stock issued for cash   2,500,000    25    117,603                142,793 
Net Loss   —                        (1,090,628)   (1,090,628)
Balance, June 30, 2022   85,727,938   $857   $11,794,476   $     $(10,538,145)  $1,257,188 

 

   Common Stock  Additional
Paid-In
  Subscription  Accumulated  Total
Shareholders’
   Shares  Amount  Capital  Receivable  Deficit  Equity
Balance, December 31, 2022   92,152,938   $922   $11,949,409   $     $(10,080,709)  $1,869,622 
Stock based compensation to employees   —            74,342                74,342 
Stock-based compensation to service provider   79,250,000    793    (793)                  
Stock issued for cash   —                                 
Net Loss   —                        (578,316)   (578,316)
Balance, Sept. 30, 2023   171,402,938   $922   $12,022,958   $     $(10,659,025)  $1,365,648 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

5
 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

              
   For the Nine Months Ended
   Sept. 30,  Sept. 30,
   2023  2022
CASH FLOWS FROM OPERATING ACTIVITIES          
Net Loss  $(578,315)  $(1,090,628)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   181,617    113,362 
Stock-based compensation to employees   (793)   65,306 
Stock-based compensation to third party         29,792 
Debt Forgiveness            
Changes in operating assets and liabilities:          
Accounts receivable   266,624    (248,610)
Inventory   (165,317)   (73,886)
Prepaid expenses and other current assets   9,872    (55,232)
Right to Use Lease Asset   84,776    (116,191)
Long Term Deposits            
Accounts Payable   255,815    211,059 
Advances from Clients   (225,438)   1,279,080 
Accrued and other current liabilities   25,387    (11,463)
Litigation Settlement Liability   (100,000)   (150,000)
Operating Lease Liability   (84,776)   116,191 
Net Cash Provided by (Used In) Operating Activities  $(330,548)  $68,780 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of property and equipment   (39,101)   (105,011)
Acquisition of Assets            
Intangible assets         (10,305)
Net Cash Used in Investing Activities  $(39,101)  $(115,316)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from sale of common stock   793    117,629 
Proceeds from note payable            
Payment of note payable         (550,000)
LTD Note Payable   260,198       
Net Cash (Used) Provided by Financing Activities  $260,991   $(432,371)
           
NET INCREASE IN CASH   (108,658)   (478,907)
           
CASH AT BEGINNING OF PERIOD   117,547    670,423 
           
CASH AT END OF PERIOD  $8,889   $191,516 
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Cash paid for income taxes  $     $   
Cash paid for interest  $     $   
Stock Based Compensation Third Party  $     $65,000 
           
Stock Issued for Receivables  $     $   
Stock Issued for Acquisition  $     $   

 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

6
 

 

  

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 1. Principles of Consolidation.

 

The unaudited condensed consolidated financial statements for the nine and three months ended September 30, 2023, and 2022 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

Note 2. Description of Business.

 

American Cannabis Company, Inc. and its wholly-owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado, and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On March 11, 2021, the Company entered into a material definitive agreement to acquire the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado. The material definitive agreement closed on April 29, 2021.

 

Naturaleaf sold and assigned to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000. See Note 4.

 

On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store); City of Colorado Springs License No. 0850714L in exchange for $100,000. The closing of the transaction is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its associated operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO. The Company will continue to occupy the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership. The Company is not obligated to pay rent at the location pending the closing of the transaction.

 

On October 5, 2023, the Company determined to voluntarily surrender License No.4070001. The effect of the surrender cancels, terminates, and annuls the Company's Marijuana Business License and related license privileges. Since the Company's acquisition of the subject license, it has never used or had any operations under the subject license.

 

Note 3. Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

7
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for (a) the financial position, (b) the result of operations, and (c) cash flows have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and we expect these trends to continue into the foreseeable future.

 

As of the date of this Quarterly Report on Form 10-Q, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would be required to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

 

8
 

 

 AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have been successful in accessing capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit and recurring losses and expects continuing future losses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds during the nine months ended September 30, 2023, and the year ended December 31, 2022, has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception but expects these conditions to improve as it develops its business model. The Company has an accumulated deficit at September 30, 2023, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

  

9
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.

 

10
 

  

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of September 30, 2023, and December 31, 2022, the Company had cash balances within of FDIC-insured limits of $250,000.

 

Accounts Receivable

 

Accounts receivables are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness, and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client’s inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of September 30, 2023, and December 31, 2022, the Company’s allowance for doubtful accounts was $4,070 and $4,071, respectively. The Company recorded a bad debt expense of $12,000 in the three months ending September 30, 2023. No bad debt expense was recorded for the similar period in 2022.

 

Deposits

 

Deposits comprise advance payments made to third parties for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory and then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory comprises products and equipment the Company owns to be sold to end customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in, first-out, and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of September 30, 2023, and December 31, 2022, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third-party vendors for retail sales at dispensaries are determined using the first in, first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production-related depreciation, and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At September 30, 2023, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

  

11
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods, which approximate the life of the contract or service period.

 

Significant Clients and Customers

 

During the nine months ended September 30, 2023, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the nine months ended September 30, 2022, three customers accounted for 42.5% of the Company’s total revenues.

 

Property and Equipment, net

 

Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of September 30, 2023, and December 31, 2022.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company recognized goodwill of $1,332,113 during the year ended December 31, 2022, as part of the Naturaleaf Acquisition.

 

The Company does not have any other indefinite-lived intangible assets. 

 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” the impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

  

12
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Intangible Assets, net

 

Definite life intangible assets at September 30, 2023, include licenses and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the nine months ended September 30, 2023, the Company recognized a depreciation and amortization expense of $42,618.

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management’s estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of September 30, 2023, and December 31, 2022.

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606).

  

13
 

 

 AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter contracts with customers that identify a single or few distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods, and accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following five steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.
     

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients' deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months that ended September 30, 2023, and 2022, sales returns were $0.

 

14
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by several factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the six months ended September 30, 2023, and 2022, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

15
 

   

 AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time permitted under the Company’s credit policy. Sales discounts were not material during the three or nine months ended September 30, 2023.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total purchase amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general, and administrative expenses are charged to expenses as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expenses and are expensed as incurred. During the nine months ended September 30, 2023, and 2022, these expenses were $169,059 and $165,544, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of the cost of revenues.

 

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The grant's fair value is based on the stock price on the grant date. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which has been one year from the grant date. During the nine months ended September 30, 2023, and 2022, stock-based compensation expense for restricted shares for Company employees was $17,021 and $121,479, respectively.

 

Research and Development

 

As a component of our equipment and supplies offerings, from time to time, we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include but are not limited to The Satchel™, Cultivation Cube™, So-Hum Living Soils™, and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the nine months ending September 30, 2023, and 2022, our research and development costs were de minimis.

  

16
 

  

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since its inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of September 30, 2023, and December 31, 2022, we had no liabilities related to federal income taxes, and the carrying value of our federal deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share.” This statement requires a dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise, or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

  

17
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Impact of COVID-19 Pandemic

 

On March 11, 2020the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

  

18
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 4. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expenses certain legal, auditing and licensing costs with the acquisition of $83,095. 

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

 

Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company’s stated intentions and strategy. Other assets include inventory and fixed assets.

 

19
 

 

 

 

During the year ended December 31, 2022, the Company finalized its valuation of Naturaleaf tangible and intangible assets and goodwill as of the acquisition date. The following table summarizes the final fair value allocation of the purchase price as of April 30, 2021:

 

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   800,000 
Total Intangible Assets   1,460,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 

 

On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store) and City of Colorado Springs License No. 0850714L in exchange for $100,000. The transaction's closing is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO location. The Company will continue to rent the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership.

 

During the nine months ended September 30, 2023, and 2022, the Company recognized an amortization expense of $138,999 and $70,000, respectively.

20
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 5. Accounts Receivable and Advance from Clients    

 

Accounts receivable were comprised of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Accounts Receivable – Trade  $206,557   $469,111 
Less:  Allowance for Doubtful Accounts   (4,070)   (4,071)
Accounts Receivable, net  $202,487   $465,040 

 

The Company had bad debt expenses during the nine months ended September 30, 2023, and 2022 of $12,000 and $0, respectively.

21
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Our Advances from Clients had the following activity:

 

       
   Sept. 30,
2023
  December 31,
2022
Beginning Balance  $156,213   $111,892 
  Additional deposits received   8,929    691,769 
  Less: Deposits recognized as revenue   (109,875)   (522,663)
Ending Balance  $55,267   $280,705 

 

Note 6. Inventory

 

Inventory consisted of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Raw Materials - Soil  $7,272   $38,464 
Work In Process - Cultivation   473,587    206,306 
Finished Goods - Soil   817    66,557 
Finished Goods - Cannabis Retail   36,612    41,644 
Total Inventory  $518,288   $352,971 

 

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 

   Sept. 30,
2023
  December 31,
2022
Office equipment  $47,380   $47,380 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   517,510    364,520 
Property and equipment, gross  $580,422   $427,432 
Less: Accumulated Depreciation   (156,268)   (113,650)
Property and equipment, net  $424,155   $313,782 

 

 

22
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 8. Intangibles Assets, Net

 

A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below: 

            
   Sept. 30, 2023
   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $800,000   ($174,522)  $625,448    15 years 
Brand  $660,000   ($219,669)  $440,331    5 years 
Patent Applications  $18,464         $18,464    —   
Total intangible assets, net  $1,478,464   ($347,888)  $1,130,576    

 

 

 

 

  

 

December 31, 2022

   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $818,464   ($134,522)  $683,912   15 years
Brand  $660,000   ($120,670)  $539,330   5 years
Total intangible assets, net  $1,488,464   ($255,222)  $1,233,242    

 

 

The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately 11.47 years. No intangible assets were acquired during the nine months ending September 30, 2023.

 

Amortization expense for intangible assets was $139,000 and $72,520 for the nine months ended September 30, 2023 and 2022, respectively. The total estimated amortization expense for our intangible assets for the years 2022 through 2026 is as follows:

 

 

       
5 years License Brand Total
2022 25,000.00  45,000  70,000.00 
2023 33,333.33  60,000  93,333.33 
2024 33,333.33  60,000  93,333.33 
2025 33,333.33  60,000  93,333.33 
2026 33,333.33  20,000  53,333.33 
Thereafter 311,111.35    311,111.35 
  652,885.76  471,669  1,124,555.07

 

23
 

 

Note 9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Accrued Interest  $114,658   $39,130 
Accrued Payroll   32,628    22,029 
Sales Tax Payable   13,987    3,931 
Other Accrued Expenses & Payables   330,442    168,258 
Accrued and other current liabilities  $491,715   $233,248 

 

Note 10. Stock Payable

 

The following summarizes the changes in common stock payable:

 

    
   Amount
December 31, 2022  $74,342 
    Additional Expenses Incurred     
    Payments Upon Issuance of Shares   17,934 
Sept. 30, 2023  $56,408 

 

Note 11. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance, and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 

As a result of our acquisition of Naturaleaf, we assumed the following leases and contingent extensions:

 

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of an extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022, until April 30, 2027. The Company's monthly rental payments from January 1, 2022, to May 1, 2022, were $3,700. From May 1, 2022, through the year ending December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022, to April 30, 2023, $3,875 May 1, 2023, to April 30, 2024, $4,050 May 1, 2024, to April 30, 2025, $4,225 May 1, 2025, to April 30, 2026, $4,400 May 1, 2026, to April 30, 2027, $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a month-to month lease with a monthly rent of $5,000.

  

24
 

 

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

 

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered an extension of the lease for a term of thirty-six months, beginning June 1, 2022, and terminating on June 1, 2024. On December 31, 2022, the monthly rent was $11,000. Rental payments due for the extended period are: June 1, 2022, to June 1, 2023, $11,000 June 1, 2023, to June 1, 2024, $11,880 June 1, 2025, to June 1, 2025, $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830

 

On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation, that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accommodation, and the membership fee will be recognized on a monthly straight-line basis.

 

On May 1, 2021, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases on September 30, 2023, was 12.5%. Leases often include rental escalation clauses, renewal options, and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.

 

As of September 30, 2023, the aggregate remaining annual lease payments of operating lease liabilities are as follows: 

 

       
    Operating
Leases
 
2023     519,244  
Total     519,244  
Less: amount representing interest     ( )
Present value of future minimum lease payments     519,244  
Less: current obligations under leases     191,539  
Long-term lease obligations   $ (327,705

 

 

25
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 12. Loans Payable 

 

Naturaleaf Seller Note

 

As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note originally had a term of 1 year with a due date of April 30, 2022, and did not require any payments prior to the due date. The note had an annual interest rate of 10%.

 

On April 30, 2022, the Company entered into an Amendment ("First Amendment") to the Asset Purchase Agreement to amend the Seller Note as follows; the due date of the Note was extended to April 30, 2023, and interest will accrue on the outstanding principal at a rate of 12.5%. In addition, the Company agreed to pay all accrued interest at April 30, 2022, and make a principal payment of $500,000. On April 29, 2022, principal in the amount of $550,000 and accrued interest of $110,000 was paid. At September 30, 2022, principal in the amount of $550,000 was outstanding, and interest of $9,493 had been accrued.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

Note 13. Related Party Transactions

 

On February 14, 2023, the Company issued a second promissory note in exchange for $100,000 to its CEO and CFO Ellis Smith. The note is not convertible and matures on August 14, 2023. The note carries 15% interest per annum. No principal or interest has been paid on this note.

 

On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due. No principal or interest has been paid on this note.

26
 

 

 AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

Note 14. Stock-Based Compensation

 

During the three and nine months ending September 30, 2023, the Company issued 79,250,000 shares of common stock and 81,425,000 shares of common stock, respectively, as compensation for consultants, employees, and service providers per its 2015 Equity Incentive Plan.

27
 

 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

   

 

Note 15. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $ 0.00001 par value. No shares of preferred stock were issued and outstanding at September 30, 2023, and December 31, 2022, respectively.

 

Common Stock

 

American Cannabis Company, Inc. is authorized to issue 500,000,000 shares of common stock at 0.00001 par value. At September 30, 2023, 171,402,938 shares were outstanding.

 

During the three and nine months ended September 30, 2023, the Company issued 79,250,000 shares of common stock and 81,425,000 shares of common stock, respectively.

    

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same. At September 30, 2023, the Company did not have any warrants or options issued and outstanding.

 

Note 16. Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company expenses legal fees in the period in which they are incurred.

28
 

 

AMERICAN CANNABIS COMPANY, INC.  

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS  

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 

 

 

 

Note 17. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after unaudited consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the nine months ended September 30, 2023, and did not find any events.

 

29
 

 

 

  ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

   

The statements contained in this report that are not statements of historical fact, including, without limitation, statements containing the words “believes,” “expects,” “anticipates,” and similar words constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time, we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

 

Government Regulation

 

Currently, thirty-six states plus the District of Columbia have laws and/or regulations that recognize, in one form or another, legitimate medical uses for cannabis and consumer use of cannabis in connection with medical treatment. Currently, sixteen states and the District of Columbia allow recreational use of cannabis. As of September 30, 2023, the policy and regulations of the Federal Government and its agencies are that cannabis has no medical benefit and a range of activities, including cultivation and use of cannabis for personal use, is prohibited based on federal law and may or may not be permitted based on state law. Active enforcement of the current federal regulatory position on cannabis on a regional or national basis may directly and adversely affect the willingness of customers of the Company’s medicinal cannabis products to invest in or buy products. Active enforcement of the current federal regulatory position on cannabis may thus indirectly and adversely affect the revenues and profits of the Company.

 

Our discussion and analysis of our financial condition and results of operations are based upon our unaudited condensed consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these unaudited condensed consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses. On an ongoing basis, we evaluate these estimates, including those related to the useful lives of real estate assets, bad debts, impairment, net lease intangibles, contingencies, and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

BACKGROUND

 

American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully integrated business model that features end to end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been decriminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry and manufactures proprietary industry solutions, including; the Satchel™, SoHum Living Soils™, Cultivation Cube™, and the High-Density Cultivation System.™ The Company also sells third-party industry-specific products and manages a strategic group partnership that offers both exclusive and nonexclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed third-party industry-specific quoted on the OTCQB Tier under the symbol “AMMJ”.

 

Naturaleaf Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Medihemp and SLAM, respectively own fixed assets and operate two retail Medical Marijuana Centers located in Colorado Springs, Colorado. Medical Cannabis owns fixed assets and operates a retail Medical Marijuana Center located in Colorado Springs, Colorado. Medical Cannabis also owns and operates a Medical Marijuana Optional Premises Cultivation license, and a Medical Marijuana-Infused Product Manufacturer license.

 

30
 

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

As a result, the Company has expanded its business model to include the cultivation and retail sale of cannabis in the medicinal cannabis industry.

 

On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store); City of Colorado Springs License No. 0850714L in exchange for $100,000. As of May 31, 2023, the Company discontinued its operations at the Palmer Park Boulevard, Ste. A, Colorado Springs, CO location. The Company will continue to rent the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership.

 

On October 5, 2023, the Company determined to voluntarily surrender License No.4070001. The effect of the surrender cancels, terminates, and annuls the Company's Marijuana Business License and related license privileges. Since the Company's acquisition of the subject license, it has never used or had any operations under the subject license.

 

RESULTS OF OPERATIONS

 

AMERICAN CANNABIS COMPANY, INC. 

CONSOLIDATED STATEMENTS OF OPERATIONS   

 

   For the Nine Months Ended   
   Sept. 30,  Sept. 30,  Increase
   2023  2022  (Decrease)
Revenues         
Consulting Services  $637,028   $308,872    328,156 
Product & Equipment   986,000    6,540,558    (5,554,558)
Cannabis Products   571,976    638,316    (66,340)
Total Revenues   2,195,004    7,487,746    (5,292,742)
                
Cost of Revenues               
Cost of Consulting Services   115,085    67,422    47,663 
Cost of Products and Equipment   695,464    5,628,432    (4,932,968)
Cost of Cannabis Products   462,823    724,529    (261,706)
Total Cost of Revenues   1,273,373    6,420,383    (5,498,752)
Gross Profit   921,631    1,067,363    (975,202)
                
Operating Expenses             —   
General and Administrative   1,408,029    1,951,008    (542,979)
Selling and Marketing   169,059    165,544    3,515 
Stock Based Compensation Expense   17,021    121,479    (104,458)
Total Operating Expenses   1,594,109    2,238,032    (643,923)
Loss from Operations   (672,477)   (1,170,668)   (498,191)
                
Other Income (Expense)               
Interest (expense)   (93,054)   32,024    (61,030)
Debt Forgiveness   —      —      —   
Other income   187,216    1,799    185,417 
Total Other (Expense) Income   94,162    80,040    14,122 
Net Loss   (578,316)   (1,090,628)   (512,312)
Income Tax Expense   —      —      —   
NET LOSS  $(578,316)  $(1,090,628)   (512,312)

 

 

31
 

 

 

Revenues

 

Total revenues were $2,195,004 for the nine months ending September 30, 2023, compared to $7,487,746 for the nine months ending September 30, 2022. The decrease in total revenue of $5,292,742 represents a decrease in the revenue streams from the sale of equipment of $5,554,558.

 

Total revenues were $599,980 for the three months ending September 30, 2023, compared to $2,123,616 for the three months ending September 30, 2023. The decrease in total revenue of $1,523,636 for the three months ended September 30, 2023, represents a decrease in equipment sales.

 

Our industry is subject to cyclical trends, often driven by macroeconomic factors and the timing of projects in our markets. In this reporting period, we encountered a phase of cyclical downturns in equipment sales. Several key factors contributed to this decline:

 

Project Progress and Completion: A significant portion of our revenue is derived from equipment sales to clients involved in various construction and infrastructure projects in various stages of completion. During this period, several of these projects were either delayed or reached their completion stages, resulting in reduced demand for equipment.

 

Reduced Capital Expenditures: In response to the completion of these projects, either in full or partially, many of our clients reduced their capital expenditures, including equipment acquisitions, leading to decreased sales volume.

 

Economic Factors: The broader economic environment also played a role in the reduced demand for and ability to pay for equipment, as economic uncertainties and market conditions influenced our clients' spending decisions.

 

Costs of Revenues

 

Costs of revenues primarily consist of labor, travel, cost of equipment, and other costs directly attributable to providing equipment, soil, and cannabis products. Costs of revenues related to our cannabis products include cultivation costs, including labor, utilities, supplies, and cultivation facility rent. During the nine months ended September 30, 2023, our total costs of revenues were $1,273,373 compared to $6,420,383 for the nine months ended September 30, 2022. The decrease of $5,147,010 in cost of revenues was a direct result of decreases in costs associated with equipment sales.

 

During the three months ended September 30, 2023, our total costs of revenues were $351,154 compared to $1,864,436 for the three months ended September 30, 2022. The decrease of $1,513,282 in cost of revenues was a direct result of decreased costs associated with equipment sales.

 

Consulting Services

 

Consulting service revenues during the nine months ended September 30, 2023, were $637,028 and $308,872 for the nine months ended September 30, 2022, respectively. Increases in consulting services result from the number and size of the type of projects worked on in the third quarter compared to the projects in the same quarter of 2022. Projects over the first nine months of 2023 focused on assisting with licensing and providing proforma and design services. The first nine months of 2023 saw an increase in projects overseeing and managing projects involving the implementation of design work provided for certain clients. As a result, while equipment sales decreased over the prior period, we saw an increase in consulting sales over the prior period.

 

Costs of consulting services were $12,000 compared to $19,500 for the three months ended September 30, 2023, and 2022, and $115,085 and $67,422 during the nine months ended September 30, 2023, and 2022, respectively. Costs associated with consulting services decreased due to the decrease in payroll expenses allocated to the cost of services.

 

32
 

Product and Equipment Revenues

 

Our product and equipment revenues for the nine months ended September 30, 2023, were $986,000 compared to $6,540,558 for the nine months ended September 30, 2022, and $218,242, and $1,866,725 for the three months ended September 30, 2023, and 2022, respectively. Decreases in product and equipment product sales were the result of trends in our revenue profile resulting from a correlation between increased consulting revenues and the initiation of new projects, particularly in the initial planning and development phases, and corresponding decreases our product and equipment revenues.

 

Costs of Products and Equipment were $695,464 and $5,628,432 during the nine months ended September 30, 2023, and 2022, respectively. Decreased costs were the result of lower associated with products and equipment sales.

 

Cannabis Product Revenues

 

Cannabis product revenues during the three months ended September 30, 2023, and 2022 were $213,120 and $190,067, respectively. During the nine months ended September 30, 2023, and 2022, cannabis product revenues were $571,976 and $638,316, respectively. The decrease in cannabis product revenues, which amounted to $66,340 for the nine months ended September 30, is primarily attributed to reduced sales during the period.

 

Costs associated with cannabis products consist of those costs incurred in the cultivation of the plants and the retail sale of the products. During the three months ended September 30, 2023, and 2022, such costs were $151,335 and $180,701. During the nine months ended September 30, 2023, and 2022, such costs were $462,823 and $724,529, respectively. The respective decreases in costs of $170,095 and $186,057 reflect decreased investment in infrastructure remodeling and upgrades.

 

Gross Profit

 

Total gross profits were $248,717 for the three months ended September 30, 2023, comprised of consulting services gross profit of $156,528, products and equipment gross profit of $30,424, and a gross profit of $61,765 for cannabis products. This compares to a total gross profit of $259,180 for the three months ended September 30, 2022, comprised of consulting services gross profit of $47,324, products and equipment gross profit of $202,490, and a gross profit of $9,366 for cannabis products.

 

Total gross profits were $921,631 for the nine months ended September 30, 2023, comprised of consulting services gross profits of $365,415, products and equipment gross profit of $230,112, and a gross profit of ($9,952). This compares to a total gross profit for the nine months ended September 30, 2022, of $1,067,363, comprised of consulting services gross profits of $241,450, products and equipment gross profit of $912,126, and cannabis products gross profits of ($86,213).

 

Operating Expenses

 

Total operating expenses were $1,594,109 for the nine months ended September 30, 2023, and $2,238,032 for the nine months ended September 30, 2022. The decrease of $643,923 in operating expenses is attributed to lower general and administrative expenses associated with maintaining the operations. The Company has seen additional increases in depreciation and amortization expenses, sales, and marketing expenses during the period. 

 

33
 

 

Other Income (Expense)

 

Other income (expense) for the nine months ending September 30, 2023, was $(93,054) compared with $32,024 for the nine months ending September 30, 2022.

 

Net Loss

 

Net loss for the nine months ending September 30, 2023, was ($578,316) compared to a net loss of ($1,090,628) for the nine months ending September 30, 2022.

 

Net loss for the three months ending September 30, 2023, was ($157,158) compared to a net loss of ($397,650) for the three months ending September 30, 2022.

 

 

LIQUIDITY AND CAPITAL RESOURCES

 

As of September 30, 2023, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $8,889 and accounts receivable of $202,487. Additionally, considering that our fixed overhead costs have decreased over 2023, management has instigated and continues to investigate opportunities for financing to support operations and growth. Management believes this strategy will adequately provide the necessary liquidity and capital resources to fund our operational, general and administrative expenses for at least the next 12 months.

  

Operating Activities

 

Net cash provided by operating activities for the nine months ended September 30, 2023, was ($330,548), compared to net cash used by operating activities of $68,780, for the nine months ended September 30, 2022. Increases in cash used resulted from decreased accounts receivable by increases in accounts payable. All a direct result of the decreased activities in equipment sales.

 

During the nine months ending September 30, 2023, the Company previously entered into consulting projects focused on constructing or improving cultivation facilities. The Company anticipates seeing greater activity in consulting and related equipment sales and, therefore, will see significant changes in advances from clients and other associated balance sheet accounts, such as prepaid expenses, accounts receivable, and accounts payable. In the case of equipment sales, the Company purchases the required equipment from 3rd party suppliers. Equipment purchases are not made until the Client has approved the estimates, been invoiced, and paid the invoice. The Company will not recognize these revenues until the equipment has been delivered to and received by the client.

 

Investing Activities

 

For the nine months ended September 30, 2023, and 2022, investing activities were a use of cash of ($39,101) and ($115,316) respectively. These funds were used to purchase property and equipment, furniture and fixtures, and office equipment.

 

Financing Activities

 

During the nine months ended September 30, 2023, proceeds used in financing activities were $260,991, and ($432,371) for the nine months ended September 30, 2022. Funds received during the nine months ended September 30, 2023, were proceeds from notes.

 

34
 

 

Off Balance Sheet Arrangements

 

As of September 30, 2023, and December 31, 2022, we did not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Non-GAAP Financial Measures

 

Adjusted EBITDA, a Non-GAAP metric, is used to monitor our overall business performance. We define Adjusted EBITDA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation, and certain nonrecurring expenses, which have been limited to costs associated with the Reverse Merger. We believe such adjustments to arrive at Adjusted EBITDA provide us with a comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in evaluating our Company.  

 

A reconciliation of net income(loss) to Adjusted EBITDA is provided below:

 

      Nine Months    
    Ended Sept. 30, 2023     Ended Sept. 30, 2022  
             
Adjusted EBITDA reconciliation:                
Net loss   $ (578,316 )   $ (1,090,628 )
Depreciation and Amortization     181,618       113,362  
Interest Expense     93,054       32,024  
Stock-based compensation for services     -       29,792  
Stock-based compensation to employees     17,021       65,309  
Adjusted EBITDA   $ (286,623 )   $ (487,189 )

 

ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

We maintain disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) that are designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer/Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

 

We carried out an evaluation under the supervision and with the participation of management, including our Chief Executive Officer/Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2023, the end of the period covered by this Report.  Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective at the reasonable assurance level due to the material weaknesses discussed below. 

 

35
 

 

Internal Control over Financial Reporting

 

Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) promulgated under the Exchange Act as a process designed by, or under the supervision of, our principal executive officer and principal financial officer and effected by the Board, management, and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP and includes those policies and procedures that:

 

opertain to the maintenance of records that in reasonable detail accurately and fairly reflect the transactions and dispositions of our assets,
oprovide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and,
oprovide reasonable assurance regarding the prevention or timely detection of unauthorized acquisition, use, or disposition of our assets that could have a material effect on the financial statements.

 

Because of our inherent limitations, our internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Projections of any effectiveness evaluation to future periods are subject to the risk that controls may become inadequate because of changes in conditions or that the degree of compliance with the policies or procedures may deteriorate.

 

Management identified the following material weaknesses:

 

·we do not have an Audit Committee – While not being legally obligated to have an Audit Committee, it is the management’s view that such a committee, including a financial expert board member, is an utmost important entity level control of the Company’s financial statements. Currently the Board of Directors acts in the capacity of the Audit Committee and does not include a member that is considered to be independent of management to provide the necessary oversight over management’s activities.

 

  we have not performed a risk assessment and mapped our processes to control objectives.

 

  we have not implemented comprehensive entity-level internal controls.

 

  we have not implemented adequate system and manual controls; and

 

  we do not have sufficient segregation of duties.

 

Our management assessed the effectiveness of internal control over financial reporting as of September 30, 2023.  In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organization of the Treadway Commission (“COSO”) in Internal Control–Integrated Framework (2013).  Based on management’s assessment, management concluded that the above material weaknesses have not been remediated and, accordingly, our internal control over financial reporting is not effective as of September 30, 2023. 

 

36
 

 

 

 

Remediation of Material Weaknesses

 

We have designed and plan to implement, or in some cases have already implemented, the specific remediation initiatives described below:

 

● We intend to allocate resources to perform a risk assessment and map processes to control objectives and, where necessary, implement and document internal controls in accordance with COSO.

  

● Our entity-level controls are generally informal, and we intend to evaluate current processes, supplement where necessary, and document requirements.  

 

● While we have implemented procedures to identify, evaluate and record significant transactions, we need to formally document these procedures and evidence the performance of the related controls.  

 

● We plan to evaluate system and manual controls, identify specific weaknesses, and implement a comprehensive system of internal controls.

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

The following sales of unregistered securities were made in reliance upon the exemption from registration provided by Section 4(2) of the Securities Act of 1933. The recipients acquired the restricted common stock for their own account, for investment purposes, and not with a view to public resale or distribution thereof within the meaning of the Securities Act. The restricted shares cannot be sold unless pursuant to an effective registration statement by the Company or by an exemption from registration requirements of Section 5 of the Securities Act—the existence of any such exemption is subject to legal review and approval by the Company.

 

On August 30, 2023, the Company issued 1,000,000 shares of restricted common stock to SRAX, Inc. as consideration for the cancellation of a contract.

 

On August 29, 2023, the Company issued 6,250,000 shares of restricted common stock to Timothy Matula as consideration for consulting services.

 

On August 29, 2023, the Company issued 6,250,000 shares of restricted common stock to Thomas Stray as consideration for consulting services.

 

On August 29, 2023, the Company issued 6,250,000 shares of restricted common stock to Kristian Kvavik as consideration for consulting services.

 

On August 29, 2023, the Company issued 6,250,000 shares of restricted common stock to Tad Mailander as consideration for consulting services.

 

On August 24, 2023, the Company issued 100,000 shares of restricted common stock to Christine Tullio as consideration for services.

 

On August 24, 2023, the Company issued 1,000,000 shares of restricted common stock to Tad Mailander as consideration for director services under contract.

 

On August 24, 2023, the Company issued 150,000 shares of restricted common stock to Benjamin Teekell as consideration for services under contract.

 

On August 24, 2023, the Company issued 500,000 shares of restricted common stock to Jon Workman as consideration for services under contract.

 

On August 24, 2023, the Company issued 500,000 shares of restricted common stock to Tyler Schloesser as consideration for services under contract.

 

On August 24, 2023, the Company issued 10,000,000 shares of restricted common stock to Ellis Smith as consideration for services under contract.

 

 

37
 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

No senior securities were issued and outstanding during the three months ended September 30, 2023 and 2022.

  

ITEM 4. MINE SAFETY DISCLOSURES

 

Not Applicable.

 

ITEM 5. OTHER INFORMATION

 

On September 5, 2023, the Company entered into an Agreement and Plan of Merger by and among the Company, HyperScale Nexus Holding Corporation, a Nevada corporation ("HyperScale Nexus"), and its wholly owned subsidiary, HyperScale Nexus Merger Sub, a Nevada Corporation, (the “Merger Sub”), (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, (i) Merger Sub will merge with and into the Company, with the Company continuing as the "Surviving Corporation" and wholly owned subsidiary of HyperScale Nexus, and the Merger Sub will be dissolved by operation of law.

 

On September 5, 2023, pursuant to Section 9 of the Company's By-Laws and Title 8, Chapter 1, §228(a) of the Delaware General Corporation Law, shareholders beneficially owning 52.402% of the Company's voting common stock consented in writing and determined that the terms and conditions of the Agreement and Plan of Merger ("Agreement") with HyperScale Nexus Holding Corporation, previously disclosed on Form 8-K on September 5, 2023, are fair, just, and reasonable to the Company and its shareholders and that it is in the best interests of the Company and its shareholders for the Company to enter into the Agreement and all related transactions, on the terms and conditions set forth in the Agreement and all agreements and transactions contemplated thereby.

 

On September 27, 2023, pursuant to Section 8.5 of the Agreement and Plan of Merger ("Agreement") with HyperScale Nexus Holding Corporation, the parties agreed to extend the time to complete the transaction for an additional sixty days until November 29, 2023.

 

On October 30, 2023, the Company entered into a Separation and Distribution Agreement by and among the Company, HyperScale Nexus Holding Corporation, a Nevada corporation ("HyperScale Nexus"), and its wholly owned subsidiary, HyperScale Nexus Merger Sub, a Nevada Corporation, (the “Merger Sub”). The Separation Agreement is directly related and is a corollary to the Agreement and Plan of Merger entered on September 5, 2023, between the parties as disclosed on Form 8-K on September 5, 2023.

 

The Agreement and Plan of Merger provided for the (i) Merger Sub to merge with and into the Company, with the Company continuing as the "Surviving Corporation" and becoming a wholly owned subsidiary of HyperScale Nexus, whose business would constitute the primary operations of the Company, and the Merger Sub will be dissolved by operation of law.

 

The Separation and Distribution Agreement serves as a corollary to the Agreement and Plan of Merger, elucidating the details of American Cannabis Company, Inc.'s immediate and complete separation from HyperScale with prejudice as the surviving company's sole wholly owned subsidiary immediately following the closing of the merger. Its primary purpose is to demarcate the post-merger relationship between American Cannabis Company, Inc. and HyperScale, redefining their respective corporate status.

 

The transactions are pending and incomplete as of the date of this filing. 

 

 

ITEM 6. EXHIBITS

 

This list is intended to constitute the exhibit index.

 

31.1 Certification of Principal Executive & Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 Certification of Principal Executive & Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes0Oxley Act of 2002.
101.INS XBRL Instance Document*
101.SCH XBRL Taxonomy Extension Schema Document*
101.CAL XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB XBRL Taxonomy Extension Label Linkbase Document*
101.PRE XBRL Taxonomy Extension Presentation Linkbase Document*

 

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 

38
 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

AMERICAN CANNABIS COMPANY, INC.

 

Date: November 14, 2023

 

By:   /s/ Ellis Smith  

 

Ellis Smith, 

Chief Executive Officer & Chief Financial Officer

39

 

 

EX-31.1 2 ex31_1.htm

Exhibit 31.1

 

CERTIFICATION OF CHIEF EXECUTIVE & CHIEF FINANCIAL OFFICER

 

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, I, Ellis Smith, certify that:

 

  1. I have reviewed this report on Form 10-Q of American Cannabis Company, Inc., for the fiscal quarter ended September 30, 2023;

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3. Based on my knowledge, the financial statements and other financial information included in this report fairly present in all material respects the financial condition, results of operations, and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonable likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

 

 

Date: November 14, 2023

 

/s/ Ellis Smith

 

Ellis Smith

 

Chief Executive Officer

& Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EX-32.1 3 ex32_1.htm

Exhibit 32.1

 

 

CERTIFICATION PURSUANT TO

 

18 U.S.C. SECTION 1350,

 

AS ADOPTED PURSUANT TO

 

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report of American Cannabis Company, Inc. (the “Company”) on Form 10-Q for the quarter ended September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Ellis Smith, Chief Executive Officer & Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes- Oxley Act of 2002, that, to the best of my knowledge and belief:

 

  1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  2. The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

 

Date: November 14, 2023

 

/s/Ellis Smith

 

Ellis Smith

 

Chief Executive Officer &

Chief Financial Officer

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

GRAPHIC 4 image_001.jpg GRAPHIC begin 644 image_001.jpg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end EX-101.SCH 5 ammj-20230930.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - Principles of Consolidation. link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Description of Business. link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Naturaleaf Asset Acquisition link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Accounts Receivable and Advance from Clients link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Inventory link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Property and Equipment, net link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Intangibles Assets, Ne link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Accrued and Other Current Liabilities link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Stock Payable link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Loans Payable link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stock-Based Compensation link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Shareholders’ Equity link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Commitments and Contingencies link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Subsequent Events link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Inventory (Tables) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Property and Equipment, net (Tables) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Intangibles Assets, Ne (Tables) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Accrued and Other Current Liabilities (Tables) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stock Payable (Tables) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Naturaleaf Asset Acquisition (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Accounts Receivable and Advance from Clients (Details) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - Accounts Receivable and Advance from Clients (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - Inventory (Details) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - Property and Equipment net (Details) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - Intangibles Assets, Net (Details) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - Intangibles Assets, Net (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - Intangibles Assets, Ne (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - Accrued and Other Current Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - Stock Payable (Details) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - Stock-Based Compensation (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - Shareholders’ Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 ammj-20230930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 ammj-20230930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 ammj-20230930_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Subscription Receivable [Member] Retained Earnings [Member] Long-Lived Tangible Asset [Axis] Office Equipment [Member] Software Development [Member] Furniture and Fixtures [Member] Machinery and Equipment [Member] Finite-Lived Intangible Assets by Major Class [Axis] License [Member] Brand [Member] Patents [Member] Award Date [Axis] May 2022 To April 2023 [Member] May 2023 To April 2024 [Member] May 2024 To April 2025 [Member] May 2025 To April 2026 [Member] May 2026 To April 2027 [Member] January 2023 [Member] January 2024 [Member] January 2025 [Member] January 2026 [Member] January 2027 [Member] June 2022 To June 2023 [Member] June 2023 To June 2024 [Member] June 2024 To June 2025 [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Statement of Financial Position [Abstract] ASSETS Current Assets Cash and Equivalents Accounts Receivable, Net Deposits Inventory Prepaid Expenses and Other Current Assets Total Current Assets Property and Equipment - Net Other Assets Intangible Assets, net amortization Goodwill Right of Use Assets - Operating Leases, net Long Term Deposits Total Other Assets TOTAL ASSETS LIABILITIES AND SHAREHOLDERS’ EQUITY Current Liabilities Accounts Payable Advances from Clients Accrued and Other Current Liabilities Stock payable Right of Use Liabilities, current Litigation Settlement, current Note payables, current Total Current Liabilities LONG TERM LIABILITIES Litigation Settlement Right of Use Liabilities – LT LTD Note Payable TOTAL LIABILITIES Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Common stock, $0.00001 par value; 500,000,000 shares authorized; 171,402,938 and 92,152,938 shares issued and outstanding at September 30, 2023, and December 31, 2022, respectively Additional paid-in capital Accumulated deficit Total Shareholders’ Equity TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common Stock, Shares Authorized Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenues Consulting Services Product & Equipment Cannabis Products Total Revenues Cost of Revenues Cost of Consulting Services Cost of Products and Equipment Cost of Cannabis Products Total Cost of Revenues Gross Profit Operating Expenses General and Administrative Selling and Marketing Stock Based Compensation Expense Total Operating Expenses Loss from Operations Other Income (Expense) Interest (expense) Debt Forgiveness Other income Total Other (Expense) Income Net Loss Income Tax Expense NET LOSS Basic net loss per common share Basic and diluted weighted average common shares outstanding Statement [Table] Statement [Line Items] Balance, December 31, 2021 Beginning Balance, Shares Stock based compensation to employees, shares Balance, December 31, 2022 Subscription Receivable Paid Stock based compensation third party Net Loss Subscription Receivable Issued Stock based compensation to employees Stock issued for cash Stock issued for cash, Shares Stock-based compensation to service provider Stock issued to service provider Balance, June 30, 2022 Ending Balance Shares Balance, Sept. 30, 2023 Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Net Loss Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation to employees Stock-based compensation to third party Debt Forgiveness Changes in operating assets and liabilities: Accounts receivable Inventory Prepaid expenses and other current assets Right to Use Lease Asset Long Term Deposits Accounts Payable Advances from Clients Accrued and other current liabilities Litigation Settlement Liability Operating Lease Liability Net Cash Provided by (Used In) Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Purchase of property and equipment Acquisition of Assets Intangible assets Net Cash Used in Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Proceeds from sale of common stock Proceeds from note payable Payment of note payable LTD Note Payable Net Cash (Used) Provided by Financing Activities NET INCREASE IN CASH CASH AT BEGINNING OF PERIOD CASH AT END OF PERIOD SUPPLEMENTAL CASH FLOW INFORMATION: Cash paid for income taxes Cash paid for interest Stock Based Compensation Third Party Stock Issued for Receivables Stock Issued for Acquisition Accounting Policies [Abstract] Principles of Consolidation. Description of Business. Summary of Significant Accounting Policies Business Combination and Asset Acquisition [Abstract] Naturaleaf Asset Acquisition Receivables [Abstract] Accounts Receivable and Advance from Clients Inventory Disclosure [Abstract] Inventory Property, Plant and Equipment [Abstract] Property and Equipment, net Goodwill and Intangible Assets Disclosure [Abstract] Intangibles Assets, Ne Payables and Accruals [Abstract] Accrued and Other Current Liabilities Stock Payable Stock Payable Operating Lease Right-of-use Assetoperating Lease Liability Operating Lease Right-of-Use Asset/Operating Lease Liability Debt Disclosure [Abstract] Loans Payable Related Party Transactions [Abstract] Related Party Transactions Equity [Abstract] Stock-Based Compensation Shareholders’ Equity Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Subsequent Events [Abstract] Subsequent Events Basis of Accounting Unaudited Interim Financial Statements Going Concern Use of Estimates in Financial Reporting Cash and Cash Equivalents Accounts Receivable Deposits Inventory Prepaid Expenses and Other Current Assets Significant Clients and Customers Property and Equipment, net Goodwill Intangible Assets, net Accounting for the Impairment of Long-Lived Assets Fair Value Measurements Revenue Recognition Product and Equipment Sales Consulting Services Cannabis Sales Loyalty Reward Program Costs of Revenues Advertising and Promotion Costs Shipping and Handling Costs Stock-Based Compensation Research and Development Income Taxes Net Loss Per Common Share Related Party Transactions Impact of COVID-19 Pandemic Recent Accounting Pronouncements Business Combination, Segment Allocation Schedule of accounts receivable and advances from clients Schedule of advances from clients Schedule of inventory Schedule of property, plant and equipment, net Schedule of Identified intangible asset Schedule of estimated amortization expense Schedule of accrued and other current liabilities Schedule of stock payable Schedule of other operating cost and expense Schedule of operating lease liabilities FDIC-insured limits Allowance for Doubtful Accounts, Premiums and Other Receivables Bad Debt expense Depreciation and amortization expense Advertising and Promotion Costs Stock based compensation expense Current Assets Inventory Property, Plant and Equipment Other Assets Total Tangible Assets Tradenames and Trademarks Licenses Total Intangible Assets Goodwill Total Consideration Accounts Receivable, before Allowance for Credit Loss Accounts Receivable, Allowance for Credit Loss, Current Accounts Receivable, net Beginning Balance Additional deposits received Less: Deposits recognized as revenue Ending Balance Bad debt expenses Raw Materials - Soil Work In Process - Cultivation Finished Goods - Soil Finished Goods - Cannabis Retail Total Inventory Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, Plant and Equipment, Gross Less: Accumulated Depreciation Property and equipment, net Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Gross Carrying amount Accumulated amortization Carrying value Estimated useful life 2022 2023 2024 2025 2026 Thereafter   Amortization expense Accrued Interest Accrued Payroll Sales Tax Payable Other Accrued Expenses & Payables Accrued and other current liabilities Loans payable Payments Upon Issuance of Shares Other loans ayable Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Sale Leaseback Transaction, Rent Expense Sale Leaseback Transaction, Rent Expense 2023 Total Less: amount representing interest Present value of future minimum lease payments Less: current obligations under leases Long-term lease obligations Common stock issued Preferred Stock, No Par Value Coomon stock Common stock Assets, Current Other Assets [Default Label] Assets Liabilities, Current Liabilities TotalShareholdersEquity Liabilities and Equity Revenues [Default Label] CostOfRevenuesNet Gross Profit Operating Expenses [Default Label] Operating Income (Loss) DebtForgiveness Nonoperating Income (Expense) NetLoss Stockholders' Equity Attributable to Parent Shares, Outstanding StockBasedCompensationToEmployeesShares StockholdersEquity1 Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Increase (Decrease) in Accounts Receivable Increase (Decrease) in Inventories Increase (Decrease) in Prepaid Expense and Other Assets IncreaseDecreaseRightToUseLeaseAsset Increase (Decrease) in Deposits Increase (Decrease) in Accounts Payable AdvancesFromClients Property, Plant and Equipment, Disposals Payments to Acquire Property, Plant, and Equipment Increase (Decrease) in Intangible Assets, Current Net Cash Provided by (Used in) Investing Activities Payments to Acquire Notes Receivable Repayments of Notes Payable Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Inventory Disclosure [Text Block] Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] StockPayableTextBlock Deposit Contracts, Policy [Policy Text Block] Inventory, Policy [Policy Text Block] PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock Property, Plant and Equipment, Policy [Policy Text Block] Goodwill and Intangible Assets, Policy [Policy Text Block] ConsultingServicesPolicyTextBlock Share-Based Payment Arrangement [Policy Text Block] RelatedPartyTransactionsPolicyTextBlock Other Selling and Marketing Expense Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Accounts Receivable, Allowance for Credit Loss, Current Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Accounts Payable and Other Accrued Liabilities Finance Lease, Liability, Payments, Due in Next Rolling 12 Months EX-101.PRE 9 ammj-20230930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover - shares
9 Months Ended
Sep. 30, 2023
Nov. 14, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Sep. 30, 2023  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 000-26108  
Entity Registrant Name AMERICAN CANNABIS COMPANY, INC.  
Entity Central Index Key 0000945617  
Entity Tax Identification Number 90-1116625  
Entity Incorporation, State or Country Code DE  
Entity Address, Address Line One 200 Union Street  
Entity Address, Address Line Two Ste. 200  
Entity Address, City or Town Lakewood  
Entity Address, State or Province CO  
Entity Address, Postal Zip Code 80228  
City Area Code 303  
Local Phone Number 974-4770  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   171,402,938
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current Assets    
Cash and Equivalents $ 8,889 $ 117,547
Accounts Receivable, Net 202,487 469,111
Deposits 9,595 9,595
Inventory 518,288 352,971
Prepaid Expenses and Other Current Assets 64,059 73,933
Total Current Assets 803,318 1,023,157
Property and Equipment - Net 424,155 427,669
Other Assets    
Intangible Assets, net amortization 1,084,242 1,223,242
Goodwill 1,332,113 1,332,113
Right of Use Assets - Operating Leases, net 519,244 604,020
Long Term Deposits 6,000 6,000
Total Other Assets 2,941,599 3,165,375
TOTAL ASSETS 4,169,072 4,616,201
Current Liabilities    
Accounts Payable 934,978 679,163
Advances from Clients 55,267 280,705
Accrued and Other Current Liabilities 491,715 233,348
Stock payable 17,021 74,343
Right of Use Liabilities, current 191,539 181,661
Litigation Settlement, current 75,000 100,000
Note payables, current 300,000 550,000
Total Current Liabilities 2,065,520 2,099,220
LONG TERM LIABILITIES    
Litigation Settlement 75,000
Right of Use Liabilities – LT 327,705 422,359
LTD Note Payable 410,198 150,000
TOTAL LIABILITIES 2,803,423 2,746,579
Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively
Common stock, $0.00001 par value; 500,000,000 shares authorized; 171,402,938 and 92,152,938 shares issued and outstanding at September 30, 2023, and December 31, 2022, respectively 1,715 922
Additional paid-in capital 12,022,958 11,949,409
Accumulated deficit (10,659,024) (10,080,709)
Total Shareholders’ Equity 1,365,649 1,869,622
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY $ 4,169,072 $ 4,616,201
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Preferred Stock, Par or Stated Value Per Share $ 0.01 $ 0.01
Preferred Stock, Shares Authorized 5,000,000 5,000,000
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Par or Stated Value Per Share $ 0.00001 $ 0.00001
Common Stock, Shares Authorized 500,000,000 500,000,000
Common Stock, Shares, Issued 171,402,938 92,152,938
Common Stock, Shares, Outstanding 171,402,938 92,152,938
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues        
Consulting Services $ 168,528 $ 66,824 $ 637,028 $ 308,872
Product & Equipment 218,242 1,866,725 986,000 6,540,558
Cannabis Products 213,120 190,067 571,976 638,316
Total Revenues 599,890 2,123,616 2,195,004 7,487,746
Cost of Revenues        
Cost of Consulting Services 12,000 19,500 115,085 67,422
Cost of Products and Equipment 187,818 1,664,235 695,464 5,628,432
Cost of Cannabis Products 151,335 180,701 462,823 724,529
Total Cost of Revenues 351,154 1,864,436 1,273,373 6,420,383
Gross Profit 248,717 259,180 921,631 1,067,363
Operating Expenses        
General and Administrative 326,429 617,270 1,408,209 1,951,008
Selling and Marketing 51,675 64,017 169,059 165,544
Stock Based Compensation Expense 56,170 17,021 121,479
Total Operating Expenses 378,104 737,457 1,594,109 2,238,031
Loss from Operations (129,367) (478,277) (672,477) (1,170,668)
Other Income (Expense)        
Interest (expense) (28,690) 77,381 (93,054) (32,024)
Debt Forgiveness
Other income 900 3,246 187,216 48,016
Total Other (Expense) Income (27,791) 80,627 94,162 80,040
Net Loss 11,844 (170,803) (451,156) (692,978)
Income Tax Expense
NET LOSS $ (157,158) $ (397,650) $ (578,316) $ (1,090,628)
Basic net loss per common share $ (0) $ (0) $ (0.01) $ (0.01)
Basic and diluted weighted average common shares outstanding 85,727,938 85,727,938 84,795,246 84,795,246
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Subscription Receivable [Member]
Retained Earnings [Member]
Total
Balance, December 31, 2021 at Dec. 31, 2021 $ 819 $ 11,565,679 $ (9,447,517) $ 2,118,981
Beginning Balance, Shares at Dec. 31, 2021 81,902,938        
Stock based compensation to employees, shares at Dec. 31, 2021 325,000        
Net Loss (1,090,628) (1,090,628)
Stock based compensation to employees 3 46,204 46,207
Stock issued for cash $ 25 117,603 142,793
Stock issued for cash, Shares 2,500,000        
Stock-based compensation to service provider $ 10 64,990 65,000
Stock issued to service provider 1,000,000        
Balance, June 30, 2022 at Sep. 30, 2022 $ 857 11,794,476 (10,538,145) 1,257,188
Ending Balance Shares at Sep. 30, 2022 85,727,938        
Balance, December 31, 2021 at Jun. 30, 2022 $ 857 11,794,476 0 (10,140,495) 1,654,838
Beginning Balance, Shares at Jun. 30, 2022 85,727,938        
Subscription Receivable Paid $ 0 0 0 0 0
Stock based compensation third party 0 0 0 0 65,000
Net Loss (397,650) (397,650)
Balance, June 30, 2022 at Sep. 30, 2022 $ 857 11,794,476 (10,538,145) 1,257,188
Ending Balance Shares at Sep. 30, 2022 85,727,938        
Beginning Balance, Shares at Dec. 31, 2022 92,152,938        
Balance, December 31, 2022 at Dec. 31, 2022 $ 922 11,949,409 (10,080,709) 1,869,622
Net Loss (578,316) (578,316)
Stock based compensation to employees 74,342 74,342
Stock issued for cash
Stock-based compensation to service provider 793 (793)
Balance, June 30, 2022 at Sep. 30, 2023 $ 922 12,023,751 (10,700,867) 1,323,806
Ending Balance Shares at Sep. 30, 2023 171,402,938        
Balance, Sept. 30, 2023 at Sep. 30, 2023 $ 922 12,022,958 (10,659,025) 1,365,648
Balance, December 31, 2021 at Jun. 30, 2023 $ 922 12,023,751 0 (10,543,709) 1,480,694
Beginning Balance, Shares at Jun. 30, 2023 92,152,938        
Net Loss (157,158) (157,158)
Subscription Receivable Issued 0 0 0
Stock based compensation to employees 0 0 0
Stock issued for cash $ 0 0 0
Stock issued for cash, Shares 92,152,938        
Balance, June 30, 2022 at Sep. 30, 2023 $ 922 12,023,751 (10,700,867) 1,323,806
Ending Balance Shares at Sep. 30, 2023 171,402,938        
Balance, Sept. 30, 2023 at Sep. 30, 2023 $ 922 $ 12,022,958 $ (10,659,025) $ 1,365,648
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES    
Net Loss $ (578,315) $ (1,090,628)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 181,617 113,362
Stock-based compensation to employees (793) 65,306
Stock-based compensation to third party 29,792
Debt Forgiveness
Changes in operating assets and liabilities:    
Accounts receivable 266,624 (248,610)
Inventory (165,317) (73,886)
Prepaid expenses and other current assets 9,872 (55,232)
Right to Use Lease Asset 84,776 (116,191)
Long Term Deposits
Accounts Payable 255,815 211,059
Advances from Clients (225,438) 1,279,080
Accrued and other current liabilities 25,387 (11,463)
Litigation Settlement Liability (100,000) (150,000)
Operating Lease Liability (84,776) 116,191
Net Cash Provided by (Used In) Operating Activities (330,548) 68,780
CASH FLOWS FROM INVESTING ACTIVITIES:    
Purchase of property and equipment (39,101) (105,011)
Acquisition of Assets
Intangible assets (10,305)
Net Cash Used in Investing Activities (39,101) (115,316)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from sale of common stock 793 117,629
Proceeds from note payable
Payment of note payable (550,000)
LTD Note Payable 260,198
Net Cash (Used) Provided by Financing Activities 260,991 (432,371)
NET INCREASE IN CASH (108,658) (478,907)
CASH AT BEGINNING OF PERIOD 117,547 670,423
CASH AT END OF PERIOD 8,889 191,516
SUPPLEMENTAL CASH FLOW INFORMATION:    
Cash paid for income taxes
Cash paid for interest
Stock Based Compensation Third Party 65,000
Stock Issued for Receivables
Stock Issued for Acquisition
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Principles of Consolidation.
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Principles of Consolidation.

Note 1. Principles of Consolidation.

 

The unaudited condensed consolidated financial statements for the nine and three months ended September 30, 2023, and 2022 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister & Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.

 

XML 17 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Description of Business.
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Description of Business.

Note 2. Description of Business.

 

American Cannabis Company, Inc. and its wholly-owned subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado, and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.

 

On March 11, 2021, the Company entered into a material definitive agreement to acquire the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado. The material definitive agreement closed on April 29, 2021.

 

Naturaleaf sold and assigned to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000. See Note 4.

 

On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store); City of Colorado Springs License No. 0850714L in exchange for $100,000. The closing of the transaction is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its associated operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO. The Company will continue to occupy the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership. The Company is not obligated to pay rent at the location pending the closing of the transaction.

 

On October 5, 2023, the Company determined to voluntarily surrender License No.4070001. The effect of the surrender cancels, terminates, and annuls the Company's Marijuana Business License and related license privileges. Since the Company's acquisition of the subject license, it has never used or had any operations under the subject license.

 

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 3. Summary of Significant Accounting Policies

 

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

 

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for (a) the financial position, (b) the result of operations, and (c) cash flows have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and we expect these trends to continue into the foreseeable future.

 

As of the date of this Quarterly Report on Form 10-Q, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would be required to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

 

 

There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have been successful in accessing capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit and recurring losses and expects continuing future losses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds during the nine months ended September 30, 2023, and the year ended December 31, 2022, has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception but expects these conditions to improve as it develops its business model. The Company has an accumulated deficit at September 30, 2023, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

  

 

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.

 

 

 

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of September 30, 2023, and December 31, 2022, the Company had cash balances within of FDIC-insured limits of $250,000.

 

Accounts Receivable

 

Accounts receivables are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness, and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client’s inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of September 30, 2023, and December 31, 2022, the Company’s allowance for doubtful accounts was $4,070 and $4,071, respectively. The Company recorded a bad debt expense of $12,000 in the three months ending September 30, 2023. No bad debt expense was recorded for the similar period in 2022.

 

Deposits

 

Deposits comprise advance payments made to third parties for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory and then recognized as a cost of revenues upon sale.

 

Inventory

 

Inventory comprises products and equipment the Company owns to be sold to end customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in, first-out, and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of September 30, 2023, and December 31, 2022, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third-party vendors for retail sales at dispensaries are determined using the first in, first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production-related depreciation, and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At September 30, 2023, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

  

 

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods, which approximate the life of the contract or service period.

 

Significant Clients and Customers

 

During the nine months ended September 30, 2023, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the nine months ended September 30, 2022, three customers accounted for 42.5% of the Company’s total revenues.

 

Property and Equipment, net

 

Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of September 30, 2023, and December 31, 2022.

 

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company recognized goodwill of $1,332,113 during the year ended December 31, 2022, as part of the Naturaleaf Acquisition.

 

The Company does not have any other indefinite-lived intangible assets. 

 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” the impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

  

 

 

Intangible Assets, net

 

Definite life intangible assets at September 30, 2023, include licenses and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the nine months ended September 30, 2023, the Company recognized a depreciation and amortization expense of $42,618.

 

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management’s estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of September 30, 2023, and December 31, 2022.

 

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606).

  

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter contracts with customers that identify a single or few distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods, and accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following five steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.
     

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients' deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months that ended September 30, 2023, and 2022, sales returns were $0.

 

 

 

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by several factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the six months ended September 30, 2023, and 2022, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

 

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time permitted under the Company’s credit policy. Sales discounts were not material during the three or nine months ended September 30, 2023.

 

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total purchase amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general, and administrative expenses are charged to expenses as incurred.

 

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expenses and are expensed as incurred. During the nine months ended September 30, 2023, and 2022, these expenses were $169,059 and $165,544, respectively.

 

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of the cost of revenues.

 

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The grant's fair value is based on the stock price on the grant date. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which has been one year from the grant date. During the nine months ended September 30, 2023, and 2022, stock-based compensation expense for restricted shares for Company employees was $17,021 and $121,479, respectively.

 

Research and Development

 

As a component of our equipment and supplies offerings, from time to time, we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include but are not limited to The Satchel™, Cultivation Cube™, So-Hum Living Soils™, and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the nine months ending September 30, 2023, and 2022, our research and development costs were de minimis.

  

 

 

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since its inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of September 30, 2023, and December 31, 2022, we had no liabilities related to federal income taxes, and the carrying value of our federal deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share.” This statement requires a dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise, or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

 

Impact of COVID-19 Pandemic

 

On March 11, 2020the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

  

 

 

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Naturaleaf Asset Acquisition
9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Naturaleaf Asset Acquisition

Note 4. Naturaleaf Asset Acquisition

 

On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.

 

Naturaleaf agreed to sell or assign to the Company the following assets:

 

  1. Three Medical Marijuana (MMC) Store Licenses;

 

  2. One Marijuana Infused Product Licenses (MIPS); and,

 

  3. One Option Premises Cultivation License (OPC); and,

 

  4. Related real property assets, goodwill, and related business assets.

 

The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.

 

On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, Business Combinations. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expenses certain legal, auditing and licensing costs with the acquisition of $83,095. 

 

As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.

 

 

Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company’s stated intentions and strategy. Other assets include inventory and fixed assets.

 

 

During the year ended December 31, 2022, the Company finalized its valuation of Naturaleaf tangible and intangible assets and goodwill as of the acquisition date. The following table summarizes the final fair value allocation of the purchase price as of April 30, 2021:

 

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   800,000 
Total Intangible Assets   1,460,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 

 

On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store) and City of Colorado Springs License No. 0850714L in exchange for $100,000. The transaction's closing is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO location. The Company will continue to rent the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership.

 

During the nine months ended September 30, 2023, and 2022, the Company recognized an amortization expense of $138,999 and $70,000, respectively.

 

 

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Receivable and Advance from Clients
9 Months Ended
Sep. 30, 2023
Receivables [Abstract]  
Accounts Receivable and Advance from Clients

Note 5. Accounts Receivable and Advance from Clients    

 

Accounts receivable were comprised of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Accounts Receivable – Trade  $206,557   $469,111 
Less:  Allowance for Doubtful Accounts   (4,070)   (4,071)
Accounts Receivable, net  $202,487   $465,040 

 

The Company had bad debt expenses during the nine months ended September 30, 2023, and 2022 of $12,000 and $0, respectively.

 

 

Our Advances from Clients had the following activity:

 

       
   Sept. 30,
2023
  December 31,
2022
Beginning Balance  $156,213   $111,892 
  Additional deposits received   8,929    691,769 
  Less: Deposits recognized as revenue   (109,875)   (522,663)
Ending Balance  $55,267   $280,705 

 

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Inventory

Note 6. Inventory

 

Inventory consisted of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Raw Materials - Soil  $7,272   $38,464 
Work In Process - Cultivation   473,587    206,306 
Finished Goods - Soil   817    66,557 
Finished Goods - Cannabis Retail   36,612    41,644 
Total Inventory  $518,288   $352,971 

 

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment, net
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Property and Equipment, net

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following:

 

   Sept. 30,
2023
  December 31,
2022
Office equipment  $47,380   $47,380 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   517,510    364,520 
Property and equipment, gross  $580,422   $427,432 
Less: Accumulated Depreciation   (156,268)   (113,650)
Property and equipment, net  $424,155   $313,782 

 

 

 

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Intangibles Assets, Ne
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangibles Assets, Ne

Note 8. Intangibles Assets, Net

 

A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below: 

            
   Sept. 30, 2023
   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $800,000   ($174,522)  $625,448    15 years 
Brand  $660,000   ($219,669)  $440,331    5 years 
Patent Applications  $18,464         $18,464    —   
Total intangible assets, net  $1,478,464   ($347,888)  $1,130,576    

 

 

 

 

  

 

December 31, 2022

   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $818,464   ($134,522)  $683,912   15 years
Brand  $660,000   ($120,670)  $539,330   5 years
Total intangible assets, net  $1,488,464   ($255,222)  $1,233,242    

 

 

The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately 11.47 years. No intangible assets were acquired during the nine months ending September 30, 2023.

 

Amortization expense for intangible assets was $139,000 and $72,520 for the nine months ended September 30, 2023 and 2022, respectively. The total estimated amortization expense for our intangible assets for the years 2022 through 2026 is as follows:

 

 

       
5 years License Brand Total
2022 25,000.00  45,000  70,000.00 
2023 33,333.33  60,000  93,333.33 
2024 33,333.33  60,000  93,333.33 
2025 33,333.33  60,000  93,333.33 
2026 33,333.33  20,000  53,333.33 
Thereafter 311,111.35    311,111.35 
  652,885.76  471,669  1,124,555.07

 

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued and Other Current Liabilities
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Accrued and Other Current Liabilities

Note 9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities consisted of the following:

 

       
   Sept. 30,
2023
  December 31,
2022
Accrued Interest  $114,658   $39,130 
Accrued Payroll   32,628    22,029 
Sales Tax Payable   13,987    3,931 
Other Accrued Expenses & Payables   330,442    168,258 
Accrued and other current liabilities  $491,715   $233,248 

 

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Payable
9 Months Ended
Sep. 30, 2023
Stock Payable  
Stock Payable

Note 10. Stock Payable

 

The following summarizes the changes in common stock payable:

 

    
   Amount
December 31, 2022  $74,342 
    Additional Expenses Incurred     
    Payments Upon Issuance of Shares   17,934 
Sept. 30, 2023  $56,408 

 

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Operating Lease Right-of-Use Asset/Operating Lease Liability
9 Months Ended
Sep. 30, 2023
Operating Lease Right-of-use Assetoperating Lease Liability  
Operating Lease Right-of-Use Asset/Operating Lease Liability

Note 11. Operating Lease Right-of-Use Asset/Operating Lease Liability

 

The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance, and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.

 

The Company’s lease portfolio consists of the following.

 

As a result of our acquisition of Naturaleaf, we assumed the following leases and contingent extensions:

 

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of an extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022, until April 30, 2027. The Company's monthly rental payments from January 1, 2022, to May 1, 2022, were $3,700. From May 1, 2022, through the year ending December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022, to April 30, 2023, $3,875 May 1, 2023, to April 30, 2024, $4,050 May 1, 2024, to April 30, 2025, $4,225 May 1, 2025, to April 30, 2026, $4,400 May 1, 2026, to April 30, 2027, $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a month-to month lease with a monthly rent of $5,000.

  

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

 

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered an extension of the lease for a term of thirty-six months, beginning June 1, 2022, and terminating on June 1, 2024. On December 31, 2022, the monthly rent was $11,000. Rental payments due for the extended period are: June 1, 2022, to June 1, 2023, $11,000 June 1, 2023, to June 1, 2024, $11,880 June 1, 2025, to June 1, 2025, $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830

 

On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation, that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accommodation, and the membership fee will be recognized on a monthly straight-line basis.

 

On May 1, 2021, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.

 

The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases on September 30, 2023, was 12.5%. Leases often include rental escalation clauses, renewal options, and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.

 

As of September 30, 2023, the aggregate remaining annual lease payments of operating lease liabilities are as follows: 

 

       
    Operating
Leases
 
2023     519,244  
Total     519,244  
Less: amount representing interest     ( )
Present value of future minimum lease payments     519,244  
Less: current obligations under leases     191,539  
Long-term lease obligations   $ (327,705

 

 

 

 

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Loans Payable
9 Months Ended
Sep. 30, 2023
Debt Disclosure [Abstract]  
Loans Payable

Note 12. Loans Payable 

 

Naturaleaf Seller Note

 

As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note originally had a term of 1 year with a due date of April 30, 2022, and did not require any payments prior to the due date. The note had an annual interest rate of 10%.

 

On April 30, 2022, the Company entered into an Amendment ("First Amendment") to the Asset Purchase Agreement to amend the Seller Note as follows; the due date of the Note was extended to April 30, 2023, and interest will accrue on the outstanding principal at a rate of 12.5%. In addition, the Company agreed to pay all accrued interest at April 30, 2022, and make a principal payment of $500,000. On April 29, 2022, principal in the amount of $550,000 and accrued interest of $110,000 was paid. At September 30, 2022, principal in the amount of $550,000 was outstanding, and interest of $9,493 had been accrued.

 

On June 8, 2023, the Company and Naturaleaf amended the promissory note to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.

 

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Related Party Transactions
9 Months Ended
Sep. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 13. Related Party Transactions

 

On February 14, 2023, the Company issued a second promissory note in exchange for $100,000 to its CEO and CFO Ellis Smith. The note is not convertible and matures on August 14, 2023. The note carries 15% interest per annum. No principal or interest has been paid on this note.

 

On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due. No principal or interest has been paid on this note.

 

 

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Stock-Based Compensation

Note 14. Stock-Based Compensation

 

During the three and nine months ending September 30, 2023, the Company issued 79,250,000 shares of common stock and 81,425,000 shares of common stock, respectively, as compensation for consultants, employees, and service providers per its 2015 Equity Incentive Plan.

 

 

   

 

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders’ Equity
9 Months Ended
Sep. 30, 2023
Equity [Abstract]  
Shareholders’ Equity

Note 15. Shareholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $ 0.00001 par value. No shares of preferred stock were issued and outstanding at September 30, 2023, and December 31, 2022, respectively.

 

Common Stock

 

American Cannabis Company, Inc. is authorized to issue 500,000,000 shares of common stock at 0.00001 par value. At September 30, 2023, 171,402,938 shares were outstanding.

 

During the three and nine months ended September 30, 2023, the Company issued 79,250,000 shares of common stock and 81,425,000 shares of common stock, respectively.

    

Net Loss Per Share

 

Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.

 

Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same. At September 30, 2023, the Company did not have any warrants or options issued and outstanding.

 

XML 31 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 16. Commitments and Contingencies

 

Legal

 

In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company expenses legal fees in the period in which they are incurred.

 

 

XML 32 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Subsequent Events
9 Months Ended
Sep. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 17. Subsequent Events

 

In accordance with ASC 855-10, the Company has analyzed its operations after unaudited consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the nine months ended September 30, 2023, and did not find any events.

XML 33 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Basis of Accounting

Basis of Accounting

 

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.

 

 

Unaudited Interim Financial Statements

Unaudited Interim Financial Statements

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for (a) the financial position, (b) the result of operations, and (c) cash flows have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Going Concern

Going Concern

 

Accounting Standards Codification (“ASC”) Topic 205-40, Presentation of Financial Statements - Going Concern ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.

 

Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and we expect these trends to continue into the foreseeable future.

 

As of the date of this Quarterly Report on Form 10-Q, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would be required to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.

 

 

There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have been successful in accessing capital markets in the past, and we are confident in our ability to access capital markets again if needed.

 

The Company has an accumulated deficit and recurring losses and expects continuing future losses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds during the nine months ended September 30, 2023, and the year ended December 31, 2022, has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception but expects these conditions to improve as it develops its business model. The Company has an accumulated deficit at September 30, 2023, and requires additional financing to fund future operations.

 

The Company’s existence is dependent upon management’s ability to develop profitable operations and obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.

 

The accompanying unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. 

  

 

Use of Estimates in Financial Reporting

Use of Estimates in Financial Reporting

 

The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.

 

 

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of September 30, 2023, and December 31, 2022, the Company had cash balances within of FDIC-insured limits of $250,000.

 

Accounts Receivable

Accounts Receivable

 

Accounts receivables are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness, and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.

 

The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client’s inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of September 30, 2023, and December 31, 2022, the Company’s allowance for doubtful accounts was $4,070 and $4,071, respectively. The Company recorded a bad debt expense of $12,000 in the three months ending September 30, 2023. No bad debt expense was recorded for the similar period in 2022.

 

Deposits

Deposits

 

Deposits comprise advance payments made to third parties for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory and then recognized as a cost of revenues upon sale.

 

Inventory

Inventory

 

Inventory comprises products and equipment the Company owns to be sold to end customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in, first-out, and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of September 30, 2023, and December 31, 2022, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.

 

Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third-party vendors for retail sales at dispensaries are determined using the first in, first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production-related depreciation, and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At September 30, 2023, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.

  

 

Prepaid Expenses and Other Current Assets

Prepaid Expenses and Other Current Assets

 

Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods, which approximate the life of the contract or service period.

 

Significant Clients and Customers

Significant Clients and Customers

 

During the nine months ended September 30, 2023, three customers accounted for 42.5% of the Company’s total revenues for the period.

 

During the nine months ended September 30, 2022, three customers accounted for 42.5% of the Company’s total revenues.

 

Property and Equipment, net

Property and Equipment, net

 

Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of September 30, 2023, and December 31, 2022.

 

Goodwill

Goodwill

 

Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under ASC Topic 350, Intangibles-Goodwill and Other. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company recognized goodwill of $1,332,113 during the year ended December 31, 2022, as part of the Naturaleaf Acquisition.

 

The Company does not have any other indefinite-lived intangible assets. 

 

In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” the impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.

  

 

 

Intangible Assets, net

Intangible Assets, net

 

Definite life intangible assets at September 30, 2023, include licenses and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the nine months ended September 30, 2023, the Company recognized a depreciation and amortization expense of $42,618.

 

Accounting for the Impairment of Long-Lived Assets

Accounting for the Impairment of Long-Lived Assets

 

The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management’s estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of September 30, 2023, and December 31, 2022.

 

Fair Value Measurements

Fair Value Measurements

 

Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:

 

Level 1 – Quoted prices in active markets for identical assets or liabilities.

 

Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.

 

Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  

 

Revenue Recognition

Revenue Recognition

 

We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “Revenue from Contracts with Customers (Topic 606).

  

 

Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.

 

We may also enter contracts with customers that identify a single or few distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods, and accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.

 

We recognize revenue in accordance with ASC 606 using the following five steps to identify revenues:

 

  (1) Identify the contract with the Customer. Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.

 

  (2) Identify the performance obligations in the contract. We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.

 

  (3) Determination of the transaction price. Prices are typically fixed, and no price protections or variables are offered.

 

  (4) Allocation of the transaction price to the performance obligations in the contract. Transaction prices are typically allocated to the performance obligations outlined in the contract.
     

 

  (5) Recognize Revenue when (or as) the entity satisfies a performance obligation. We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.

 

Advances from Client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients' deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.

 

Product and Equipment Sales

Product and Equipment Sales

 

Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months that ended September 30, 2023, and 2022, sales returns were $0.

 

 

 

Consulting Services

Consulting Services

 

We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.

 

Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by several factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the six months ended September 30, 2023, and 2022, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.

 

We primarily enter arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.

 

Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.

 

While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.

 

Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.

  

 

Cannabis Sales

Cannabis Sales

 

Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time permitted under the Company’s credit policy. Sales discounts were not material during the three or nine months ended September 30, 2023.

 

Loyalty Reward Program

Loyalty Reward Program

 

The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total purchase amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.

 

Costs of Revenues

Costs of Revenues

 

The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general, and administrative expenses are charged to expenses as incurred.

 

Advertising and Promotion Costs

Advertising and Promotion Costs

 

Advertising and Promotion costs are included as a component of selling and marketing expenses and are expensed as incurred. During the nine months ended September 30, 2023, and 2022, these expenses were $169,059 and $165,544, respectively.

 

Shipping and Handling Costs

Shipping and Handling Costs

 

For product and equipment sales, shipping and handling costs are included as a component of the cost of revenues.

 

Stock-Based Compensation

Stock-Based Compensation

 

Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The grant's fair value is based on the stock price on the grant date. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which has been one year from the grant date. During the nine months ended September 30, 2023, and 2022, stock-based compensation expense for restricted shares for Company employees was $17,021 and $121,479, respectively.

 

Research and Development

Research and Development

 

As a component of our equipment and supplies offerings, from time to time, we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include but are not limited to The Satchel™, Cultivation Cube™, So-Hum Living Soils™, and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the nine months ending September 30, 2023, and 2022, our research and development costs were de minimis.

  

 

 

Income Taxes

Income Taxes

 

The Company’s corporate status changed from an S Corporation, which it had been since its inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of September 30, 2023, and December 31, 2022, we had no liabilities related to federal income taxes, and the carrying value of our federal deferred tax asset was zero.

 

Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“IRC”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.

 

Net Loss Per Common Share

Net Loss Per Common Share

 

The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share.” This statement requires a dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise, or contingent exercise of securities since that would have an anti-dilutive effect on earnings.

 

Related Party Transactions

Related Party Transactions

 

The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions.

 

Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

 

Impact of COVID-19 Pandemic

Impact of COVID-19 Pandemic

 

On March 11, 2020the World Health Organization declared the current coronavirus (“COVID-19”) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-19 within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.

 

In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.

 

While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-19 cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.

  

 

 

XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Naturaleaf Asset Acquisition (Tables)
9 Months Ended
Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]  
Business Combination, Segment Allocation

 

      
Current Assets  $15,000 
Inventory   72,172 
Property, Plant and Equipment   26,715 
Other Assets   6,000 
Total Tangible Assets   119,887 
      
Tradenames and Trademarks   660,000 
Licenses   800,000 
Total Intangible Assets   1,460,000 
      
Goodwill   1,332,113 
Total Consideration  $2,912,000 
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Receivable and Advance from Clients (Tables)
9 Months Ended
Sep. 30, 2023
Receivables [Abstract]  
Schedule of accounts receivable and advances from clients

 

       
   Sept. 30,
2023
  December 31,
2022
Accounts Receivable – Trade  $206,557   $469,111 
Less:  Allowance for Doubtful Accounts   (4,070)   (4,071)
Accounts Receivable, net  $202,487   $465,040 
Schedule of advances from clients

 

       
   Sept. 30,
2023
  December 31,
2022
Beginning Balance  $156,213   $111,892 
  Additional deposits received   8,929    691,769 
  Less: Deposits recognized as revenue   (109,875)   (522,663)
Ending Balance  $55,267   $280,705 
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory (Tables)
9 Months Ended
Sep. 30, 2023
Inventory Disclosure [Abstract]  
Schedule of inventory

 

       
   Sept. 30,
2023
  December 31,
2022
Raw Materials - Soil  $7,272   $38,464 
Work In Process - Cultivation   473,587    206,306 
Finished Goods - Soil   817    66,557 
Finished Goods - Cannabis Retail   36,612    41,644 
Total Inventory  $518,288   $352,971 
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment, net (Tables)
9 Months Ended
Sep. 30, 2023
Property, Plant and Equipment [Abstract]  
Schedule of property, plant and equipment, net

 

   Sept. 30,
2023
  December 31,
2022
Office equipment  $47,380   $47,380 
Software   13,204    13,204 
Furniture and Fixtures   2,328    2,328 
Machinery and Equipment   517,510    364,520 
Property and equipment, gross  $580,422   $427,432 
Less: Accumulated Depreciation   (156,268)   (113,650)
Property and equipment, net  $424,155   $313,782 
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Intangibles Assets, Ne (Tables)
9 Months Ended
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Identified intangible asset

            
   Sept. 30, 2023
   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $800,000   ($174,522)  $625,448    15 years 
Brand  $660,000   ($219,669)  $440,331    5 years 
Patent Applications  $18,464         $18,464    —   
Total intangible assets, net  $1,478,464   ($347,888)  $1,130,576    

 

 

 

 

  

 

December 31, 2022

   Gross
carrying
amount
  Accumulated
amortization
  Carrying
value
  Estimated
useful
life
Licenses  $818,464   ($134,522)  $683,912   15 years
Brand  $660,000   ($120,670)  $539,330   5 years
Total intangible assets, net  $1,488,464   ($255,222)  $1,233,242    

 

Schedule of estimated amortization expense

 

       
5 years License Brand Total
2022 25,000.00  45,000  70,000.00 
2023 33,333.33  60,000  93,333.33 
2024 33,333.33  60,000  93,333.33 
2025 33,333.33  60,000  93,333.33 
2026 33,333.33  20,000  53,333.33 
Thereafter 311,111.35    311,111.35 
  652,885.76  471,669  1,124,555.07
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued and Other Current Liabilities (Tables)
9 Months Ended
Sep. 30, 2023
Payables and Accruals [Abstract]  
Schedule of accrued and other current liabilities

 

       
   Sept. 30,
2023
  December 31,
2022
Accrued Interest  $114,658   $39,130 
Accrued Payroll   32,628    22,029 
Sales Tax Payable   13,987    3,931 
Other Accrued Expenses & Payables   330,442    168,258 
Accrued and other current liabilities  $491,715   $233,248 

XML 40 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Payable (Tables)
9 Months Ended
Sep. 30, 2023
Stock Payable  
Schedule of stock payable

 

    
   Amount
December 31, 2022  $74,342 
    Additional Expenses Incurred     
    Payments Upon Issuance of Shares   17,934 
Sept. 30, 2023  $56,408 
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)
9 Months Ended
Sep. 30, 2023
Operating Lease Right-of-use Assetoperating Lease Liability  
Schedule of other operating cost and expense

 

  o 1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of an extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022, until April 30, 2027. The Company's monthly rental payments from January 1, 2022, to May 1, 2022, were $3,700. From May 1, 2022, through the year ending December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022, to April 30, 2023, $3,875 May 1, 2023, to April 30, 2024, $4,050 May 1, 2024, to April 30, 2025, $4,225 May 1, 2025, to April 30, 2026, $4,400 May 1, 2026, to April 30, 2027, $4,575

 

May 1, 2022 to April 30, 2023 $3,875
May 1, 2023 to April 30, 2024 $4,050
May 1, 2024 to April 30, 2025 $4,225
May 1, 2025 to April 30, 2026 $4,400
May 1, 2026 to April 30, 2027 $4,575

 

  o 2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a month-to month lease with a monthly rent of $5,000.

  

  o 5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262

 

January 1, 2023 $2,898
January 1, 2024 $2,985
January 1, 2025 $3,075
January 1, 2026 $3,167
January 1, 2027 $3,262

 

  o 2611 Durango Drive, CO Springs, CO. The Company and landlord entered a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered an extension of the lease for a term of thirty-six months, beginning June 1, 2022, and terminating on June 1, 2024. On December 31, 2022, the monthly rent was $11,000. Rental payments due for the extended period are: June 1, 2022, to June 1, 2023, $11,000 June 1, 2023, to June 1, 2024, $11,880 June 1, 2025, to June 1, 2025, $12,830  

 

 

June 1, 2022 to June 1, 2023 $11,000
June 1, 2023 to June 1, 2024 $11,880
June 1, 2025 to June 1, 2025 $12,830
Schedule of operating lease liabilities

 

       
    Operating
Leases
 
2023     519,244  
Total     519,244  
Less: amount representing interest     ( )
Present value of future minimum lease payments     519,244  
Less: current obligations under leases     191,539  
Long-term lease obligations   $ (327,705
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Summary of Significant Accounting Policies (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Accounting Policies [Abstract]          
FDIC-insured limits $ 250,000   $ 250,000   $ 250,000
Allowance for Doubtful Accounts, Premiums and Other Receivables 4,070   4,070   4,071
Bad Debt expense 12,000 $ 0      
Goodwill $ 1,332,113   1,332,113   1,332,113
Depreciation and amortization expense         $ 42,618
Advertising and Promotion Costs     169,059 $ 165,544  
Stock based compensation expense     $ 17,021 $ 121,479  
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Naturaleaf Asset Acquisition (Details)
Sep. 30, 2023
USD ($)
Business Combination and Asset Acquisition [Abstract]  
Current Assets $ 15,000
Inventory 72,172
Property, Plant and Equipment 26,715
Other Assets 6,000
Total Tangible Assets 119,887
Tradenames and Trademarks 660,000
Licenses 800,000
Total Intangible Assets 1,460,000
Goodwill 1,332,113
Total Consideration $ 2,912,000
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Receivable and Advance from Clients (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Receivables [Abstract]    
Accounts Receivable, before Allowance for Credit Loss $ 206,557 $ 469,111
Accounts Receivable, Allowance for Credit Loss, Current (4,070) (4,071)
Accounts Receivable, net $ 202,487 $ 465,040
XML 45 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Receivable and Advance from Clients (Details 1) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Receivables [Abstract]    
Beginning Balance $ 156,213 $ 111,892
Additional deposits received 8,929 691,769
Less: Deposits recognized as revenue (109,875) (522,663)
Ending Balance $ 55,267 $ 280,705
XML 46 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Accounts Receivable and Advance from Clients (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Receivables [Abstract]    
Bad debt expenses $ 12,000 $ 0
XML 47 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Inventory (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Inventory Disclosure [Abstract]    
Raw Materials - Soil $ 7,272 $ 38,464
Work In Process - Cultivation 473,587 206,306
Finished Goods - Soil 817 66,557
Finished Goods - Cannabis Retail 36,612 41,644
Total Inventory $ 518,288 $ 352,971
XML 48 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Property and Equipment net (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 580,422 $ 427,432
Less: Accumulated Depreciation (156,268) (113,650)
Property and equipment, net 424,155 313,782
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 47,380 47,380
Software Development [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 13,204 13,204
Furniture and Fixtures [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross 2,328 2,328
Machinery and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, Plant and Equipment, Gross $ 517,510 $ 364,520
XML 49 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Intangibles Assets, Net (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying amount $ 1,478,464 $ 1,488,464
Accumulated amortization 347,888 255,222
Carrying value 1,130,576 1,233,242
License [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying amount 800,000 818,464
Accumulated amortization 174,522 134,522
Carrying value $ 625,448 $ 683,912
Estimated useful life 15 15
Brand [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying amount $ 660,000 $ 660,000
Accumulated amortization 219,669 120,670
Carrying value $ 440,331 $ 539,330
Estimated useful life 5 5
Patents [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying amount $ 18,464  
Accumulated amortization  
Carrying value $ 18,464  
XML 50 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Intangibles Assets, Net (Details 1)
Sep. 30, 2023
USD ($)
Finite-Lived Intangible Assets [Line Items]  
2022 $ 70,000.00
2023 93,333.33
2024 93,333.33
2025 93,333.33
2026 53,333.33
Thereafter 311,111.35
  1,124,555.07
License [Member]  
Finite-Lived Intangible Assets [Line Items]  
2022 25,000.00
2023 33,333.33
2024 33,333.33
2025 33,333.33
2026 33,333.33
Thereafter 311,111.35
  652,885.76
Brand [Member]  
Finite-Lived Intangible Assets [Line Items]  
2022 45,000
2023 60,000
2024 60,000
2025 60,000
2026 20,000
  $ 471,669
XML 51 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Intangibles Assets, Ne (Details Narrative) - USD ($)
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization expense $ 139,000 $ 72,520
XML 52 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Accrued and Other Current Liabilities (Details) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued Interest $ 114,658 $ 39,130
Accrued Payroll 32,628 22,029
Sales Tax Payable 13,987 3,931
Other Accrued Expenses & Payables 330,442 168,258
Accrued and other current liabilities $ 491,715 $ 233,248
XML 53 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Payable (Details)
Sep. 30, 2023
USD ($)
shares
Stock Payable  
Loans payable $ 74,342
Payments Upon Issuance of Shares | shares 17,934
Other loans ayable $ 56,408
XML 54 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)
9 Months Ended
Sep. 30, 2023
USD ($)
May 2022 To April 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense $ 3,875
Sale Leaseback Transaction, Rent Expense 3,875
May 2023 To April 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 4,050
Sale Leaseback Transaction, Rent Expense 4,050
May 2024 To April 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 4,225
Sale Leaseback Transaction, Rent Expense 4,225
May 2025 To April 2026 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 4,400
Sale Leaseback Transaction, Rent Expense 4,400
May 2026 To April 2027 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 4,575
Sale Leaseback Transaction, Rent Expense 4,575
January 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 2,898
Sale Leaseback Transaction, Rent Expense 2,898
January 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 2,985
Sale Leaseback Transaction, Rent Expense 2,985
January 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 3,075
Sale Leaseback Transaction, Rent Expense 3,075
January 2026 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 3,167
Sale Leaseback Transaction, Rent Expense 3,167
January 2027 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 3,262
Sale Leaseback Transaction, Rent Expense 3,262
June 2022 To June 2023 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 11,000
Sale Leaseback Transaction, Rent Expense 11,000
June 2023 To June 2024 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 11,880
Sale Leaseback Transaction, Rent Expense 11,880
June 2024 To June 2025 [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Sale Leaseback Transaction, Rent Expense 12,830
Sale Leaseback Transaction, Rent Expense $ 12,830
XML 55 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)
Sep. 30, 2023
USD ($)
Operating Lease Right-of-use Assetoperating Lease Liability  
2023 $ 519,244
Total 519,244
Less: amount representing interest
Present value of future minimum lease payments 519,244
Less: current obligations under leases 191,539
Long-term lease obligations $ (327,705)
XML 56 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Stock-Based Compensation (Details Narrative) - shares
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Equity [Abstract]    
Common stock issued 79,250,000 81,425,000
XML 57 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Shareholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Equity [Abstract]      
Preferred Stock, Shares Authorized 5,000,000 5,000,000 5,000,000
Preferred Stock, No Par Value $ 0.00001 $ 0.00001  
Coomon stock $ 79,250,000    
Common stock   $ 81,425,000  
XML 58 ammj_10q_htm.xml IDEA: XBRL DOCUMENT 0000945617 2023-01-01 2023-09-30 0000945617 2023-11-14 0000945617 2023-09-30 0000945617 2022-12-31 0000945617 2023-07-01 2023-09-30 0000945617 2022-07-01 2022-09-30 0000945617 2022-01-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2022-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000945617 ammj:SubscriptionReceivableMember 2022-06-30 0000945617 us-gaap:RetainedEarningsMember 2022-06-30 0000945617 2022-06-30 0000945617 us-gaap:CommonStockMember 2023-06-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000945617 ammj:SubscriptionReceivableMember 2023-06-30 0000945617 us-gaap:RetainedEarningsMember 2023-06-30 0000945617 2023-06-30 0000945617 us-gaap:CommonStockMember 2021-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000945617 ammj:SubscriptionReceivableMember 2021-12-31 0000945617 us-gaap:RetainedEarningsMember 2021-12-31 0000945617 2021-12-31 0000945617 us-gaap:CommonStockMember 2022-12-31 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000945617 ammj:SubscriptionReceivableMember 2022-12-31 0000945617 us-gaap:RetainedEarningsMember 2022-12-31 0000945617 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-07-01 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-07-01 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0000945617 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-01-01 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-01-01 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0000945617 us-gaap:CommonStockMember 2022-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000945617 ammj:SubscriptionReceivableMember 2022-09-30 0000945617 us-gaap:RetainedEarningsMember 2022-09-30 0000945617 2022-09-30 0000945617 us-gaap:CommonStockMember 2023-09-30 0000945617 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0000945617 ammj:SubscriptionReceivableMember 2023-09-30 0000945617 us-gaap:RetainedEarningsMember 2023-09-30 0000945617 2022-01-01 2022-12-31 0000945617 us-gaap:OfficeEquipmentMember 2023-09-30 0000945617 us-gaap:OfficeEquipmentMember 2022-12-31 0000945617 us-gaap:SoftwareDevelopmentMember 2023-09-30 0000945617 us-gaap:SoftwareDevelopmentMember 2022-12-31 0000945617 us-gaap:FurnitureAndFixturesMember 2023-09-30 0000945617 us-gaap:FurnitureAndFixturesMember 2022-12-31 0000945617 us-gaap:MachineryAndEquipmentMember 2023-09-30 0000945617 us-gaap:MachineryAndEquipmentMember 2022-12-31 0000945617 us-gaap:LicenseMember 2023-09-30 0000945617 us-gaap:LicenseMember 2023-01-01 2023-09-30 0000945617 ammj:BrandMember 2023-09-30 0000945617 ammj:BrandMember 2023-01-01 2023-09-30 0000945617 us-gaap:PatentsMember 2023-09-30 0000945617 us-gaap:LicenseMember 2022-12-31 0000945617 us-gaap:LicenseMember 2022-01-01 2022-12-31 0000945617 ammj:BrandMember 2022-12-31 0000945617 ammj:BrandMember 2022-01-01 2022-12-31 0000945617 ammj:May2022ToApril2023Member 2023-01-01 2023-09-30 0000945617 ammj:May2023ToApril2024Member 2023-01-01 2023-09-30 0000945617 ammj:May2024ToApril2025Member 2023-01-01 2023-09-30 0000945617 ammj:May2025ToApril2026Member 2023-01-01 2023-09-30 0000945617 ammj:May2026ToApril2027Member 2023-01-01 2023-09-30 0000945617 ammj:January2023Member 2023-01-01 2023-09-30 0000945617 ammj:January2024Member 2023-01-01 2023-09-30 0000945617 ammj:January2025Member 2023-01-01 2023-09-30 0000945617 ammj:January2026Member 2023-01-01 2023-09-30 0000945617 ammj:January2027Member 2023-01-01 2023-09-30 0000945617 ammj:June2022ToJune2023Member 2023-01-01 2023-09-30 0000945617 ammj:June2023ToJune2024Member 2023-01-01 2023-09-30 0000945617 ammj:June2024ToJune2025Member 2023-01-01 2023-09-30 iso4217:USD shares iso4217:USD shares 0000945617 false Q3 --12-31 2023 10-Q true 2023-09-30 false 000-26108 AMERICAN CANNABIS COMPANY, INC. DE 90-1116625 200 Union Street Ste. 200 Lakewood CO 80228 303 974-4770 Yes Yes Non-accelerated Filer true false false 171402938 8889 117547 202487 469111 9595 9595 518288 352971 64059 73933 803318 1023157 424155 427669 1084242 1223242 1332113 1332113 519244 604020 6000 6000 2941599 3165375 4169072 4616201 934978 679163 55267 280705 491715 233348 17021 74343 191539 181661 75000 100000 300000 550000 2065520 2099220 75000 327705 422359 410198 150000 2803423 2746579 0.01 0.01 5000000 5000000 0 0 0 0 0.00001 0.00001 500000000 500000000 171402938 171402938 92152938 92152938 1715 922 12022958 11949409 -10659024 -10080709 1365649 1869622 4169072 4616201 168528 66824 637028 308872 218242 1866725 986000 6540558 213120 190067 571976 638316 599890 2123616 2195004 7487746 12000 19500 115085 67422 187818 1664235 695464 5628432 151335 180701 462823 724529 351154 1864436 1273373 6420383 248717 259180 921631 1067363 326429 617270 1408209 1951008 51675 64017 169059 165544 56170 17021 121479 378104 737457 1594109 2238031 -129367 -478277 -672477 -1170668 -28690 77381 -93054 -32024 900 3246 187216 48016 -27791 80627 94162 80040 11844 -170803 -451156 -692978 -157158 -397650 -578316 -1090628 -0 -0 -0.01 -0.01 85727938 85727938 84795246 84795246 85727938 857 11794476 0 -10140495 1654838 0 0 0 0 0 0 0 0 0 65000 -397650 -397650 85727938 857 11794476 -10538145 1257188 92152938 922 12023751 0 -10543709 1480694 0 0 0 0 0 0 0 0 0 -157158 -157158 92152938 922 12023751 -10700867 1323806 81902938 819 11565679 -9447517 2118981 325000 3 46204 46207 1000000 10 64990 65000 2500000 25 117603 142793 -1090628 -1090628 85727938 857 11794476 -10538145 1257188 92152938 922 11949409 -10080709 1869622 74342 74342 793 -793 -578316 -578316 171402938 922 12022958 -10659025 1365648 -578315 -1090628 181617 113362 -793 65306 29792 -266624 248610 165317 73886 -9872 55232 -84776 116191 255815 211059 225438 -1279080 25387 -11463 -100000 -150000 -84776 116191 -330548 68780 39101 105011 10305 -39101 -115316 793 117629 550000 260198 260991 -432371 -108658 -478907 117547 670423 8889 191516 65000 <p id="xdx_808_eus-gaap--OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_zVG5RSFTBo07" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 1. <span id="xdx_822_zc7DgeXxTlTa">Principles of Consolidation.</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited condensed consolidated financial statements for the nine and three months ended September 30, 2023, and 2022 include the accounts of American Cannabis Company, Inc. and its wholly owned subsidiary, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Company, Inc. Intercompany accounts and transactions have been eliminated.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_804_eus-gaap--BusinessDescriptionAndBasisOfPresentationTextBlock_zEUCvAE2HzL4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 2. <span id="xdx_82C_zwsumiB6VPb">Description of Business.</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Cannabis Company, Inc. and its wholly-owned subsidiary Company, Hollister &amp; Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado, and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. We provide advisory and consulting services specific to this industry, design industry-specific products and facilities, and sell both exclusive and non-exclusive customer products commonly used in the industry.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2021, the Company entered into a material definitive agreement to acquire the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado. The material definitive agreement closed on April 29, 2021.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naturaleaf sold and assigned to the Company the following assets:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Medical Marijuana (MMC) Store Licenses;</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Marijuana Infused Product Licenses (MIPS); and,</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Option Premises Cultivation License (OPC); and,</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related real property assets, goodwill, and related business assets.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate consideration paid for the assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000. See Note 4.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store); City of Colorado Springs License No. 0850714L in exchange for $100,000. The closing of the transaction is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its associated operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO. The Company will continue to occupy the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership. The Company is not obligated to pay rent at the location pending the closing of the transaction.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 5, 2023, the Company determined to voluntarily surrender License No.4070001. The effect of the surrender cancels, terminates, and annuls the Company's Marijuana Business License and related license privileges. Since the Company's acquisition of the subject license, it has never used or had any operations under the subject license.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_805_eus-gaap--SignificantAccountingPoliciesTextBlock_zh5vr9WDAJs7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 3. <span id="xdx_828_zVdK0PO2Pe08">Summary of Significant Accounting Policies</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHJWuCER2PDk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zClVGk5zR70b">Basis of Accounting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_ecustom--UnauditedInterimFinancialStatementsTextBlock_zGTcPzJNBZEd" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zvYHgt5T1lld">Unaudited Interim Financial Statements</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for (a) the financial position, (b) the result of operations, and (c) cash flows have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zdoy022yqoY5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zTjb21eRvS88">Going Concern</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 205-40, <i>Presentation of Financial Statements - Going Concern</i> ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and we expect these trends to continue into the foreseeable future.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this Quarterly Report on Form 10-Q, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would be required to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have been successful in accessing capital markets in the past, and we are confident in our ability to access capital markets again if needed.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an accumulated deficit and recurring losses and expects continuing future losses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds during the nine months ended September 30, 2023, and the year ended December 31, 2022, has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception but expects these conditions to improve as it develops its business model. The Company has an accumulated deficit at September 30, 2023, and requires additional financing to fund future operations.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s existence is dependent upon management’s ability to develop profitable operations and obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zzmIa4MjerM9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zUdfxb8qtVki">Use of Estimates in Financial Reporting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLhew98nT5b" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z0FPFMRcdos6">Cash and Cash Equivalents</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of September 30, 2023, and December 31, 2022, the Company had cash balances within of FDIC-insured limits of $<span id="xdx_901_eus-gaap--TimeDepositLiabilityUninsured_iI_c20230930_zqiJzEcRsmWe" title="FDIC-insured limits"><span id="xdx_909_eus-gaap--TimeDepositLiabilityUninsured_iI_c20221231_zbgoGbsiTXWd" title="FDIC-insured limits">250,000</span></span>.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zIvApOf4ZJC" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zQmgmaS8DGc4">Accounts Receivable</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness, and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client’s inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of September 30, 2023, and December 31, 2022, the Company’s allowance for doubtful accounts was $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20230930_zqHELegA3KI" title="Allowance for Doubtful Accounts, Premiums and Other Receivables">4,070</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_zhFfEDghfcJh">4,071</span>, respectively. The Company recorded a bad debt expense of $<span id="xdx_903_ecustom--BadDebtExpense_c20230701__20230930_zdJ4dueR0G0g" title="Bad debt expense">12,000</span> in the three months ending September 30, 2023. <span id="xdx_909_ecustom--BadDebtExpense_do_c20220701__20220930_zm77wYuU5uw" title="Bad Debt expense">No</span> bad debt expense was recorded for the similar period in 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--DepositContractsPolicy_zBNOvxZfklJg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_ztaeqYKaCxba">Deposits</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits comprise advance payments made to third parties for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory and then recognized as a cost of revenues upon sale.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zXI2NTi3EjMc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zCG5hwEHLiud">Inventory</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory comprises products and equipment the Company owns to be sold to end customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in, first-out, and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of September 30, 2023, and December 31, 2022, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third-party vendors for retail sales at dispensaries are determined using the first in, first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production-related depreciation, and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At September 30, 2023, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIrUW8NafUk1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zTjT6lLwlut3">Prepaid Expenses and Other Current Assets</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods, which approximate the life of the contract or service period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z9dLjU92S2P1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zAaHZ5tgTrhl">Significant Clients and Customers</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, three customers accounted for 42.5% of the Company’s total revenues for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2022, three customers accounted for 42.5% of the Company’s total revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znYL4YcL6bhd" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zgiv1N0r7Cue">Property and Equipment, net</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of September 30, 2023, and December 31, 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zBxzwuuZbGT5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zw8nY0ypwy2c">Goodwill</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under <i>ASC Topic 350, Intangibles-Goodwill and Other</i>. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company recognized goodwill of $<span id="xdx_90B_eus-gaap--Goodwill_iI_c20230930_z8sJokhv9rve" title="Goodwill">1,332,113</span> during the year ended December 31, 2022, as part of the Naturaleaf Acquisition.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any other indefinite-lived intangible assets. </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” the impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zYAiLSA9oW9l" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zKJQ4Liy8fE1">Intangible Assets, net</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite life intangible assets at September 30, 2023, include licenses and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the nine months ended September 30, 2023, the Company recognized a depreciation and amortization expense of $<span id="xdx_902_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20221231_zzd7FpZgx4Fh" title="Depreciation and amortization expense">42,618</span>.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zdEotOWXtMub" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zgCsNSVnMqoa">Accounting for the Impairment of Long-Lived Assets</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management’s estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of September 30, 2023, and December 31, 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zaZoVbDsBAS3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zII0XP783duc">Fair Value Measurements</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zcrwK80Gvfv9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_za2QHfoyzkt5">Revenue Recognition</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may also enter contracts with customers that identify a single or few distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods, and accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue in accordance with ASC 606 using the following five steps to identify revenues:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(3)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(4)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(5)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances from Client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients' deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ProductAndEquipmentSalesPolicyTextBlock_zgQXCeQ6fdCg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z6G0VZzRKVkg">Product and Equipment Sales</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months that ended September 30, 2023, and 2022, sales returns were $0.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--ConsultingServicesPolicyTextBlock_zj8nr3BrmNHl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zVy5VFrGecza">Consulting Services</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by several factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the six months ended September 30, 2023, and 2022, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We primarily enter arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--CannabisSalesPolicyTextBlock_zry4IkGWt0vi" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zPH1bd0UUM84">Cannabis Sales</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time permitted under the Company’s credit policy. Sales discounts were not material during the three or nine months ended September 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--LoyaltyRewardProgramPolicyTextBlock_ziqFCeKYuTl4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zmBruaO4qRj5">Loyalty Reward Program</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total purchase amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zVBJ0dmGRyV5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zVDsRE7BsVMe">Costs of Revenues</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general, and administrative expenses are charged to expenses as incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--AdvertisingCostsPolicyTextBlock_zXEuYhLArTp2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zOdcCs8Wk5Ji">Advertising and Promotion Costs</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and Promotion costs are included as a component of selling and marketing expenses and are expensed as incurred. During the nine months ended September 30, 2023, and 2022, these expenses were $<span id="xdx_90D_eus-gaap--OtherSellingAndMarketingExpense_c20230101__20230930_zB2UGwCwC3Wg" title="Advertising and Promotion Costs">169,059</span> and $<span id="xdx_90C_eus-gaap--OtherSellingAndMarketingExpense_c20220101__20220930_z6q50kamPPv9" title="Advertising and Promotion Costs">165,544</span>, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zJUfN2LLLTW" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zdSIr1lrIRwg">Shipping and Handling Costs</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For product and equipment sales, shipping and handling costs are included as a component of the cost of revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z0LrsSELwn4g" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_ztlEvCP8nFgc">Stock-Based Compensation</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The grant's fair value is based on the stock price on the grant date. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which has been one year from the grant date. During the nine months ended September 30, 2023, and 2022, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_908_ecustom--StockbasedCompensationExpense_c20230101__20230930_zy34RdKIfrR9" title="Stock based compensation expense">17,021</span> and $<span id="xdx_900_ecustom--StockbasedCompensationExpense_c20220101__20220930_zCaGIT6TFuQ6" title="Stock based compensation expense">121,479</span>, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zLoBbo99ONC4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zGdMqzBQTA6h">Research and Development</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a component of our equipment and supplies offerings, from time to time, we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include but are not limited to The Satchel™, Cultivation Cube™, So-Hum Living Soils™, and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the nine months ending September 30, 2023, and 2022, our research and development costs were de minimis.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zopcyU7JMIWi" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zqgOaxRPdAJd">Income Taxes</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s corporate status changed from an S Corporation, which it had been since its inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of September 30, 2023, and December 31, 2022, we had no liabilities related to federal income taxes, and the carrying value of our federal deferred tax asset was zero.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_za88ldoFU1h3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z2v7cFwCA3Yh">Net Loss Per Common Share</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share.” This statement requires a dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise, or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--RelatedPartyTransactionsPolicyTextBlock_z2A3UZUO1pOc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_z7h05bwxZkdi">Related Party Transactions</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--ImpactOfCovid19PandemicPolicyTextBlock_zm1j3kpCuv7b" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zuCdocwKGCnl">Impact of COVID-19 Pandemic</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUNFE5rrrnJj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zplpgYMs2vp2">Recent Accounting Pronouncements</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zHJWuCER2PDk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_860_zClVGk5zR70b">Basis of Accounting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America, pursuant to the rules and regulations of the Securities and Exchange Commission. In the opinion of management, the accompanying unaudited condensed consolidated financial statements include normal recurring adjustments that are necessary for a fair presentation of the results for the periods presented.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p id="xdx_849_ecustom--UnauditedInterimFinancialStatementsTextBlock_zGTcPzJNBZEd" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zvYHgt5T1lld">Unaudited Interim Financial Statements</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the unaudited consolidated financial statements do not include all the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for (a) the financial position, (b) the result of operations, and (c) cash flows have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zdoy022yqoY5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zTjb21eRvS88">Going Concern</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounting Standards Codification (“ASC”) Topic 205-40, <i>Presentation of Financial Statements - Going Concern</i> ("ASC 205-40") requires management to assess the Company’s ability to continue as a going concern for one year after the date the financial statements are issued. Under ASC 205-40, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about our ability to meet future financial obligations as they become due within one year after the date that the financial statements are issued. As required by this standard, management’s evaluation shall initially not take into consideration the potential mitigating effects of management’s plans that have not been fully implemented as of the date the financial statements are issued.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our assessment included the preparation of a detailed cash forecast that included all projected cash inflows and outflows. During 2022, we secured additional cash financings through the sales and issuances of our common stock through. However, we continue to focus on growing our revenues. Accordingly, operating expenditures may exceed the revenue we expect to receive for the foreseeable future. We also have a history of operating losses, negative operating cash flows, and negative working capital, and we expect these trends to continue into the foreseeable future.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the date of this Quarterly Report on Form 10-Q, while we believe we have adequate capital resources to complete our near-term operations, there is no guarantee that such capital resources will be sufficient until such time we reach profitability. We may access capital markets to fund strategic acquisitions or ongoing operations on terms we believe are favorable. The timing and amount of capital that may be raised are dependent on market conditions and the terms and conditions upon which investors would be required to provide such capital. We may utilize debt or sell newly issued equity securities through public or private transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There can be no assurance that we will be able to obtain additional funding on satisfactory terms or at all. In addition, no assurance can be given that any such financing, if obtained, will be adequate to meet our capital needs and support our growth. If additional funding cannot be obtained on a timely basis and on satisfactory terms, our operations would be materially negatively impacted; however, we have been successful in accessing capital markets in the past, and we are confident in our ability to access capital markets again if needed.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has an accumulated deficit and recurring losses and expects continuing future losses. These factors, among others, raise substantial doubt about the Company’s ability to continue as a going concern. The Company’s primary source of operating funds during the nine months ended September 30, 2023, and the year ended December 31, 2022, has been funds generated from proceeds from the sale of common stock and operations. The Company has experienced net losses from operations since its inception but expects these conditions to improve as it develops its business model. The Company has an accumulated deficit at September 30, 2023, and requires additional financing to fund future operations.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s existence is dependent upon management’s ability to develop profitable operations and obtain additional funding sources. There can be no assurance that the Company’s financing efforts will result in profitable operations or the resolution of the Company’s liquidity problems. The accompanying statements do not include any adjustments that might result should the Company be unable to continue as a going concern.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying unaudited consolidated financial statements have been prepared on a going-concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--UseOfEstimates_zzmIa4MjerM9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zUdfxb8qtVki">Use of Estimates in Financial Reporting</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities and disclosures of contingent assets and liabilities as of the date of the condensed consolidated financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the consolidated financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying consolidated financial statements include but are not limited to following those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, the allocation of the asset purchase price, contingencies, and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental, and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company’s consolidated financial statements will change as new events occur, as more experience is acquired, as additional information is obtained, and as the Company’s operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the unaudited consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_842_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zbLhew98nT5b" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_z0FPFMRcdos6">Cash and Cash Equivalents</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents are held in operating accounts at a major financial institution. Cash balances may exceed federally insured limits. Management believes the financial risk associated with these balances is minimal and has not experienced any losses to date. As of September 30, 2023, and December 31, 2022, the Company had cash balances within of FDIC-insured limits of $<span id="xdx_901_eus-gaap--TimeDepositLiabilityUninsured_iI_c20230930_zqiJzEcRsmWe" title="FDIC-insured limits"><span id="xdx_909_eus-gaap--TimeDepositLiabilityUninsured_iI_c20221231_zbgoGbsiTXWd" title="FDIC-insured limits">250,000</span></span>.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 250000 250000 <p id="xdx_84C_eus-gaap--ReceivablesPolicyTextBlock_zIvApOf4ZJC" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_zQmgmaS8DGc4">Accounts Receivable</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivables are recorded at the net value of face amount less an allowance for doubtful accounts. The Company evaluates its accounts receivable periodically based on specific identification of any accounts receivable for which the Company deems the net realizable value to be less than the gross amount of accounts receivable recorded; in these cases, an allowance for doubtful accounts is established for those balances. In determining its need for an allowance for doubtful accounts, the Company considers historical experience, analysis of past due amounts, client creditworthiness, and any other relevant available information. However, the Company’s actual experience may vary from its estimates. If the financial condition of its clients were to deteriorate, resulting in their inability or unwillingness to pay the Company’s fees, it may need to record additional allowances or write-offs in future periods. This risk is mitigated to the extent that the Company receives retainers from its clients prior to performing significant services.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The allowance for doubtful accounts, if any, is recorded as a reduction in revenue to the extent the provision relates to fee adjustments and other discretionary pricing adjustments. To the extent the provision relates to a client’s inability to make required payments on accounts receivables, the provision is recorded in operating expenses. As of September 30, 2023, and December 31, 2022, the Company’s allowance for doubtful accounts was $<span id="xdx_90D_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20230930_zqHELegA3KI" title="Allowance for Doubtful Accounts, Premiums and Other Receivables">4,070</span> and $<span id="xdx_901_eus-gaap--AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables_iI_c20221231_zhFfEDghfcJh">4,071</span>, respectively. The Company recorded a bad debt expense of $<span id="xdx_903_ecustom--BadDebtExpense_c20230701__20230930_zdJ4dueR0G0g" title="Bad debt expense">12,000</span> in the three months ending September 30, 2023. <span id="xdx_909_ecustom--BadDebtExpense_do_c20220701__20220930_zm77wYuU5uw" title="Bad Debt expense">No</span> bad debt expense was recorded for the similar period in 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 4070 4071 12000 0 <p id="xdx_840_eus-gaap--DepositContractsPolicy_zBNOvxZfklJg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86B_ztaeqYKaCxba">Deposits</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deposits comprise advance payments made to third parties for rent, utilities, and inventory for which the Company has not yet taken title. When the Company takes title to inventory for which deposits are made, the related amount is classified as inventory and then recognized as a cost of revenues upon sale.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--InventoryPolicyTextBlock_zXI2NTi3EjMc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zCG5hwEHLiud">Inventory</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory comprises products and equipment the Company owns to be sold to end customers. The Company’s inventory as it relates to its soil products and equipment is valued at cost using the first-in, first-out, and specific identification methods, unless and until the market value for the inventory is lower than cost, in which case an allowance is established to reduce the valuation to net realizable value. As of September 30, 2023, and December 31, 2022, market values of all the Company’s inventory were greater than cost, and accordingly, no such valuation allowance was recognized.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory also consists of pre-harvested cannabis plants and related end products. Inventory is valued at the lower of cost or net realizable value. Costs of inventory purchased from third-party vendors for retail sales at dispensaries are determined using the first in, first out method. Costs are capitalized to cultivated inventory until substantially ready for sale. Costs include direct and indirect labor, consumables, materials, packaging supplies, utilities, facilities costs, quality and testing costs, production-related depreciation, and other overhead costs. The Company periodically reviews physical inventory for excess, obsolete, and potentially impaired items. The reserve estimate for excess and obsolete inventory is based on expected future use and on an assessment of market conditions. At September 30, 2023, the Company’s management determined that a reserve for excess and obsolete inventory was not necessary.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock_zIrUW8NafUk1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zTjT6lLwlut3">Prepaid Expenses and Other Current Assets</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prepaid expenses and other current assets are primarily comprised of advance payments made to third parties for independent contractors’ services or other general expenses. Prepaid services and general expenses are amortized over the applicable periods, which approximate the life of the contract or service period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_z9dLjU92S2P1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zAaHZ5tgTrhl">Significant Clients and Customers</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, three customers accounted for 42.5% of the Company’s total revenues for the period.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2022, three customers accounted for 42.5% of the Company’s total revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_znYL4YcL6bhd" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zgiv1N0r7Cue">Property and Equipment, net</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and Equipment are stated at net book value, cost less depreciation. Maintenance and repairs are expensed as incurred. Depreciation of owned equipment is provided using the straight-line method over the estimated useful lives of the assets, ranging from two to seven years. Costs associated with in-progress construction are capitalized as incurred, and depreciation is consummated once the underlying asset is placed into service. Property and equipment are reviewed for impairment as discussed below under “Accounting for the Impairment of Long-Lived Assets.” The Company did not capitalize any interest as of September 30, 2023, and December 31, 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_848_eus-gaap--GoodwillAndIntangibleAssetsPolicyTextBlock_zBxzwuuZbGT5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zw8nY0ypwy2c">Goodwill</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill represents the excess of the purchase price over the fair value of assets acquired and liabilities assumed. The Company accounts for goodwill under <i>ASC Topic 350, Intangibles-Goodwill and Other</i>. The Company tests goodwill for impairment annually or more frequently whenever events or circumstances indicate impairment may exist. Goodwill is stated at cost less accumulated impairment losses. The Company completes its goodwill impairment test annually in the fourth quarter. The Company recognized goodwill of $<span id="xdx_90B_eus-gaap--Goodwill_iI_c20230930_z8sJokhv9rve" title="Goodwill">1,332,113</span> during the year ended December 31, 2022, as part of the Naturaleaf Acquisition.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not have any other indefinite-lived intangible assets. </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with FASB ASC 350, “Intangibles – Goodwill and Other,” the impairment test for goodwill uses a two-step approach. Step one compares the estimated fair value of a reporting unit with goodwill to its carrying value. If the carrying value exceeds the estimated fair value, step two must be performed. Step two compares the carrying value of the reporting unit to the fair value of all of the assets and liabilities of the reporting unit (including any unrecognized intangibles) as if the reporting unit was acquired in a business combination. If the carrying amount of a reporting unit’s goodwill exceeds the implied fair value of its goodwill, an impairment loss is recognized in an amount equal to the excess.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1332113 <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zYAiLSA9oW9l" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_zKJQ4Liy8fE1">Intangible Assets, net</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definite life intangible assets at September 30, 2023, include licenses and brand names recognized as part of the Naturaleaf Acquisition. Intangible assets are recorded at cost. Licenses and brand names represent the estimated fair value of these items at the date of acquisition, April 30, 2021. Intangible assets are amortized on a straight-line basis over their estimated useful life. Licenses are assigned a life of 15 years, and tradenames are assigned a life of 5 years. During the nine months ended September 30, 2023, the Company recognized a depreciation and amortization expense of $<span id="xdx_902_eus-gaap--DepreciationDepletionAndAmortization_c20220101__20221231_zzd7FpZgx4Fh" title="Depreciation and amortization expense">42,618</span>.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 42618 <p id="xdx_846_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_zdEotOWXtMub" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_zgCsNSVnMqoa">Accounting for the Impairment of Long-Lived Assets</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Upon such an occurrence, the recoverability of assets to be held and used is measured by comparing the carrying amount of an asset to forecasted undiscounted net cash flows expected to be generated by the asset. If the carrying amount of the asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset. For long-lived assets held for sale, assets are written down to fair value, less cost to sell. Fair value is determined based on discounted cash flows, appraised values, or management’s estimates, depending upon the nature of the assets. The Company had not recorded any impairment charges related to long-lived assets as of September 30, 2023, and December 31, 2022.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_846_eus-gaap--FairValueMeasurementPolicyPolicyTextBlock_zaZoVbDsBAS3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86A_zII0XP783duc">Fair Value Measurements</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability, in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. The fair value hierarchy is based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 1 – Quoted prices in active markets for identical assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 2 – Inputs other than Level 1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3 – Unobservable inputs that are supported by little or no market activity and that are significant to the measurement of the fair value of the assets or liabilities.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our financial instruments include cash, deposits, accounts receivable, accounts payables, advances from clients, accrued expense, and other current liabilities. The carrying values of these financial instruments approximate their fair value due to their short maturities.  </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--RevenueRecognitionPolicyTextBlock_zcrwK80Gvfv9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86F_za2QHfoyzkt5">Revenue Recognition</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have adopted the following accounting principles related to revenue recognition: (a) FASB ASU 2016-12 “<i>Revenue from Contracts with Customers (Topic 606). </i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0 0 6pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our service and product revenues arise from contracts with customers. Service revenue includes Operations Divisions' consulting revenue. Product revenue includes (a) Operations Division product sales (So-Hum Living Soils), (b) Equipment sales division, and (c) Cannabis sales division. The majority of our revenue is derived from distinct performance obligations, such as time spent delivering a service or the delivery of a specific product.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may also enter contracts with customers that identify a single or few distinct performance obligations, but that also have non-distinct, underlying performance obligations. These contracts are typically fulfilled within one to six months. Only an insignificant portion of our revenue would be assessed for allocation between distinct (contractual) performance obligations and non-distinct deliverables between reporting periods, and accordingly, we do not record a contract asset for completed, non-distinct performance obligations prior to invoicing the customer.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue in accordance with ASC 606 using the following five steps to identify revenues:</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(1)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the contract with the Customer. </i>Our customary practice is to obtain written evidence, typically in the form of a contract or purchase order.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(2)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identify the performance obligations in the contract. </i>We have rights to payment when services are completed in accordance with the underlying contract, or for the sale of goods when custody is transferred to our customers either upon delivery to our customers’ locations, with no right of return or further obligations.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(3)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price. </i>Prices are typically fixed, and no price protections or variables are offered.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(4)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i>. Transaction prices are typically allocated to the performance obligations outlined in the contract.</span></td></tr> <tr style="vertical-align: top"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(5)</i></span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognize Revenue when (or as) the entity satisfies a performance obligation. </i>We typically require a retainer for all or a portion of the goods or services to be delivered. We recognize revenue as the performance obligations detailed in the contract are met.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advances from Client deposits are contract liabilities with customers that represent our obligation to either transfer goods or services in the future or refund the amount received. Where possible, we obtain retainers to lessen our risk of non-payment by our customers. Advances from Clients' deposits are recognized as revenue as we meet specified performance obligations as detailed in the contract.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--ProductAndEquipmentSalesPolicyTextBlock_zgQXCeQ6fdCg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_z6G0VZzRKVkg">Product and Equipment Sales</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from product and equipment sales, including delivery fees, is recognized when an order has been obtained from the customer, the price is fixed and determinable when the order is placed, the product is delivered, the title has been transferred, and collectability is reasonably assured. Generally, our suppliers drop-ship orders to our clients with destination terms. The Company realizes revenue upon delivery to the customer. Given the facts that (1) our customers exercise discretion in determining the timing of when they place their product order; and, (2) the price negotiated in our product sales contracts is fixed and determinable at the time the customer places the order, we are not of the opinion that our product sales indicate or involve any significant financing that would materially change the amount of revenue recognized under the contract, or would otherwise contain a significant financing component for us or the customer under FASB ASC Topic 606. During the six months that ended September 30, 2023, and 2022, sales returns were $0.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_ecustom--ConsultingServicesPolicyTextBlock_zj8nr3BrmNHl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zVy5VFrGecza">Consulting Services</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We also generate revenues from professional services consulting agreements. These arrangements are generally entered into: (1) on an hourly basis for a fixed fee; or (2) on a contingent fee basis. Generally, we require a complete or partial prepayment or retainer prior to performing services. For hourly-based fixed-fee service contracts, we utilize and rely upon the proportional performance method, which recognizes revenue as services are completed. Under this method, to determine the amount of revenue to be recognized, we calculate the amount of completed work in comparison to the total services to be provided under the arrangement or deliverable. We segregate upon entry into a contract any advances or retainers received from clients for fixed fee hourly services into a separate “Advances from Clients account and only recognize revenues as we incur and charge billable hours, and then deposit the funds earned into our operating account. Because our hourly fees for services are fixed and determinable and are only earned and recognized as revenue upon actual performance, we are of the opinion that such arrangements are not an indicator of a vendor or customer-based significant financing that would materially change the amount of revenue we recognize under the contract or would otherwise contain a significant financing component under FASB ASC Topic 606.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Occasionally, our fixed-fee hourly engagements are recognized under the completed performance method. Some fixed fee arrangements are for the completion of a final deliverable or act which is significant to the arrangement. These engagements do not generally exceed a one-year term. If the performance is for a final deliverable or act, we recognize revenue under the completed performance method, in which revenue is recognized once the final act or deliverable is performed or delivered for a fixed fee. Revenue recognition is affected by several factors that change the estimated amount of work required to complete the deliverable, such as changes in scope, timing, awaiting notification of license award from local government, and the level of client involvement. Losses, if any, on fixed-fee engagements are recognized in the period in which the loss first becomes probable and reasonably estimable. FASB ASC Topic 606 provides a practical expedient to disregard the effects of a financing component if the period between payment and performance is one year or less. As our fixed fee hourly engagements do not exceed one year, no significant customer-based financing is implicated under FASB ASC Topic 606. During the six months ended September 30, 2023, and 2022, we incurred no losses from fixed fee engagements that terminated prior to completion. We believe that if an engagement terminates prior to completion, we can recover the costs incurred related to the services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We primarily enter arrangements for which fixed and determinable revenues are contingent and agreed upon, achieving a pre-determined deliverable or future outcome. Any contingent revenue for these arrangements is not recognized until the contingency is resolved and collectability is reasonably assured.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our arrangements with clients may include terms to deliver multiple services or deliverables. These contracts specifically identify the services to be provided with the corresponding deliverable. The value for each deliverable is determined based on the prices charged when each element is sold separately or by other vendor-specific objective evidence (“VSOE”) or estimates of stand-alone selling prices. Revenues are recognized in accordance with our accounting policies for the elements as described above (see Product Sales). The elements qualify for separation when the deliverables have value on a stand-alone basis, and the value of the separate elements can be established by VSOE or an estimated selling price.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While assigning values and identifying separate elements requires judgment, selling prices of the separate elements are generally readily identifiable as fixed and determinable as we also sell those elements individually outside of a multiple services engagement. Contracts with multiple elements typically incorporate a fixed-fee or hourly pricing structure. Arrangements are typically terminable by either party upon sufficient notice or do not include provisions for refunds relating to services provided.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Reimbursable expenses, including those relating to travel, other out-of-pocket expenses, and any third-party costs, are included as a component of revenues. Typically, an equivalent amount of reimbursable expenses is included in total direct client service costs. Reimbursable expenses related to time and materials and fixed-fee engagements are recognized as revenue in the period in which the expense is incurred and collectability is reasonably assured. Taxes collected from customers and remitted to governmental authorities are recognized as liabilities and paid to the appropriate government entities.</span></p> <p style="margin: 0; text-align: justify"></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--CannabisSalesPolicyTextBlock_zry4IkGWt0vi" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_865_zPH1bd0UUM84">Cannabis Sales</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues consist of the retail sale of cannabis and related products. Revenue is recognized at the point of sale for retail customers. Payment is typically due upon transferring the goods to the customer or within a specified time permitted under the Company’s credit policy. Sales discounts were not material during the three or nine months ended September 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_ecustom--LoyaltyRewardProgramPolicyTextBlock_ziqFCeKYuTl4" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zmBruaO4qRj5">Loyalty Reward Program</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company offers a loyalty reward program to its dispensary customers that provides a discount on purchases based on the total purchase amount at the time of purchase. Management has determined that there is no separate performance obligation to the reward program, i.e., the accumulation and redemption of points, and as such, the Company recognizes the revenue at the time of purchase.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--CostOfSalesPolicyTextBlock_zVBJ0dmGRyV5" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zVDsRE7BsVMe">Costs of Revenues</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s policy is to recognize costs of revenue in the same manner in conjunction with revenue recognition. Cost of revenue includes the costs directly attributable to revenue recognition and includes compensation and fees for services, travel, and other expenses for services and costs of products and equipment. Selling, general, and administrative expenses are charged to expenses as incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--AdvertisingCostsPolicyTextBlock_zXEuYhLArTp2" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zOdcCs8Wk5Ji">Advertising and Promotion Costs</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advertising and Promotion costs are included as a component of selling and marketing expenses and are expensed as incurred. During the nine months ended September 30, 2023, and 2022, these expenses were $<span id="xdx_90D_eus-gaap--OtherSellingAndMarketingExpense_c20230101__20230930_zB2UGwCwC3Wg" title="Advertising and Promotion Costs">169,059</span> and $<span id="xdx_90C_eus-gaap--OtherSellingAndMarketingExpense_c20220101__20220930_z6q50kamPPv9" title="Advertising and Promotion Costs">165,544</span>, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 169059 165544 <p id="xdx_847_eus-gaap--ShippingAndHandlingCostPolicyTextBlock_zJUfN2LLLTW" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zdSIr1lrIRwg">Shipping and Handling Costs</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For product and equipment sales, shipping and handling costs are included as a component of the cost of revenues.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z0LrsSELwn4g" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86E_ztlEvCP8nFgc">Stock-Based Compensation</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restricted shares are awarded to employees and entitle the grantee to receive shares of common stock at the end of the established vesting period. The grant's fair value is based on the stock price on the grant date. We recognize related compensation costs on a straight-line basis over the requisite vesting period of the award, which has been one year from the grant date. During the nine months ended September 30, 2023, and 2022, stock-based compensation expense for restricted shares for Company employees was $<span id="xdx_908_ecustom--StockbasedCompensationExpense_c20230101__20230930_zy34RdKIfrR9" title="Stock based compensation expense">17,021</span> and $<span id="xdx_900_ecustom--StockbasedCompensationExpense_c20220101__20220930_zCaGIT6TFuQ6" title="Stock based compensation expense">121,479</span>, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 17021 121479 <p id="xdx_842_eus-gaap--ResearchAndDevelopmentExpensePolicy_zLoBbo99ONC4" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_864_zGdMqzBQTA6h">Research and Development</span></i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a component of our equipment and supplies offerings, from time to time, we design and develop our own proprietary products to meet demand in markets where current offerings are insufficient. These products include but are not limited to The Satchel™, Cultivation Cube™, So-Hum Living Soils™, and the HDCS™. Costs associated with the development of new products are expensed as incurred as research and development operating expenses. During the nine months ending September 30, 2023, and 2022, our research and development costs were de minimis.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84F_eus-gaap--IncomeTaxPolicyTextBlock_zopcyU7JMIWi" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86C_zqgOaxRPdAJd">Income Taxes</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s corporate status changed from an S Corporation, which it had been since its inception, to a C Corporation during the year ended December 31, 2014. As provided in Section 1361 of the Internal Revenue Code, for income tax purposes, S Corporations are not subject to corporate income taxes; instead, the owners are taxed on their proportionate share of the S Corporation’s taxable income. We recognize deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns in accordance with applicable accounting guidance for accounting for income taxes, using currently enacted tax rates in effect for the year in which the differences are expected to reverse. We record a valuation allowance when necessary to reduce deferred tax assets to the amount expected to be realized. For the year ended December 31, 2022, due to cumulative losses since our corporate status changed, we recorded a valuation allowance against our deferred tax asset that reduced our income tax benefit for the period to zero. As of September 30, 2023, and December 31, 2022, we had no liabilities related to federal income taxes, and the carrying value of our federal deferred tax asset was zero.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Due to its cannabis operations, the Company is subject to the limitations of Internal Revenue Code (“<b>IRC</b>”) Section 280E, under which the Company is only allowed to deduct expenses directly related to sales of product. This results in permanent differences between ordinary and necessary business expenses deemed non-allowable under IRC Section 280E.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--EarningsPerSharePolicyTextBlock_za88ldoFU1h3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_867_z2v7cFwCA3Yh">Net Loss Per Common Share</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company reports net loss per common share in accordance with FASB ASC 260, “Earnings per Share.” This statement requires a dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted earnings per share is equal to basic earnings per share because there are no potential dilatable instruments that would have an anti-dilutive effect on earnings. Diluted net loss per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise, or contingent exercise of securities since that would have an anti-dilutive effect on earnings.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_ecustom--RelatedPartyTransactionsPolicyTextBlock_z2A3UZUO1pOc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_86D_z7h05bwxZkdi">Related Party Transactions</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company follows FASB ASC subtopic 850-10, <i>Related Party Disclosures,</i> for the identification of related parties and disclosure of related party transactions.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84E_ecustom--ImpactOfCovid19PandemicPolicyTextBlock_zm1j3kpCuv7b" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_863_zuCdocwKGCnl">Impact of COVID-19 Pandemic</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On March 11, 2020<i>, </i>the World Health Organization declared the current coronavirus (“COVID-<i>19”</i>) outbreak to be a global pandemic. In response to this declaration and the rapid spread of COVID-<i>19</i> within the United States, federal, state and local governments throughout the country have imposed varying degrees of restrictions on social and commercial activity to promote social distancing in an effort to slow the spread of the illness. These measures had a significant adverse impact on many sectors of the economy, including retail commerce.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In response to state and local measures and for the protection of both employees, the Company made required changes to operations, which did not have a material impact on operations or the financial condition of the Company.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">While the state and local governments have eased restrictions on restrictions and activities, it is possible that a resurgence in COVID-<i>19</i> cases could prompt a return to or new tighter restrictions to be instituted in the future. The Company is not aware of any specific event or circumstance that would require an update to its estimates or judgments or a revision of the carrying value of its assets or liabilities as of the date of issuance of these unaudited condensed consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zUNFE5rrrnJj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zplpgYMs2vp2">Recent Accounting Pronouncements</span></i></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective if adopted, would have a material effect on the accompanying unaudited condensed consolidated financial statements.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_803_eus-gaap--AssetAcquisitionTextBlock_z49ENmDdFVhk" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 4. <span id="xdx_823_z9DeP5PP9gfj">Naturaleaf Asset Acquisition</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2021, the Company closed its acquisition of the assets of Medihemp, LLC, and its wholly owned subsidiary SLAM Enterprises, LLC, and Medical Cannabis Caregivers, Inc., each an entity organized and operating under the laws of the State of Colorado, and all doing business as “Naturaleaf” in the medicinal cannabis industry in Colorado.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Naturaleaf agreed to sell or assign to the Company the following assets:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Three Medical Marijuana (MMC) Store Licenses;</span></td></tr> </table> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Marijuana Infused Product Licenses (MIPS); and,</span></td></tr> </table> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One Option Premises Cultivation License (OPC); and,</span></td></tr> </table> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 24px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Related real property assets, goodwill, and related business assets.</span></td></tr> </table> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The aggregate consideration paid for the Assets was $2,890,000, which consisted of (i) a cash payment of $1,100,000, (ii) the issuance of a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”), and (iii) the issuance of 3,000,000 shares of the Company’s restricted common stock valued at $0.23 per share or $690,000.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 29, 2022, the Company and Naturaleaf amended the promissory note to restructure the payment schedule ("First Amendment"). The parties agreed that in consideration of the Company's payment of $550,000, and outstanding interest of $110,000, a new promissory note with a maturity date of April 29, 2023, in the principal amount of $550,000 and 12% interest accruing annually, would resolve all Company payments of the purchase price. The parties entered into the First Amendment, and the Company paid the consideration of $550,000 in principal and $110,000 in interest.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 8, 2023, the Company and Naturaleaf amended the promissory note ("Second Amendment") to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The asset acquisition was accounted for under the acquisition method of accounting in accordance with ASC Topic 805, <i>Business Combinations</i>. As the acquirer for accounting purposes, the Company has estimated the fair value of Medihemp LLC and Medical Cannabis Caregivers, Inc.’s (hereafter “Naturaleaf’s”) assets acquired and conformed the accounting policies of Naturaleaf to its own accounting policies. The Company expenses certain legal, auditing and licensing costs with the acquisition of $83,095. </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the acquisition, the owners of Naturaleaf retained the outstanding cash balance on the date of the acquisition and had agreed to the payment of all outstanding accounts payables and related party advances.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill from the acquisition primarily relates to the future economic benefits arising from the assets acquired, the assembled workforce acquired and synergies between the cultivation and retail operations and is consistent with the Company’s stated intentions and strategy. Other assets include inventory and fixed assets.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2022, the Company finalized its valuation of Naturaleaf tangible and intangible assets and goodwill as of the acquisition date. The following table summarizes the final fair value allocation of the purchase price as of April 30, 2021:</span></p> <p id="xdx_895_eus-gaap--BusinessCombinationSegmentAllocationTableTextBlock_zr4WRTYpvpca" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zlUuguWX9A7a" style="display: none">Business Combination, Segment Allocation</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_302_134_zVXHMVVNAYZe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20230930_z2XefYQq15u3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zRm3JlwhSmHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zhdYLANNyyK8" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_z64FOshhl4o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zur4c82k7zu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zjie14LzXgDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Tangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,887</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedTradenamesAndTrademarks_iI_ziwukWXDw2a7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradenames and Trademarks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLicenses_iI_z5Uj0hODLzqk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--FiniteLivedIntangibleAssetsGrossAssets_iI_z9EqJwMvLl8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Intangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,460,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_zz3gLPTjS4Sj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,332,113</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_zr0FXcj8ojF3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Consideration</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,912,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AB_z6oJavcZXu75" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 31, 2023, the Company sold Colorado State License No. 402-01065 (Medical Marijuana Store) and City of Colorado Springs License No. 0850714L in exchange for $100,000. The transaction's closing is pending approval by the Colorado Marijuana Enforcement Division. As of May 31, 2023, the Company discontinued its operations at Palmer Park Boulevard, Ste. A, Colorado Springs, CO location. The Company will continue to rent the facility on a month-to-month tenancy pending final regulatory approval from the Colorado Marijuana Enforcement Division concerning the change of ownership.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the nine months ended September 30, 2023, and 2022, the Company recognized an amortization expense of $138,999 and $70,000, respectively.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_eus-gaap--BusinessCombinationSegmentAllocationTableTextBlock_zr4WRTYpvpca" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zlUuguWX9A7a" style="display: none">Business Combination, Segment Allocation</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_302_134_zVXHMVVNAYZe" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Naturaleaf Asset Acquisition (Details)"> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_491_20230930_z2XefYQq15u3" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_iI_zRm3JlwhSmHh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Assets</span></td><td style="width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 18%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_iI_zhdYLANNyyK8" style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">72,172</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment_iI_z64FOshhl4o7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property, Plant and Equipment</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">26,715</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets_iI_zur4c82k7zu7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Assets</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_iI_zjie14LzXgDf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Tangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">119,887</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedTradenamesAndTrademarks_iI_ziwukWXDw2a7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tradenames and Trademarks</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_ecustom--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLicenses_iI_z5Uj0hODLzqk" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_ecustom--FiniteLivedIntangibleAssetsGrossAssets_iI_z9EqJwMvLl8l" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Intangible Assets</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,460,000</span></td><td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iI_zz3gLPTjS4Sj" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,332,113</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AssetAcquisitionContingentConsiderationLiability_iI_zr0FXcj8ojF3" style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Consideration</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,912,000</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 15000 72172 26715 6000 119887 660000 800000 1460000 1332113 2912000 <p id="xdx_800_eus-gaap--LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_zFhIrgd9pUUd" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 5. <span id="xdx_820_zjOBz0xuZUd9">Accounts Receivable and Advance from Clients</span>    </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts receivable were comprised of the following:</span></p> <p id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z56TBJKymVLl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zuFe3KN2OSb9" style="display: none">Schedule of accounts receivable and advances from clients</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_zHnrC68XTMCa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable – Trade</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AccountsReceivableGross_iI_c20230930_zeIxydy1g2u4" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,557</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--AccountsReceivableGross_iI_c20221231_z1MPIDR47O5i" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,111</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:  Allowance for Doubtful Accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_c20230930_zAYSuGqHnaWc" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,070</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_c20221231_zkFT3YFMWmZ4" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,071</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AccountsAndNotesReceivableNet_iI_c20230930_zhPh3FMkCEU3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accounts Receivable, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202,487</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AccountsAndNotesReceivableNet_iI_c20221231_z97AYXg4eF69" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accounts Receivable, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,040</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zN1uiLIiVac7" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had bad debt expenses during the nine months ended September 30, 2023, and 2022 of $<span id="xdx_904_ecustom--BadDebtExpenses_c20230101__20230930_zTtcTriOw4W3" title="Bad debt expenses">12,000</span> and $<span id="xdx_907_ecustom--BadDebtExpenses_c20220101__20220930_zSPHOiuc1Cze">0</span>, respectively.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our Advances from Clients had the following activity:</span></p> <p id="xdx_897_ecustom--ScheduleOfAdvanceFromClientsTableTextBlock_z682eY1MyuGe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zEp5Vxn5D2Zk" style="display: none">Schedule of advances from clients</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zqcI9zxYR4Ea" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning Balance</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AdvancesToAffiliate_iI_c20230930_zQg7d1CDKYLl" style="width: 12%; text-align: right" title="Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,213</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AdvancesToAffiliate_iI_c20221231_zTWkyN2YZ91d" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--AdditionalDepositsReceived_iI_c20230930_zkVrdwgZJ7J8" style="text-align: right" title="Additional deposits received"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--AdditionalDepositsReceived_iI_c20221231_zHb5fCzqzIPc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">691,769</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--LessDepositsRecognizedAsRevenue_iI_c20230930_zKmpcDDxJRsh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Deposits recognized as revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(109,875</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--LessDepositsRecognizedAsRevenue_iI_c20221231_zqOIz4ZoHaQ4" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,663</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending Balance</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--AdvancesFromClientOne_iI_c20230930_zAnCc4NQG8Jd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,267</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--AdvancesFromClientOne_iI_c20221231_zsfs8iiBkhfj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,705</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A4_zVryiXPxWddc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89A_eus-gaap--ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_z56TBJKymVLl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zuFe3KN2OSb9" style="display: none">Schedule of accounts receivable and advances from clients</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_300_134_zHnrC68XTMCa" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details)"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable – Trade</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AccountsReceivableGross_iI_c20230930_zeIxydy1g2u4" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,557</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--AccountsReceivableGross_iI_c20221231_z1MPIDR47O5i" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">469,111</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less:  Allowance for Doubtful Accounts</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_c20230930_zAYSuGqHnaWc" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,070</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--AllowanceForDoubtfulAccountsReceivableCurrent_iNI_di_c20221231_zkFT3YFMWmZ4" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,071</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts Receivable, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--AccountsAndNotesReceivableNet_iI_c20230930_zhPh3FMkCEU3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accounts Receivable, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">202,487</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--AccountsAndNotesReceivableNet_iI_c20221231_z97AYXg4eF69" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Accounts Receivable, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">465,040</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 206557 469111 4070 4071 202487 465040 12000 0 <p id="xdx_897_ecustom--ScheduleOfAdvanceFromClientsTableTextBlock_z682eY1MyuGe" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zEp5Vxn5D2Zk" style="display: none">Schedule of advances from clients</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30A_134_zqcI9zxYR4Ea" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accounts Receivable and Advance from Clients (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning Balance</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AdvancesToAffiliate_iI_c20230930_zQg7d1CDKYLl" style="width: 12%; text-align: right" title="Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">156,213</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AdvancesToAffiliate_iI_c20221231_zTWkyN2YZ91d" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">111,892</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Additional deposits received</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_ecustom--AdditionalDepositsReceived_iI_c20230930_zkVrdwgZJ7J8" style="text-align: right" title="Additional deposits received"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,929</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_ecustom--AdditionalDepositsReceived_iI_c20221231_zHb5fCzqzIPc" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">691,769</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  Less: Deposits recognized as revenue</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98D_ecustom--LessDepositsRecognizedAsRevenue_iI_c20230930_zKmpcDDxJRsh" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Deposits recognized as revenue"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(109,875</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_ecustom--LessDepositsRecognizedAsRevenue_iI_c20221231_zqOIz4ZoHaQ4" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(522,663</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending Balance</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_ecustom--AdvancesFromClientOne_iI_c20230930_zAnCc4NQG8Jd" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">55,267</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_ecustom--AdvancesFromClientOne_iI_c20221231_zsfs8iiBkhfj" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">280,705</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 156213 111892 8929 691769 -109875 -522663 55267 280705 <p id="xdx_809_eus-gaap--InventoryDisclosureTextBlock_zOuIKmb21sl9" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 6. <span id="xdx_82D_zRLGk3rGmcsl">Inventory</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inventory consisted of the following:</span></p> <p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z5RRFK1ZWN3e" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zENjdw5iozS" style="display: none">Schedule of inventory</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zuDTgIdMv6Ae" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_491_20230930_zY2WqCMCSWX4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49D_20221231_z6M49UeIRTD2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr id="xdx_408_eus-gaap--InventoryRawMaterials_iI_z7SkL11QnGDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw Materials - Soil</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,272</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_zPRIkDPgkA4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work In Process - Cultivation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">473,587</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--FinishedGoodsSoil_iI_zDsG0gMhxlli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods - Soil</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_zyblks3aUBMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods - Cannabis Retail</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,612</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,644</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--InventoryNoncurrent_iI_zSND0d7I7lKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Inventory</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">518,288</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352,971</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A2_zc4lK2lqpSif" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfInventoryCurrentTableTextBlock_z5RRFK1ZWN3e" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B2_zENjdw5iozS" style="display: none">Schedule of inventory</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_30E_134_zuDTgIdMv6Ae" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Inventory (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_491_20230930_zY2WqCMCSWX4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" id="xdx_49D_20221231_z6M49UeIRTD2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr id="xdx_408_eus-gaap--InventoryRawMaterials_iI_z7SkL11QnGDl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Raw Materials - Soil</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,272</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--InventoryWorkInProcess_iI_zPRIkDPgkA4e" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Work In Process - Cultivation</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">473,587</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">206,306</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_404_ecustom--FinishedGoodsSoil_iI_zDsG0gMhxlli" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods - Soil</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">817</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">66,557</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--InventoryFinishedGoods_iI_zyblks3aUBMd" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Finished Goods - Cannabis Retail</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,612</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">41,644</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40B_eus-gaap--InventoryNoncurrent_iI_zSND0d7I7lKb" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Inventory</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">518,288</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">352,971</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 7272 38464 473587 206306 817 66557 36612 41644 518288 352971 <p id="xdx_805_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zdwKkEHZeOIh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 7. <span id="xdx_82D_zw9P27vVr6Wb">Property and Equipment, net</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net, was comprised of the following:</span></p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zInVoXHbE3N3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zlziHKsvcyDl" style="display: none">Schedule of property, plant and equipment, net</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_zpFfRskMVgi5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment net (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZHDusBjMu68" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1CNtpcLXKMi" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zkET8T3r59yf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zNlLw6c3xzLj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z6jlzV6ceTx8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuKQrCjnbgj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zlIRzGPVsEZf" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">517,510</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zLW4s1aUOq9h" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,520</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930_zP2cmNXspPre" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">580,422</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zmW4wsgCu6Sf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,432</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated Depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zolc2jgk0aL" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(156,268</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zX7qr4P6CRok" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(113,650</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetOther_iI_c20230930_zV6c1HIbzYY3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">424,155</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetOther_iI_c20221231_zGiGIYDNZGbf" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,782</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zBYiiTF1Zlrl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 6pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_893_eus-gaap--PropertyPlantAndEquipmentTextBlock_zInVoXHbE3N3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zlziHKsvcyDl" style="display: none">Schedule of property, plant and equipment, net</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_zpFfRskMVgi5" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Property and Equipment net (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zZHDusBjMu68" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_z1CNtpcLXKMi" style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">47,380</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Software</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zkET8T3r59yf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98B_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--SoftwareDevelopmentMember_zNlLw6c3xzLj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,204</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furniture and Fixtures</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_988_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_z6jlzV6ceTx8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--FurnitureAndFixturesMember_zuKQrCjnbgj" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,328</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Machinery and Equipment</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98C_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zlIRzGPVsEZf" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">517,510</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231__us-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--MachineryAndEquipmentMember_zLW4s1aUOq9h" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">364,520</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, gross</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20230930_zP2cmNXspPre" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">580,422</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--PropertyPlantAndEquipmentGross_iI_c20221231_zmW4wsgCu6Sf" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">427,432</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: Accumulated Depreciation</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_985_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20230930_zolc2jgk0aL" style="border-bottom: Black 1pt solid; text-align: right" title="Less: Accumulated Depreciation"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(156,268</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_982_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_c20221231_zX7qr4P6CRok" style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(113,650</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_ecustom--PropertyPlantAndEquipmentNetOther_iI_c20230930_zV6c1HIbzYY3" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">424,155</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_ecustom--PropertyPlantAndEquipmentNetOther_iI_c20221231_zGiGIYDNZGbf" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Property and equipment, net"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">313,782</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 47380 47380 13204 13204 2328 2328 517510 364520 580422 427432 156268 113650 424155 313782 <p id="xdx_80F_eus-gaap--IntangibleAssetsDisclosureTextBlock_zmJjuF2hpKcc" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 8. <span id="xdx_82B_zmdiJEtlUoB6">Intangibles Assets, Ne</span>t</b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A significant amount of the Company’s current identified intangible assets were assumed upon consummation of the Naturaleaf acquisition on April 30, 2021. The Company has incurred capitalizable costs in connection with patent applications that it started work on. Identified intangible assets consisted of the following at the dates indicated below: </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zTqwiKPVdX92" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zabzUGtJHwVj" style="display: none">Schedule of Identified intangible asset</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_z69dC4q6Q2gi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangibles Assets, Net (Details)"> <tr style="vertical-align: bottom"> <td></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, 2023</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross <br/> carrying <br/> amount</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated <br/> amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying<br/> value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated<br/> useful <br/> life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z62lesRM8ge" style="width: 10%; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoSRfMnI6Jl7" style="width: 10%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,522</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zvs9F3hLmnsg" style="width: 10%; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,448</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20230101__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zT7RMKzg03F8" title="Estimated useful life">15</span> years</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zq3fP96ZO8ec" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zDFlHRDwhCS3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z5d6zZV5BoSk" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20230101__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z8FtHOIQLRU8" title="Estimated useful life">5</span> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent Applications</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z73bjkwZmrF3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zaqVML6RtXw6" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0845">—</span>  </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrzp8vUG4Fcf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—  </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930_zhzZW3Mcxs16" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,478,464</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930_zia7fjMli4c6" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930_zWBi377LEit8" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,130,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross <br/> carrying <br/> amount</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated <br/> amortization</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying <br/> value</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated <br/> useful <br/> life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_znWhV0VzebR4" style="width: 16%; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">818,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zbYSrNhLz6Ei" style="width: 16%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,522</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zsTfUH0RxoLg" style="width: 15%; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,912</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zZhehnjNjCJl" title="Estimated useful life">15</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z2L77PTBKCoe" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zXtv4KTVLbVi" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zY8LmusdF355" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,330</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zIxTXTzgxZCc" title="Estimated useful life">5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231_zL8FlebKRYo2" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,488,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231_zO2lPPart6Bi" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,222</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_z3HDjl31lnn8" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233,242</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_8A8_zaqW1AKUZsej" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The weighted-average amortization period for intangible assets we acquired during the year ended December 31, 2022, was approximately 11.47 years. No intangible assets were acquired during the nine months ending September 30, 2023.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expense for intangible assets was $<span id="xdx_909_eus-gaap--AdjustmentForAmortization_c20230101__20230930_zQfA4xXoHR1b" title="Amortization expense">139,000</span> and $<span id="xdx_90B_eus-gaap--AdjustmentForAmortization_c20220101__20220930_zvKekde7vym7" title="Amortization expense">72,520</span> for the nine months ended September 30, 2023 and 2022, respectively. The total estimated amortization expense for our intangible assets for the years 2022 through 2026 is as follows:</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"></p> <p id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zoT6ivsjq6ij" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zcU7IWc3YChi"><span id="xdx_8BB_zcuXIOhGOay5" style="display: none">Schedule of estimated amortization expense</span></span></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_300_134_zG1NCQ7JfRLj" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangibles Assets, Net (Details 1)"> <tr style="vertical-align: middle"> <td style="border: #CCCCCC 1pt solid; text-align: left; font-weight: bold"> </td> <td id="xdx_4BE_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--LicenseMember_zbUdoDj2uDHe" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold"> </td> <td id="xdx_4BD_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_custom--BrandMember_zmy04qCjwsFg" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold"> </td> <td id="xdx_4B4_zEHPjFqO2c39" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"> </td></tr> <tr style="vertical-align: middle"> <td style="border: #CCCCCC 1pt solid; text-align: left; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td></tr> <tr id="xdx_43B_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod_iI_pp2d_zff5cNQwrHIk" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000.00 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000.00 </span></td></tr> <tr id="xdx_434_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonth_iI_pp2d_zewgCorQnop8" style="vertical-align: middle"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_436_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo1_iI_pp2d_zJUvJ8Uxzvm1" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_43A_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree1_iI_pp2d_zqyc2OEOuWdh" style="vertical-align: middle"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_432_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour1_iI_pp2d_zBaCKRiFoqA9" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,333.33 </span></td></tr> <tr id="xdx_439_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive1_iI_pp2d_zyDI6dcbp7D1"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,111.35 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,111.35 </span></td></tr> <tr id="xdx_431_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFiveTotal_iI_pp2d_zY6FJdODQkE6"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">652,885.76 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,669 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,124,555.07</span></td></tr> </table> <p id="xdx_8A1_z4VOfghTYpWl" style="margin: 0 0 6pt; text-align: center"> </p> <p style="margin: 0 0 6pt; text-align: center"></p> <p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zTqwiKPVdX92" style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B4_zabzUGtJHwVj" style="display: none">Schedule of Identified intangible asset</span></span></p> <table cellpadding="0" cellspacing="0" id="xdx_305_134_z69dC4q6Q2gi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Intangibles Assets, Net (Details)"> <tr style="vertical-align: bottom"> <td></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="15" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, 2023</span></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross <br/> carrying <br/> amount</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated <br/> amortization</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying<br/> value</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated<br/> useful <br/> life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_z62lesRM8ge" style="width: 10%; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">800,000</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_987_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zoSRfMnI6Jl7" style="width: 10%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">174,522</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zvs9F3hLmnsg" style="width: 10%; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">625,448</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20230101__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zT7RMKzg03F8" title="Estimated useful life">15</span> years</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zq3fP96ZO8ec" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_98A_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zDFlHRDwhCS3" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">219,669</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z5d6zZV5BoSk" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">440,331</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20230101__20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z8FtHOIQLRU8" title="Estimated useful life">5</span> years</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Patent Applications</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_z73bjkwZmrF3" style="border-bottom: Black 1pt solid; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98F_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zaqVML6RtXw6" style="border-bottom: Black 1pt solid; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0845">—</span>  </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--PatentsMember_zrzp8vUG4Fcf" style="border-bottom: Black 1pt solid; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,464</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">—  </span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20230930_zhzZW3Mcxs16" style="border-bottom: Black 2.5pt double; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,478,464</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20230930_zia7fjMli4c6" style="border-bottom: Black 2.5pt double; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">347,888</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20230930_zWBi377LEit8" style="border-bottom: Black 2.5pt double; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,130,576</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 2.5pt; text-align: right"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="13" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></p></td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gross <br/> carrying <br/> amount</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated <br/> amortization</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Carrying <br/> value</span></td><td style="font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Estimated <br/> useful <br/> life</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 18%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licenses</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_znWhV0VzebR4" style="width: 16%; text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">818,464</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_98B_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zbYSrNhLz6Ei" style="width: 16%; text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">134,522</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zsTfUH0RxoLg" style="width: 15%; text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,912</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 17%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--LicenseMember_zZhehnjNjCJl" title="Estimated useful life">15</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_z2L77PTBKCoe" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">660,000</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zXtv4KTVLbVi" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">120,670</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zY8LmusdF355" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">539,330</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_ecustom--FiniteLivedIntangibleAssetUsefulLifeOne_dtY_c20220101__20221231__us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--BrandMember_zIxTXTzgxZCc" title="Estimated useful life">5</span> years</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total intangible assets, net</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_pp0p0_c20221231_zL8FlebKRYo2" style="text-align: right" title="Gross Carrying amount"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,488,464</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">($</span></td><td id="xdx_988_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_pp0p0_c20221231_zO2lPPart6Bi" style="text-align: right" title="Accumulated amortization"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">255,222</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_pp0p0_c20221231_z3HDjl31lnn8" style="text-align: right" title="Carrying value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,233,242</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 800000 174522 625448 15 660000 219669 440331 5 18464 18464 1478464 347888 1130576 818464 134522 683912 15 660000 120670 539330 5 1488464 255222 1233242 139000 72520 <p id="xdx_89F_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zoT6ivsjq6ij" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B0_zcU7IWc3YChi"><span id="xdx_8BB_zcuXIOhGOay5" style="display: none">Schedule of estimated amortization expense</span></span></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table border="0" cellpadding="0" cellspacing="0" id="xdx_300_134_zG1NCQ7JfRLj" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Intangibles Assets, Net (Details 1)"> <tr style="vertical-align: middle"> <td style="border: #CCCCCC 1pt solid; text-align: left; font-weight: bold"> </td> <td id="xdx_4BE_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_us-gaap--LicenseMember_zbUdoDj2uDHe" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold"> </td> <td id="xdx_4BD_us-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis_custom--BrandMember_zmy04qCjwsFg" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold"> </td> <td id="xdx_4B4_zEHPjFqO2c39" style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"> </td></tr> <tr style="vertical-align: middle"> <td style="border: #CCCCCC 1pt solid; text-align: left; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5 years</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">License</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; width: 23%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brand</span></td> <td style="border-top: #CCCCCC 1pt solid; border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td></tr> <tr id="xdx_43B_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod_iI_pp2d_zff5cNQwrHIk" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2022</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">25,000.00 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">45,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">70,000.00 </span></td></tr> <tr id="xdx_434_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonth_iI_pp2d_zewgCorQnop8" style="vertical-align: middle"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_436_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo1_iI_pp2d_zJUvJ8Uxzvm1" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2024</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_43A_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree1_iI_pp2d_zqyc2OEOuWdh" style="vertical-align: middle"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2025</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">60,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">93,333.33 </span></td></tr> <tr id="xdx_432_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseYearFour1_iI_pp2d_zBaCKRiFoqA9" style="vertical-align: middle; background-color: #CCEEFF"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2026</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">33,333.33 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">20,000 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">53,333.33 </span></td></tr> <tr id="xdx_439_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive1_iI_pp2d_zyDI6dcbp7D1"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; text-align: left; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thereafter</span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,111.35 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: black 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">311,111.35 </span></td></tr> <tr id="xdx_431_c20230930_ecustom--FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFiveTotal_iI_pp2d_zY6FJdODQkE6"> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; border-left: #CCCCCC 1pt solid; font: 11pt Calibri, Helvetica, Sans-Serif; text-align: left; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">652,885.76 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,669 </span></td> <td style="border-right: #CCCCCC 1pt solid; border-bottom: #CCCCCC 1pt solid; font-weight: bold; vertical-align: middle; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,124,555.07</span></td></tr> </table> 25000.00 45000 70000.00 33333.33 60000 93333.33 33333.33 60000 93333.33 33333.33 60000 93333.33 33333.33 20000 53333.33 311111.35 311111.35 652885.76 471669 1124555.07 <p id="xdx_802_eus-gaap--AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_z10IXyuUqqni" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9. <span id="xdx_82B_zzkypYdsyO75">Accrued and Other Current Liabilities</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities consisted of the following:</span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zachcqkjCVg8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zxO4Nym4FxW" style="display: none">Schedule of accrued and other current liabilities</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zam0Bi8ceRRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_492_20230930_zig62KQWNjG3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49C_20221231_zdW42S9k5ct8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_zKE4K3YqFSpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Interest</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,658</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,130</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_zpjhFXKVwHBi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_zqa6Tf2vZA6a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales Tax Payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,987</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableOtherCurrent_iI_zmAxzHunlay5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Accrued Expenses &amp; Payables</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,442</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,258</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_za0LUZSyAdN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">491,715</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,248</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"></p> <p id="xdx_8AB_zypkzALFZbmj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_89F_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_zachcqkjCVg8" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zxO4Nym4FxW" style="display: none">Schedule of accrued and other current liabilities</span> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30C_134_zam0Bi8ceRRd" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Accrued and Other Current Liabilities (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_492_20230930_zig62KQWNjG3" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" id="xdx_49C_20221231_zdW42S9k5ct8" style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, <br/> 2023</span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, <br/> 2022</span></td></tr> <tr id="xdx_408_eus-gaap--AccruedLiabilitiesCurrent_iI_zKE4K3YqFSpl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 56%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Interest</span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,658</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="width: 12%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">39,130</span></td><td style="width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--AccruedSalariesCurrent_iI_zpjhFXKVwHBi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued Payroll</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32,628</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">22,029</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40A_eus-gaap--SalesAndExciseTaxPayableCurrent_iI_zqa6Tf2vZA6a" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales Tax Payable</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,987</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,931</span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--AccountsPayableOtherCurrent_iI_zmAxzHunlay5" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Accrued Expenses &amp; Payables</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">330,442</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">168,258</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--AccountsPayableAndOtherAccruedLiabilities_iI_za0LUZSyAdN7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accrued and other current liabilities</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">491,715</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">233,248</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="margin: 0"></p> 114658 39130 32628 22029 13987 3931 330442 168258 491715 233248 <p id="xdx_80D_ecustom--StockPayableTextBlock_zhYvK9ah6vb" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 10. <span id="xdx_826_zwFaCagBkJ9e">Stock Payable</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The following summarizes the changes in common stock payable:</b></span></p> <p id="xdx_89E_ecustom--ScheduleOfStockPayableTableTextBlock_zLHvh4E98JPg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLLzxcv6Mzti" style="display: none">Schedule of stock payable</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zjCFytUMUXn9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="width: 10%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--LoansPayable_iI_c20230930_zDohO28q1PG1" style="width: 18%; font-weight: bold; text-align: right" title="Loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">    Additional Expenses Incurred</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">    Payments Upon Issuance of Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230930_zl7JoybfKyo2" style="border-bottom: Black 1pt solid; text-align: right" title="Payments Upon Issuance of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,934</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, 2023</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--OtherLoansPayable_iI_c20230930_zNhTqzivSFn7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Other loans ayable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,408</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AF_zs1rU6M5J4Fj" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0"></p> <p id="xdx_89E_ecustom--ScheduleOfStockPayableTableTextBlock_zLHvh4E98JPg" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BA_zLLzxcv6Mzti" style="display: none">Schedule of stock payable</span><b> </b></span></p> <table cellpadding="0" cellspacing="0" id="xdx_301_134_zjCFytUMUXn9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Stock Payable (Details)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31, 2022</span></td><td style="width: 10%; font-weight: bold"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--LoansPayable_iI_c20230930_zDohO28q1PG1" style="width: 18%; font-weight: bold; text-align: right" title="Loans payable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">74,342</span></td><td style="width: 1%; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">    Additional Expenses Incurred</span></td><td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">    Payments Upon Issuance of Shares</span></td><td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1pt solid; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20230930_zl7JoybfKyo2" style="border-bottom: Black 1pt solid; text-align: right" title="Payments Upon Issuance of Shares"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,934</span></td><td style="padding-bottom: 1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sept. 30, 2023</span></td><td style="font-weight: bold; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--OtherLoansPayable_iI_c20230930_zNhTqzivSFn7" style="border-bottom: Black 2.5pt double; font-weight: bold; text-align: right" title="Other loans ayable"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">56,408</span></td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 74342 17934 56408 <p id="xdx_80C_ecustom--OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock_z030iQI2pyTf" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 11. <span id="xdx_82C_z6a1iJ63cEGj">Operating Lease Right-of-Use Asset/Operating Lease Liability</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company leases property under operating leases. Property leases include retail and cultivation space with fixed rent payments and lease terms ranging from one to two years. The Company is obligated to pay the lessor for maintenance, real estate taxes, insurance, and other operating expenses on certain property leases. These expenses are variable and are not included in the measurement of the lease asset or lease liability. These expenses are recognized as variable rent expense when incurred.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s lease portfolio consists of the following.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As a result of our acquisition of Naturaleaf, we assumed the following leases and contingent extensions:</span></p> <p id="xdx_896_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zy3zZBSC60ca" style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zZk2k4bXP1S2" style="display: none">Schedule of other operating cost and expense</span></span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of an extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022, until April 30, 2027. The Company's monthly rental payments from January 1, 2022, to May 1, 2022, were $3,700. From May 1, 2022, through the year ending December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022, to April 30, 2023, $3,875 May 1, 2023, to April 30, 2024, $4,050 May 1, 2024, to April 30, 2025, $4,225 May 1, 2025, to April 30, 2026, $4,400 May 1, 2026, to April 30, 2027, $4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_z45x9HZYMgIl" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 79%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2022 to April 30, 2023</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2022ToApril2023Member_zQnzN4yjDke2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 21%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,875</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2023 to April 30, 2024</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2023ToApril2024Member_zl8GOcnvLZUi" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,050</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2024 to April 30, 2025</span></td> <td id="xdx_98A_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2024ToApril2025Member_zeUjYM4TnY1a" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,225</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2025 to April 30, 2026</span></td> <td id="xdx_98D_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2025ToApril2026Member_zzeNyHLd83Cg" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,400</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2026 to April 30, 2027</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2026ToApril2027Member_zlVKI3f1z2fk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,575</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="width: 94%; padding-right: 0.3pt; padding-bottom: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a month-to month lease with a monthly rent of $5,000.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 77%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2023</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2023Member_z6WnlhlnNrTa" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,898</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2024</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2024Member_zpOtB72mcTGc" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,985</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2025</span></td> <td id="xdx_98E_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2025Member_zKo5eNSY7UDa" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,075</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2026</span></td> <td id="xdx_988_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2026Member_zOAbaosyazB3" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,167</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2027</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2027Member_zvFv5HEu1o7g" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2611 Durango Drive, CO Springs, CO. The Company and landlord entered a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered an extension of the lease for a term of thirty-six months, beginning June 1, 2022, and terminating on June 1, 2024. On December 31, 2022, the monthly rent was $11,000. Rental payments due for the extended period are: June 1, 2022, to June 1, 2023, $11,000 June 1, 2023, to June 1, 2024, $11,880 June 1, 2025, to June 1, 2025, $12,830  </span></td></tr> </table> <p style="margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 71%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2022 to June 1, 2023</span></td> <td id="xdx_985_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2022ToJune2023Member_z3zOguKggq8k" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 29%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11,000</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2023 to June 1, 2024</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2023ToJune2024Member_zPIyCwFmqHYc" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11,880</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2025 to June 1, 2025</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_iT_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2024ToJune2025Member_zsvFAq7QrYZk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,830</span></td></tr> </table> <p id="xdx_8A1_z9ANrVDx37C1" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 12, 2022, the Company entered into an accommodation for office space, effective September 1, 2022, located at 200 Union St., Suite 200, Lakewood, CO 80228. The accommodation creates no tenancy, leasehold or other real property interest concerning the Registrant. The Registrant's telephone number is unchanged. We determined under ASC 842, due to the nature of the accommodation, that the membership agreement met the criteria of ASC 842-20-25-2, and as such, it was not necessary to capitalize the accommodation, and the membership fee will be recognized on a monthly straight-line basis.</span></p> <p style="margin: 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On May 1, 2021, as part of the Naturaleaf Acquisition, leases for grow facilities and dispensaries were assigned to the Company. These leases were determined to be operating leases under ASC 842, and such leases were capitalized. It was determined that the Tejon lease, due to the short-term nature of the lease, met the criteria of ASC 842-20-25-2 and as such it was not necessary to capitalize the lease, and rent would be recognized on a straight-line basis.</span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company records the lease asset and lease liability at the present value of lease payments over the lease term. The leases typically do not provide an implicit rate; therefore, the Company uses its estimated incremental borrowing rate at the time of lease commencement to discount the present value of lease payments. The Company’s discount rate for operating leases on September 30, 2023, was 12.5%. Leases often include rental escalation clauses, renewal options, and/or termination options that are factored into the determination of lease payments when appropriate. Lease expense is recognized on a straight-line basis over the lease term to the extent that collection is considered probable. As a result, the Company has been recognizing rents as they become payable.</span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of September 30, 2023, the aggregate remaining annual lease payments of operating lease liabilities are as follows: </span></p> <p id="xdx_89C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zmjYM08tfxLe" style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zIt37xqEDc9j" style="display: none">Schedule of operating lease liabilities</span></span></p> <p style="margin: 0; text-align: justify; background-color: white"></p> <table cellpadding="0" cellspacing="0" id="xdx_307_133_zar4rYbaC1O3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20230930_zJt9pS9pKXAk" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating<br/> Leases</b></span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_zzZS3J185n83" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 87%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_zI5FXWlC1ssk" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--AmountRepresentingInterest_iI_zzH1ADOwApKf" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amount representing interest</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions_iI_zptoShZ4Dd3b" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CapitalLeaseObligationsCurrent_iI_zFhN2apArpU7" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current obligations under leases</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">191,539</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--LongtermLeaseObligations_iI_zdkTptaGZ2ff" style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term lease obligations</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(327,705</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> </table> <p id="xdx_8A6_zWPLRWpgKlBe" style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_896_eus-gaap--ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock_zy3zZBSC60ca" style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B1_zZk2k4bXP1S2" style="display: none">Schedule of other operating cost and expense</span></span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1004 S. Tejon Street, Colorado Springs, CO 80903; The Company assumed a lease originally entered into on February 12, 2016, which was the subject of an extension agreement dated April 5, 2022. The term of the lease was extended from May 1, 2022, until April 30, 2027. The Company's monthly rental payments from January 1, 2022, to May 1, 2022, were $3,700. From May 1, 2022, through the year ending December 31, 2022, monthly rent was $3,875. Remaining rental payments due for the extended period are:   May 1, 2022, to April 30, 2023, $3,875 May 1, 2023, to April 30, 2024, $4,050 May 1, 2024, to April 30, 2025, $4,225 May 1, 2025, to April 30, 2026, $4,400 May 1, 2026, to April 30, 2027, $4,575</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 72.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" id="xdx_30B_134_z45x9HZYMgIl" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 79%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2022 to April 30, 2023</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2022ToApril2023Member_zQnzN4yjDke2" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 21%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,875</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2023 to April 30, 2024</span></td> <td id="xdx_98F_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2023ToApril2024Member_zl8GOcnvLZUi" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,050</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2024 to April 30, 2025</span></td> <td id="xdx_98A_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2024ToApril2025Member_zeUjYM4TnY1a" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,225</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2025 to April 30, 2026</span></td> <td id="xdx_98D_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2025ToApril2026Member_zzeNyHLd83Cg" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,400</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May 1, 2026 to April 30, 2027</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--May2026ToApril2027Member_zlVKI3f1z2fk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$4,575</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="width: 94%; padding-right: 0.3pt; padding-bottom: 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2727 Palmer Park Blvd. Suite A, Colorado Springs, CO 80909 subject to a month-to month lease with a monthly rent of $5,000.</span></td></tr> </table> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">  </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5870 Lehman Drive Suite 200, Colorado Springs, CO 80918 The Company and landlord  previously entered into a lease in 2017 which expired December 31, 2022. At December 31, 2022, the Company's monthly rent was $2,732. On April 26, 2022, the Company and landlord entered into an extension agreement which extended the tenancy from January 1, 2023 through January 1, 2027. Rental payments due for the extended period are:   January 1, 2023 $2,898 January 1, 2024 $2,985 January 1, 2025 $3,075 January 1, 2026 $3,167 January 1, 2027 $3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 77%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2023</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2023Member_z6WnlhlnNrTa" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 23%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,898</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2024</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2024Member_zpOtB72mcTGc" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$2,985</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2025</span></td> <td id="xdx_98E_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2025Member_zKo5eNSY7UDa" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,075</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2026</span></td> <td id="xdx_988_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2026Member_zOAbaosyazB3" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,167</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">January 1, 2027</span></td> <td id="xdx_98B_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--January2027Member_zvFv5HEu1o7g" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$3,262</span></td></tr> </table> <p style="margin: 0 0.3pt 0.25pt 0; text-align: justify; text-indent: -0.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 3%; padding-bottom: 0.25pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">o</span></td> <td style="border: Black 1pt solid; width: 94%; padding-right: 0.3pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2611 Durango Drive, CO Springs, CO. The Company and landlord entered a lease on March 10, 2021, which terminated on May 31, 2022. On June 23, 2021, the Company and landlord entered an extension of the lease for a term of thirty-six months, beginning June 1, 2022, and terminating on June 1, 2024. On December 31, 2022, the monthly rent was $11,000. Rental payments due for the extended period are: June 1, 2022, to June 1, 2023, $11,000 June 1, 2023, to June 1, 2024, $11,880 June 1, 2025, to June 1, 2025, $12,830  </span></td></tr> </table> <p style="margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0 0 0.25pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)"> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border: black 1pt solid; width: 71%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2022 to June 1, 2023</span></td> <td id="xdx_985_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2022ToJune2023Member_z3zOguKggq8k" style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 29%; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11,000</span></td></tr> <tr style="vertical-align: top; background-color: white"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2023 to June 1, 2024</span></td> <td id="xdx_987_eus-gaap--SaleLeasebackTransactionRentExpense_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2023ToJune2024Member_zPIyCwFmqHYc" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$11,880</span></td></tr> <tr style="vertical-align: top; background-color: #CCEEFF"> <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">June 1, 2025 to June 1, 2025</span></td> <td id="xdx_989_eus-gaap--SaleLeasebackTransactionRentExpense_iT_c20230101__20230930__us-gaap--AwardDateAxis__custom--June2024ToJune2025Member_zsvFAq7QrYZk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-bottom: 0.25pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$12,830</span></td></tr> </table> 3875 4050 4225 4400 4575 2898 2985 3075 3167 3262 11000 11880 12830 <p id="xdx_89C_eus-gaap--ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock_zmjYM08tfxLe" style="margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B6_zIt37xqEDc9j" style="display: none">Schedule of operating lease liabilities</span></span></p> <p style="margin: 0; text-align: justify; background-color: white"></p> <table cellpadding="0" cellspacing="0" id="xdx_307_133_zar4rYbaC1O3" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse" summary="xdx: Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)"> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" id="xdx_493_20230930_zJt9pS9pKXAk" style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="vertical-align: bottom"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Operating<br/> Leases</b></span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_400_eus-gaap--FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths_iI_zzZS3J185n83" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 87%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2023</span></td> <td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td style="width: 1%; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--FinanceLeaseLiabilityPaymentsDue_iI_zI5FXWlC1ssk" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_ecustom--AmountRepresentingInterest_iI_zzH1ADOwApKf" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: amount representing interest</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(<span style="-sec-ix-hidden: xdx2ixbrl0965">—</span></span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_402_eus-gaap--PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions_iI_zptoShZ4Dd3b" style="vertical-align: bottom; background-color: white"> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Present value of future minimum lease payments</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">519,244</span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--CapitalLeaseObligationsCurrent_iI_zFhN2apArpU7" style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Less: current obligations under leases</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">191,539</span></td> <td style="padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_ecustom--LongtermLeaseObligations_iI_zdkTptaGZ2ff" style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Long-term lease obligations</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(327,705</span></td> <td style="padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> </table> 519244 519244 519244 191539 -327705 <p id="xdx_80A_eus-gaap--DebtDisclosureTextBlock_znvc5kYoYbS3" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 12. <span id="xdx_82A_zv21KtMgrgs2">Loans Payable</span> </b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Naturaleaf Seller Note</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Naturaleaf Acquisition, the Company issued a promissory note to the owner of Naturaleaf in the principal amount of $1,100,000 (the “Seller Note”). The note originally had a term of 1 year with a due date of April 30, 2022, and did not require any payments prior to the due date. The note had an annual interest rate of 10%.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 30, 2022, the Company entered into an Amendment ("First Amendment") to the Asset Purchase Agreement to amend the Seller Note as follows; the due date of the Note was extended to April 30, 2023, and interest will accrue on the outstanding principal at a rate of 12.5%. In addition, the Company agreed to pay all accrued interest at April 30, 2022, and make a principal payment of $500,000. On April 29, 2022, principal in the amount of $550,000 and accrued interest of $110,000 was paid. At September 30, 2022, principal in the amount of $550,000 was outstanding, and interest of $9,493 had been accrued.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 8, 2023, the Company and Naturaleaf amended the promissory note to restructure the remaining payments due to be made by the Company under the amended Note, totaling principal and interest of $651,162.50 ("Second Amendment"). Pursuant to the Second Amendment, the Company agreed to pay $150,000 by June 30, 2023; $100,000 by July 31, 2023; and the balance by May 1, 2024. The Company made both payments and granted Naturaleaf a first-priority lien and security interest on the assets of the Registrant, securing the payment and performance of the payment schedule.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_809_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zegBVAJudfvf" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 13. <span id="xdx_820_zk6J5zITZ2W">Related Party Transactions</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 14, 2023, the Company issued a second promissory note in exchange for $100,000 to its CEO and CFO Ellis Smith. The note is not convertible and matures on August 14, 2023. The note carries 15% interest per annum. No principal or interest has been paid on this note.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 22, 2022, the Company issued a promissory note to Ellis Smith in exchange for $150,000. Interest on the note is 15% per annum. The note has a maturity date of May 21, 2023. If not paid within ten days of maturity, the note contains default interest of 18% per annum and a late charge penalty of 5% of the principal amount due. No principal or interest has been paid on this note.</span></p> <p style="margin: 0"></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_808_eus-gaap--ShareholdersEquityAndShareBasedPaymentsTextBlock_zokwaodvy7ng" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 14. <span id="xdx_82E_z225aeAvShzl">Stock-Based Compensation</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three and nine months ending September 30, 2023, the Company issued <span id="xdx_90C_ecustom--TemporaryEquityIssued_c20230701__20230930_z0RrHQSTiyk6" title="Common stock issued">79,250,000</span> shares of common stock and <span id="xdx_908_ecustom--TemporaryEquityIssued_c20230101__20230930_zz4R47sr6eTk" title="Common stock issued">81,425,000</span> shares of common stock, respectively, as compensation for consultants, employees, and service providers per its 2015 Equity Incentive Plan.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0 0 6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">   </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 79250000 81425000 <p id="xdx_808_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zj09LTlrOrjl" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 15. <span id="xdx_821_zQCMgo8HE1D9">Shareholders’ Equity</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Cannabis Company, Inc. is authorized to issue <span id="xdx_90B_eus-gaap--PreferredStockSharesAuthorized_iI_c20230930_zsVmA98qjQVb">5,000,000</span> shares of preferred stock at $ <span id="xdx_905_eus-gaap--PreferredStockNoParValue_iI_c20230930_zWfKdePSrGsi">0.00001</span> par value. No shares of preferred stock were issued and outstanding at September 30, 2023, and December 31, 2022, respectively.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">American Cannabis Company, Inc. is authorized to issue 500,000,000 shares of common stock at 0.00001 par value. At September 30, 2023, 171,402,938 shares were outstanding.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the three and nine months ended September 30, 2023, the Company issued <span id="xdx_90F_eus-gaap--RestrictedStockExpense_c20230701__20230930_zn5JuL5imMKg" title="Coomon stock">79,250,000</span> shares of common stock and <span id="xdx_909_eus-gaap--IssuanceOfStockAndWarrantsForServicesOrClaims_c20230101__20230930_zN0YheWgAyxd" title="Common stock">81,425,000</span> shares of common stock, respectively.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">    </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Net Loss Per Share</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Basic net loss per share is computed by dividing net loss by the weighted average number of common shares outstanding during the reporting period. Diluted net loss per share is computed similarly to basic loss per share, except that it includes the potential dilution that could occur if dilutive securities are exercised.</span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding stock options and common stock warrants are considered anti-dilutive because we are in a net loss position.  Accordingly, the number of weighted average shares outstanding for basic and fully diluted net loss per share are the same. At September 30, 2023, the Company did not have any warrants or options issued and outstanding.</span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5000000 0.00001 79250000 81425000 <p id="xdx_80F_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zYkPcP01I4rh" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 16. <span id="xdx_82D_z3vfWChpncU">Commitments and Contingencies</span></b></span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Legal</i></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of its business, the Company becomes involved in various legal proceedings involving a variety of matters. The Company does not believe there are any pending legal proceedings that will have a material adverse effect on the Company’s business, consolidated financial position, results of operations, or cash flows. However, the outcome of such legal matters is inherently unpredictable and subject to significant uncertainties. The Company expenses legal fees in the period in which they are incurred.</span></p> <p style="margin: 0 0 6pt; text-align: center"></p> <p style="margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_800_eus-gaap--SubsequentEventsTextBlock_zM8I0LySjYW6" style="margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 17. <span id="xdx_823_zDOrgRART1Nb">Subsequent Events</span></b></span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 855-10, the Company has analyzed its operations after unaudited consolidated financial statements were available to be issued and determined that there were no other significant subsequent events or transactions that would require recognition or disclosure in the unaudited condensed consolidated financial statements for the nine months ended September 30, 2023, and did not find any events.</span></p> EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( &5C;E<'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " !E8VY7_U5*4N\ K @ $0 &1O8U!R;W!S+V-O&ULS9)1 M2\,P$,>_BN2]O:;5#4+7%\4G!<&!XEM(;EM8DX;DI-VW-XU;A^@'\#%W__SN M=W"M\D(- 5_"X#&0P7@SV=Y%H?R&'8B\ (CJ@%;&,B5<:NZ&8"6E9]B#E^HH M]PAU5:W (DDM2<(,+/Q"9%VKE5 !)0WAC-=JP?O/T&>85H ]6G04@9<<6#=/ M]*>I;^$*F&&$P<;O NJ%F*M_8G,'V#DY1;.DQG$LQR;GT@X%W%;:#-COS MCXTO@ET+O^ZB^P)02P,$% @ 96-N5YE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T$W-I=MNTF83M M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY\^XN8NB&B)3R M> +]O6N[!3+ MUES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4?,_@5RU2-9:,! M$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA5,+$P&IG/U9K MQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M&N#C\7@XMLO2 MBW A(5M>5 TR M6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T1G*=D 4. #?$ MT4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH] M5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J-2S%UGB5P/&M MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2.FJW"$2M"/F(9 M-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$.$9)>-T(^8LZ+ MD!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]072N0/)J<_Z3(T M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+ M.7\N?<^E[[GT/:'2MSAD6R4)RU3393>* M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.WF)&Y M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_# M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0 MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYNTB42%(JP# 4A M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.' MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_ M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]! MU4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04 M" !E8VY753"XX',% #]' & 'AL+W=ORJ12==*<!1''>8XO4[,PZ0UO,R.3=7P4JYU%"9BJDBZ MCF.N7J]%)+=7+=K:'7@(%TMM#G2&ERN^$#.AOZVF"O8ZI4L0QB))0YD0)>97 MK1&]\%S'"+(K_@C%-GVS30S*DY3/9F<<7+4<4R(1"5\;"PX_&^&)*#).4(Y_ M"]-6>4\C?+N]<[_-X 'FB:?"D]&?8:"75ZWS%@G$G*\C_2"WGT4!=&;\?!FE MV7^RS:_M=EO$7Z=:QH482A"'2?[+7XH'\4;@LAH!*P3L@X#6W<$M!&X&FI*KDEREP-;F8C>S:9&FC"Q%3C3"LX&X).#SVY$8JT2;KD2J27'0V> MYDS'+_37N9[5Z ?D3B9ZF9*;)!#!>WT'RE(6B.T*=,U0PYE8G1+7.2',8:ZE M/!XNG\C-*:%=F_Q=<=SR^;B9GXL^G[]'3ZE6T.3^L3VAW*%K=S#]\")=<5]< MM:"CI4)M1&OXR\^TY_QJP_M!9N]@NR5L%W,??I+^&KJH)H^O*V$CQ>74:7^U M(:&JADAG)=(96J81\ 09TVW$%S8F7#_G46I[%!XJ:PC5*Z%ZA]73US576JCH ME3R(E53:QH=;:;6VXJ&JAGC]$J]_8#-4'-X7V7!?SX=[U=8?*FL(>%X"GA\& M.!4JE($9.PF,WM8NASN5HV7M<(GJ&W(.2L[!89RW8>KS:(=["X>MKQK<[:N5 M#]4TY*-.]?9T_A?A=\%5/=\>L[HJQ&5-&=\D!(H6RULK]1$1:[%[[-IMRMHN MM8*BRJ:@K )E:,EN$AWJ5^",!)FLXR>AK'BXB>,X;=:CSKD5$-4V!:RR#$73 MPP[P02Q"$V>@3B<\MMZ,)@;_)Z'H\^\F[OYN.)M]/R'CBG5K1 MCQ%L:)5L*)Y-"G0/&K*"1CR&M/I"?A>O5GC<"FK8&73/>K1OY3Q&VJ%5W*%X M7BDX'_D+&0< &\Y#GV=O4*1%XY8#ITTI[?78F97W&$&(5DF(XOFEX!TGOE20 M$#+4$S+3,#81J8@GUU#A4.\RL+?S/4'KQHI\C'!$JW1$\4A3((^" -S3D]T& M^0+7D?O$SHE;PJ2??$M,*X&C,)6T4A\C,=$J,E$\Z:#4CUMII=X3GK0XA=SD M6&F/D9MH%9PHGG4^TGIF#]KSH]PF5E+<[@M_%ELI ROI,1(4JQ(4PT//1]*R MZTZ5W(2);VW.>SR]>^N'@V/$*%;%*(;GGH^@4YEJ>!/]%:YJ1Z<]CN<.8]:8 M@>N:DE8YBN$1*&NL(R5X/1ANX#KV+S_'2$^L2D\,#SU?9#:'6F5OXL(0&Z]X8J]7W+#VTQBN:PI:91]V4/:9+074(X:'V]3C'2/P MN%7@<0\*/ 69WE;^L^0>K+E%W*_UA *D@#JU[K0\(,23+'2D+N=96YFN6\S MI'W:==C A52Q>0O9>;/ 9-I?MNZ6$M_,KO*UIO)HN;8WRE:T.M7E^<+@'3?- M-R61F(/4.>W#_56^UI;O:+G*EJN>I-8RSC:7@@="F0O@_%Q*O=LQ-RA7/(?_ M 5!+ P04 " !E8VY7&>*,Q0@' "%'0 & 'AL+W=O=I5*K MS[U>-E^*F&>G)IW^>?'=;=H_ MEVL5A8FX35&VCF.>/G\1D7RZZ)#.RQ=WX>-2Y5_T^N;RR@K_D=/.UO<0?-UIF2\&T?(/16X*;X@F3/+'.%4I_#4$/]4? MWER/QM?3\0C!I^G-Y&HTF,'%E\%D<#T#R;HH_W"5\'H1+!)W2"[J @'Y,+WY[F9?MC>C+3>;BM4I8KB+**9,XSXTNX_$'-Q)X4X/W7L0 M=AD[+6.GQ7BL+?9UFHI$H4&6"97IPMGZ6WK_?(5]SE9\+BXZL(0RD6Y$I__A M'7'PF2ZX-QKL(%16ALI,H_>'/%LBG@1H_&,=;G@$86L#WH[B%*/D%6#3]SS/ M/^]M]@-I&A'BVI9;FAU(M$J)EE'B8#Z7:Y"%[L1<@,:'2'31M5 ZF=N1[#T% M,"4LSZT);9I9CD\(T0NU2Z&V4>A(K&06ZO-G-^[HV[Y=DW7$Z$"44XIRC**N MD@T\4YD^ZU0YC1O:Q*.>5]/5-&,V]=V6=+FE,M>H[#85*Q["S/L)Z,E$5DS# M&[44*3J^ -V&),?"=GU"-JUK$$5[3! MQI*[?>[MR=RYOU'%?:O1#H/=0RLYLB853QY#*&2[B+LH@<:,QS)5X2^>MS': M'!#-5/'@,=':0](94LKV#0^55V D1ACUOTH9/(51I)5'FW=EC!+"ZO*.&Q[* MJV!&S#0KFDTD%^@^>TDMS/@;6 B0U.01300T=MML:R-@FGKH4\NJ!]"T<["% M*6[17Y&.F%$WD2!R)M(8F5A"FOAR,,9UD4>L#B56C"-FR&VKW]'EVD09]:&< M^/4*K3%DQ+&9VX(]4G&/F,$WNYD-)F@PG4*?JI78I)I%'!^[C=6D,72(0W$+ M_T@%0.*^JL^9 MZ#/+=^OHU-@YKD^WCC#<:[3#J"JK4 MO*W4+@%MU'\ 0J0-6+/-M-OG6X5*:D9E6PE"']YYT"V?H3BHRZ^[#9 MR6[:6;!+L%OV+06761W(1WY#\J6/,W/4=9J*=/PEPC.4/EEF&4OC8)H>7$]C":B3FNV]W!ZM=!..L1'&\'FF/D\RA_,:*>H.!#M-=89^9L3^4 M<0R5(ZMR#?_VTGV&[&VRVQ(./507MH)=GWE%&GW:)?;V\@^>1/>/'X6FPVAV M=QHKG[8<$K"](V5S$S((@C"OOP#+_(#O)$S0G*]"@*=6J::SR&/T[7HMT%D2 MW_(MW+;*JBZ$'3UC7L?KB"MX,(%8A/-0BPS6;"U."%#=Q[1^1J WQ7G7WZ:V M:D38:QJ1:3Z=EC(*1)H51'#/BH,^I9\0S3:#,,=VK,8AOL;0IE(R+CTO!X2GD!O#WA03V M[2[R-W'EF]?^_U!+ P04 " !E8VY7E5G481$# ?"@ & 'AL+W=O M3"O8-(%*A:J6M1 MTW8?IGUPDP.QFL29[4"W7S_;H1F!<"D:'\!VSOOF.2?'Q+T%9:\\!!#H+8X2 MWC="(=(+T^1^"#'F-9I"(J],*8NQD%,V,WG* =:%$>F8UDM,\8D,=R>7ILP MMT)O.".0QI])T$(NP;'0,%,,59)![HXAJ6"365 MGT\CKK_1(H]M=PWD9US0>"F6!#%)\E_\MBS$BL!N;!$X2X%SJ*"^%-1UHCF9 M3FN$!79[C"X04]'230UT;;1:9D,2]1@]P>15(G7"'=[?C<9WWGB$Y,B[O[T9 M#1[EY')P.[@;CI%W/1X_>NCD*<%90 0$I^AD@ADD(@1!?!R=HG/T&9F(AW*5 M]TPAF92SZ2_O?YG?W]ER?P_2&JI;9\BQG'J%?+A;/@)?RFTM=\IR4U:B*(=3 ME,/1?O5M. (+D%TJ$)VB*Y+@Q"ZZ'X,7+ICLO9]5J>;>C6IOM2$O M>(I]Z!MRQW%@PD8@P!Y@OJO9T@^ M5(O=O:W_U5S)WK9IE]\SY:HI[@DKHC0*]\3%T MC0/!%6XN6=SA:1IZ<\:\?ZX$G2S@&X>!7W#>58-W-P 64?=%5&" M;!60K:,@[S/!!4X"DLRJ2%M[27=%E$C;!6E[)^F0QK'6>&QX=QJ MKE'OBRJ1=PKRS@?(#VK=SK:6W&C>0R)+U-V"NOMAZK,=S=O= +';=L-RNO7. M&O)F9->QFZ7 $K%M_7OO64W.CI]PVQ&$HXBF$JI M56M+#Y:?1O*)H*E^H;]0(8\'>AC*$QPP%2"O3RD5[Q-U1BC.A.Y?4$L#!!0 M ( &5C;E<)85?A.P< !DC 8 >&PO=V]R:W-H965T&ULK5IK;]LX%OTKA'R^E:OI53H1YX5]>5DK=3F?#JMEVN9 M)_6'5^A>IOG2?6_:YF5KY<3,GF[\25]7JOFQG1VL4F>Y4*JKYO[2E]-]RRK-)=% MG98%JN33Y>2*G,-E,>R_-9/C]C?UC*UZ+>4QJ.2^S_Z8KM;ZL:M-*G.^UMX*)$);.+JGQ%58/6;,V7-OIM:QVO MM&@6RD)5^K^I;J=F\[O;*+Y=Q!'2WQ9WGVZBJP=]L7C0'Y_CVX<%NON([N[C M+U)$MY.=%YJY;5BYS, M?O\7\?$?4%#')(O&)(M'(CL*/]^'G[O89_.RJ'6>2XMGM-#4Z1*>B1V)WY(T M]>!E1OS H\'%].4PQC;,]P/*CU$1@&("FV2Q#6,X" 3=PXX$>WO!GE/P?56N MMDN%?D_RS1\H_KY--[H6*4CTCL@[& E6@TU1-LP$OB^H)XAV\:%@8\Q-F3; M,-_CV/,"6+>_U^V[)SHIBN0QK5$7 '":?4 Q(]08XMR&D5";!6$(MF&>(*'P M#<$VS&AU(E&7)E%V$/+PR#T!1KPRBAS">&C C"A1[&QNJ/ M;9S@@1!\0&^PUQLX\^B\K!4JGYR*@S'SZ9ADT9AD\4AD1],0[J#@PTE!LPWS!Z4!6);CW=O@DX6_I!27%RIU> M.\+CQ"D"8A85".?[G#(SP0) /_2X;^Y .?Y-.!L* @'!I><-ONG)-N.ZTB7 M1Y@I:P[A BPP,>7;.*YE-2;O6+Z-$Y1[-!Q03WOU](24>THBZH@.A\ \O5JY M*=W&Z=K*.3.3+P2D@C%AB;>!>BEA77 &U/<^ECA]VNS/JJS;"7]*X>7.[ *A M$S\1IF8 YX5ZQDW)-BZDQ&?$5&SCB*[5S!]2W%M'PITEYVXCJZ1-B^UX.GIC2]S.]D]9Z/G(VL1[M=+G][16S?R\2'!: M;)_)J-X*H;D< 3]*!!76<@1L,,U+3"<_!W""">Y9"\3&$2_DQ-X:-I!2%N"#G'XL MOW>EQ&U+/S6UZ:DJ\[<0:'L*2K?=X1FA(3//=G,(R$5 A24> .K#,3>!,=BU M7B.^/Y 8:.]-*787*K66%;HIEF4NT;MNZL$GB=1I15Z)UW385O5,QKXUAD=P G! M,A0W0APZ;MC"$!%.W";Z5"C7%#E0*.$\2 M<+.L [ S78=T&3:E D#>'&.MJ0: ?DA#,539>LM+W9:WJVD/R0^7V7.3_$I* M&8DH&HLH'H'H./2]ZZ9NUWT;/Z!/=XL%&'!A_79Q1CQ!///9%@1DH? ]TS]# M0$\UD41Z]>7ZH%&ODPI> M>8$U&BNK_A02=1!QJ E_,!^ Q3^%'>ONS3-UF^>=[N94N4JSK=*GK-?VG0#] M)7G1;OI9'L6A1N56U4KC!XZ?U':Z@:>/U"&SEL>IR A"ZF.39]6G^!3D+E#3 M@Y_ZTNCI=R^- MZ./[CA5KOW,'87JMRT+QH\EDJ5>?MU+9.5K!J _O]36:JW MBZ:#_=LPL_\#4$L#!!0 ( &5C;E<)D'*>&P@ $<] 8 >&PO=V]R M:W-H965T&ULM5M=9R#?Q'&8??]$5^GSZ0B.7D[<1(_+HCPQGIRL MPT/%WEU5_PO(LU1F"^R8LTWC5F M&<11LOT,O^V(.&B 4$L#M&N &@VPW=( [QK@9@/#=S^]/Q@5+K^QD/-^E\FF; M"FI+)8UC=J_-BG3^%?SSA<;W-/M7 C-5PYPM6"KLI@U7X#J,%D=1 J;A.BK8 ML0+45X/.-O?Y/(O6537?76:9$,#P T &@B L M #MYO#\ATWC;@UWU4 YK3Q,7>B?CIT,!Q1@(+=NRG4:@KTRW''0_YNMP3D]' M;%3-:?9$1Q,@DT+L\,@S3<>"#M\A$0,1A*[GPGT<1RS>$XO5Q-+'*"E5!B\4 M@]DR9#GWHG2+;?&4&LC#;H-791)RNK92RPI")UB@$XQH N.4-/=*FDHEMZ-3 M.90^IWDN4TG9LO](--6$XVO""2SA[CN"AF?8J#&VD!Z! M'.GVGG3[[04E4\06ZZ91,F*$:2/#;,PQRO0&,*D)A\BS=N0L.WN6G1XL1WF^ M830S/P+F8;Z4L>J($Z#5H-41$H30L8T&^[XRH0&\:L(ADK1-Y'A83JR[)]8= M3NS+["XCV!72J$9[8;Q7=CMTO-<)%N@$(YK ..V\O79>MW9'\J&G["N:4[#. MTJ=H03.9E)ZXC&VJZ EJVZ;G-:)\99H#2D43#I%DS:U(.+:A45M-HW^M].1X M!\F5K2&K%W7?0PM&*UJ@%8WH0N-5/'A@ >8Q-\W"078J):WJ%SOSNCZ>']" MJB@4':+E--6$LDFF]&QVHW;4V0XH'DF7;(5C81>:C1F0R+)#E@/=EK40K TX M5#OP(%DVRH=IF*Q^8 M=),F>NJV6M!JJ[6B!5K1B"XT7M#:6D.UMVY[@%H^HI5*: GWO3#CBY:TN;#J M#@FZ0X@RA.>C=KWPM;9W&64+L ZSXKN4%]$>"KQTAOC=(4%W")&$J-:)M5>% M:K.J>@ZC;CK@08PN(%\74 !%AWJ$/8=1VN2].Y!GOC:S4.UFW[RV<_O,5J(% M;INM7N$.Y=2*7;:N[239*==VM=N$:KOYAK6=:,C:YK-76$#%?*83+="*1G2A M\1MEM9=%:B_;>T='*B@27:V'H"79TE&G,510K6B!5C2B"XT7M+:U:(BM;2[6 M43]916OKE9&\HC)KZYF>:0B[G[JLK:1+-OP9KN$T^R2R[%S;LP\N@R?X8&]9 M;6U5L[JZZ8!971>0KPLH0*(O/[(<%T.[R7QW(,]\[4.1VH>^>HM%C3M$%M$H M.B8V4?.&U]1?H N(=";.2U+[6]1G&[G'?HP:9X@$FH!\74"!+B"B 8B7L7:U MJ,/5OG$' 8G.\G!':J><9.M5B/+5F0Z111,0T0#$RU*;:Z0VUP-L#);*8O>9 MQT7W"TM QX)-:71M,4NZ9/.XPV9R6WB129(=1M@UVF:3VITCM3OO96/DM$JV M8!UHRMYD4N

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end XML 60 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 82 254 1 false 24 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ammj/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Sheet http://ammj/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Sheet http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Sheet http://ammj/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited) Sheet http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited) Statements 5 false false R6.htm 00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) Sheet http://ammj/role/CondensedConsolidatedStatementsOfCashFlow CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - Principles of Consolidation. Sheet http://ammj/role/PrinciplesOfConsolidation. Principles of Consolidation. Notes 7 false false R8.htm 00000008 - Disclosure - Description of Business. Sheet http://ammj/role/DescriptionOfBusiness. Description of Business. Notes 8 false false R9.htm 00000009 - Disclosure - Summary of Significant Accounting Policies Sheet http://ammj/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 9 false false R10.htm 00000010 - Disclosure - Naturaleaf Asset Acquisition Sheet http://ammj/role/NaturaleafAssetAcquisition Naturaleaf Asset Acquisition Notes 10 false false R11.htm 00000011 - Disclosure - Accounts Receivable and Advance from Clients Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClients Accounts Receivable and Advance from Clients Notes 11 false false R12.htm 00000012 - Disclosure - Inventory Sheet http://ammj/role/Inventory Inventory Notes 12 false false R13.htm 00000013 - Disclosure - Property and Equipment, net Sheet http://ammj/role/PropertyAndEquipmentNet Property and Equipment, net Notes 13 false false R14.htm 00000014 - Disclosure - Intangibles Assets, Ne Sheet http://ammj/role/IntangiblesAssetsNe Intangibles Assets, Ne Notes 14 false false R15.htm 00000015 - Disclosure - Accrued and Other Current Liabilities Sheet http://ammj/role/AccruedAndOtherCurrentLiabilities Accrued and Other Current Liabilities Notes 15 false false R16.htm 00000016 - Disclosure - Stock Payable Sheet http://ammj/role/StockPayable Stock Payable Notes 16 false false R17.htm 00000017 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability Operating Lease Right-of-Use Asset/Operating Lease Liability Notes 17 false false R18.htm 00000018 - Disclosure - Loans Payable Sheet http://ammj/role/LoansPayable Loans Payable Notes 18 false false R19.htm 00000019 - Disclosure - Related Party Transactions Sheet http://ammj/role/RelatedPartyTransactions Related Party Transactions Notes 19 false false R20.htm 00000020 - Disclosure - Stock-Based Compensation Sheet http://ammj/role/Stock-basedCompensation Stock-Based Compensation Notes 20 false false R21.htm 00000021 - Disclosure - Shareholders??? Equity Sheet http://ammj/role/ShareholdersEquity Shareholders??? Equity Notes 21 false false R22.htm 00000022 - Disclosure - Commitments and Contingencies Sheet http://ammj/role/CommitmentsAndContingencies Commitments and Contingencies Notes 22 false false R23.htm 00000023 - Disclosure - Subsequent Events Sheet http://ammj/role/SubsequentEvents Subsequent Events Notes 23 false false R24.htm 00000024 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://ammj/role/SummaryOfSignificantAccountingPolicies 24 false false R25.htm 00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables) Sheet http://ammj/role/NaturaleafAssetAcquisitionTables Naturaleaf Asset Acquisition (Tables) Tables http://ammj/role/NaturaleafAssetAcquisition 25 false false R26.htm 00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables Accounts Receivable and Advance from Clients (Tables) Tables http://ammj/role/AccountsReceivableAndAdvanceFromClients 26 false false R27.htm 00000027 - Disclosure - Inventory (Tables) Sheet http://ammj/role/InventoryTables Inventory (Tables) Tables http://ammj/role/Inventory 27 false false R28.htm 00000028 - Disclosure - Property and Equipment, net (Tables) Sheet http://ammj/role/PropertyAndEquipmentNetTables Property and Equipment, net (Tables) Tables http://ammj/role/PropertyAndEquipmentNet 28 false false R29.htm 00000029 - Disclosure - Intangibles Assets, Ne (Tables) Sheet http://ammj/role/IntangiblesAssetsNeTables Intangibles Assets, Ne (Tables) Tables http://ammj/role/IntangiblesAssetsNe 29 false false R30.htm 00000030 - Disclosure - Accrued and Other Current Liabilities (Tables) Sheet http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables Accrued and Other Current Liabilities (Tables) Tables http://ammj/role/AccruedAndOtherCurrentLiabilities 30 false false R31.htm 00000031 - Disclosure - Stock Payable (Tables) Sheet http://ammj/role/StockPayableTables Stock Payable (Tables) Tables http://ammj/role/StockPayable 31 false false R32.htm 00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables) Tables http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability 32 false false R33.htm 00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative) Sheet http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative Summary of Significant Accounting Policies (Details Narrative) Details http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies 33 false false R34.htm 00000034 - Disclosure - Naturaleaf Asset Acquisition (Details) Sheet http://ammj/role/NaturaleafAssetAcquisitionDetails Naturaleaf Asset Acquisition (Details) Details http://ammj/role/NaturaleafAssetAcquisitionTables 34 false false R35.htm 00000035 - Disclosure - Accounts Receivable and Advance from Clients (Details) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails Accounts Receivable and Advance from Clients (Details) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 35 false false R36.htm 00000036 - Disclosure - Accounts Receivable and Advance from Clients (Details 1) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1 Accounts Receivable and Advance from Clients (Details 1) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 36 false false R37.htm 00000037 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative) Sheet http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative Accounts Receivable and Advance from Clients (Details Narrative) Details http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables 37 false false R38.htm 00000038 - Disclosure - Inventory (Details) Sheet http://ammj/role/InventoryDetails Inventory (Details) Details http://ammj/role/InventoryTables 38 false false R39.htm 00000039 - Disclosure - Property and Equipment net (Details) Sheet http://ammj/role/PropertyAndEquipmentNetDetails Property and Equipment net (Details) Details http://ammj/role/PropertyAndEquipmentNetTables 39 false false R40.htm 00000040 - Disclosure - Intangibles Assets, Net (Details) Sheet http://ammj/role/IntangiblesAssetsNetDetails Intangibles Assets, Net (Details) Details http://ammj/role/IntangiblesAssetsNeTables 40 false false R41.htm 00000041 - Disclosure - Intangibles Assets, Net (Details 1) Sheet http://ammj/role/IntangiblesAssetsNetDetails1 Intangibles Assets, Net (Details 1) Details http://ammj/role/IntangiblesAssetsNeTables 41 false false R42.htm 00000042 - Disclosure - Intangibles Assets, Ne (Details Narrative) Sheet http://ammj/role/IntangiblesAssetsNeDetailsNarrative Intangibles Assets, Ne (Details Narrative) Details http://ammj/role/IntangiblesAssetsNeTables 42 false false R43.htm 00000043 - Disclosure - Accrued and Other Current Liabilities (Details) Sheet http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails Accrued and Other Current Liabilities (Details) Details http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables 43 false false R44.htm 00000044 - Disclosure - Stock Payable (Details) Sheet http://ammj/role/StockPayableDetails Stock Payable (Details) Details http://ammj/role/StockPayableTables 44 false false R45.htm 00000045 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails Operating Lease Right-of-Use Asset/Operating Lease Liability (Details) Details http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables 45 false false R46.htm 00000046 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Sheet http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1 Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1) Details http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables 46 false false R47.htm 00000047 - Disclosure - Stock-Based Compensation (Details Narrative) Sheet http://ammj/role/Stock-basedCompensationDetailsNarrative Stock-Based Compensation (Details Narrative) Details http://ammj/role/Stock-basedCompensation 47 false false R48.htm 00000048 - Disclosure - Shareholders??? Equity (Details Narrative) Sheet http://ammj/role/ShareholdersEquityDetailsNarrative Shareholders??? Equity (Details Narrative) Details http://ammj/role/ShareholdersEquity 48 false false All Reports Book All Reports ammj-20230930.xsd ammj-20230930_cal.xml ammj-20230930_def.xml ammj-20230930_lab.xml ammj-20230930_pre.xml ammj_10q.htm image_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 64 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ammj_10q.htm": { "nsprefix": "ammj", "nsuri": "http://ammj/20230930", "dts": { "schema": { "local": [ "ammj-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] }, "calculationLink": { "local": [ "ammj-20230930_cal.xml" ] }, "definitionLink": { "local": [ "ammj-20230930_def.xml" ] }, "labelLink": { "local": [ "ammj-20230930_lab.xml" ] }, "presentationLink": { "local": [ "ammj-20230930_pre.xml" ] }, "inline": { "local": [ "ammj_10q.htm" ] } }, "keyStandard": 194, "keyCustom": 60, "axisStandard": 4, "axisCustom": 0, "memberStandard": 9, "memberCustom": 15, "hidden": { "total": 81, "http://fasb.org/us-gaap/2022": 61, "http://ammj/20230930": 15, "http://xbrl.sec.gov/dei/2022": 5 }, "contextCount": 82, "entityCount": 1, "segmentCount": 24, "elementCount": 360, "unitCount": 3, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 423, "http://xbrl.sec.gov/dei/2022": 27 }, "report": { "R1": { "role": "http://ammj/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://ammj/role/CondensedConsolidatedBalanceSheets", "longName": "00000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R3": { "role": "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical", "longName": "00000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "unitRef": "USDPShares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R4": { "role": "http://ammj/role/CondensedConsolidatedStatementsOfOperations", "longName": "00000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "ammj:ConsultingAndAdvisoryRevenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "ammj:ConsultingAndAdvisoryRevenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "longName": "00000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS EQUITY (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2021-12-31_us-gaap_CommonStockMember", "name": "us-gaap:StockholdersEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow", "longName": "00000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)", "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ProfitLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R7": { "role": "http://ammj/role/PrinciplesOfConsolidation.", "longName": "00000007 - Disclosure - Principles of Consolidation.", "shortName": "Principles of Consolidation.", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://ammj/role/DescriptionOfBusiness.", "longName": "00000008 - Disclosure - Description of Business.", "shortName": "Description of Business.", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessDescriptionAndBasisOfPresentationTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://ammj/role/SummaryOfSignificantAccountingPolicies", "longName": "00000009 - Disclosure - Summary of Significant Accounting Policies", "shortName": "Summary of Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://ammj/role/NaturaleafAssetAcquisition", "longName": "00000010 - Disclosure - Naturaleaf Asset Acquisition", "shortName": "Naturaleaf Asset Acquisition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AssetAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AssetAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClients", "longName": "00000011 - Disclosure - Accounts Receivable and Advance from Clients", "shortName": "Accounts Receivable and Advance from Clients", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://ammj/role/Inventory", "longName": "00000012 - Disclosure - Inventory", "shortName": "Inventory", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://ammj/role/PropertyAndEquipmentNet", "longName": "00000013 - Disclosure - Property and Equipment, net", "shortName": "Property and Equipment, net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://ammj/role/IntangiblesAssetsNe", "longName": "00000014 - Disclosure - Intangibles Assets, Ne", "shortName": "Intangibles Assets, Ne", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://ammj/role/AccruedAndOtherCurrentLiabilities", "longName": "00000015 - Disclosure - Accrued and Other Current Liabilities", "shortName": "Accrued and Other Current Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://ammj/role/StockPayable", "longName": "00000016 - Disclosure - Stock Payable", "shortName": "Stock Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:StockPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:StockPayableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability", "longName": "00000017 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://ammj/role/LoansPayable", "longName": "00000018 - Disclosure - Loans Payable", "shortName": "Loans Payable", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://ammj/role/RelatedPartyTransactions", "longName": "00000019 - Disclosure - Related Party Transactions", "shortName": "Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://ammj/role/Stock-basedCompensation", "longName": "00000020 - Disclosure - Stock-Based Compensation", "shortName": "Stock-Based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://ammj/role/ShareholdersEquity", "longName": "00000021 - Disclosure - Shareholders\u2019 Equity", "shortName": "Shareholders\u2019 Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://ammj/role/CommitmentsAndContingencies", "longName": "00000022 - Disclosure - Commitments and Contingencies", "shortName": "Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://ammj/role/SubsequentEvents", "longName": "00000023 - Disclosure - Subsequent Events", "shortName": "Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "23", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies", "longName": "00000024 - Disclosure - Summary of Significant Accounting Policies (Policies)", "shortName": "Summary of Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "24", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://ammj/role/NaturaleafAssetAcquisitionTables", "longName": "00000025 - Disclosure - Naturaleaf Asset Acquisition (Tables)", "shortName": "Naturaleaf Asset Acquisition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables", "longName": "00000026 - Disclosure - Accounts Receivable and Advance from Clients (Tables)", "shortName": "Accounts Receivable and Advance from Clients (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://ammj/role/InventoryTables", "longName": "00000027 - Disclosure - Inventory (Tables)", "shortName": "Inventory (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://ammj/role/PropertyAndEquipmentNetTables", "longName": "00000028 - Disclosure - Property and Equipment, net (Tables)", "shortName": "Property and Equipment, net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://ammj/role/IntangiblesAssetsNeTables", "longName": "00000029 - Disclosure - Intangibles Assets, Ne (Tables)", "shortName": "Intangibles Assets, Ne (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables", "longName": "00000030 - Disclosure - Accrued and Other Current Liabilities (Tables)", "shortName": "Accrued and Other Current Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R31": { "role": "http://ammj/role/StockPayableTables", "longName": "00000031 - Disclosure - Stock Payable (Tables)", "shortName": "Stock Payable (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:ScheduleOfStockPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ammj:StockPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:ScheduleOfStockPayableTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ammj:StockPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R32": { "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables", "longName": "00000032 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative", "longName": "00000033 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)", "shortName": "Summary of Significant Accounting Policies (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:TimeDepositLiabilityUninsured", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "AsOf2022-12-31", "name": "us-gaap:TimeDepositLiabilityUninsured", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "us-gaap:TimeDepositLiabilityUninsured", "span", "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "unique": true } }, "R34": { "role": "http://ammj/role/NaturaleafAssetAcquisitionDetails", "longName": "00000034 - Disclosure - Naturaleaf Asset Acquisition (Details)", "shortName": "Naturaleaf Asset Acquisition (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessCombinationSegmentAllocationTableTextBlock", "us-gaap:AssetAcquisitionTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R35": { "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails", "longName": "00000035 - Disclosure - Accounts Receivable and Advance from Clients (Details)", "shortName": "Accounts Receivable and Advance from Clients (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccountsReceivableGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R36": { "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1", "longName": "00000036 - Disclosure - Accounts Receivable and Advance from Clients (Details 1)", "shortName": "Accounts Receivable and Advance from Clients (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AdvancesToAffiliate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfAdvanceFromClientsTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AdvancesToAffiliate", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfAdvanceFromClientsTableTextBlock", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R37": { "role": "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative", "longName": "00000037 - Disclosure - Accounts Receivable and Advance from Clients (Details Narrative)", "shortName": "Accounts Receivable and Advance from Clients (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:BadDebtExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "ammj:BadDebtExpenses", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R38": { "role": "http://ammj/role/InventoryDetails", "longName": "00000038 - Disclosure - Inventory (Details)", "shortName": "Inventory (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:InventoryRawMaterials", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R39": { "role": "http://ammj/role/PropertyAndEquipmentNetDetails", "longName": "00000039 - Disclosure - Property and Equipment net (Details)", "shortName": "Property and Equipment net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R40": { "role": "http://ammj/role/IntangiblesAssetsNetDetails", "longName": "00000040 - Disclosure - Intangibles Assets, Net (Details)", "shortName": "Intangibles Assets, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R41": { "role": "http://ammj/role/IntangiblesAssetsNetDetails1", "longName": "00000041 - Disclosure - Intangibles Assets, Net (Details 1)", "shortName": "Intangibles Assets, Net (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "ammj:FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "ammj:FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://ammj/role/IntangiblesAssetsNeDetailsNarrative", "longName": "00000042 - Disclosure - Intangibles Assets, Ne (Details Narrative)", "shortName": "Intangibles Assets, Ne (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-01-01to2023-09-30", "name": "us-gaap:AdjustmentForAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R43": { "role": "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails", "longName": "00000043 - Disclosure - Accrued and Other Current Liabilities (Details)", "shortName": "Accrued and Other Current Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:AccruedLiabilitiesCurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R44": { "role": "http://ammj/role/StockPayableDetails", "longName": "00000044 - Disclosure - Stock Payable (Details)", "shortName": "Stock Payable (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LoansPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfStockPayableTableTextBlock", "ammj:StockPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:LoansPayable", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "ammj:ScheduleOfStockPayableTableTextBlock", "ammj:StockPayableTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R45": { "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails", "longName": "00000045 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "From2023-01-012023-09-30_custom_May2022ToApril2023Member", "name": "us-gaap:SaleLeasebackTransactionRentExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true }, "uniqueAnchor": null }, "R46": { "role": "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1", "longName": "00000046 - Disclosure - Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "shortName": "Operating Lease Right-of-Use Asset/Operating Lease Liability (Details 1)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "ammj:OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R47": { "role": "http://ammj/role/Stock-basedCompensationDetailsNarrative", "longName": "00000047 - Disclosure - Stock-Based Compensation (Details Narrative)", "shortName": "Stock-Based Compensation (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "ammj:TemporaryEquityIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "ammj:TemporaryEquityIssued", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "p", "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true, "unique": true } }, "R48": { "role": "http://ammj/role/ShareholdersEquityDetailsNarrative", "longName": "00000048 - Disclosure - Shareholders\u2019 Equity (Details Narrative)", "shortName": "Shareholders\u2019 Equity (Details Narrative)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "AsOf2023-09-30", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Shares", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "From2023-07-012023-09-30", "name": "us-gaap:RestrictedStockExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "ammj_10q.htm", "unique": true } } }, "tag": { "us-gaap_AccruedSalariesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccruedSalariesCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Payroll", "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17", "r339" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical", "http://ammj/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r4" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockValue", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, $0.01 par value, 5,000,000 shares authorized; 0 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r4", "r350" ] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CountryRegion", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CityAreaCode", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Extension", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "LocalPhoneNumber", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_InterestIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InterestIncomeExpenseNet", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Interest (expense)", "documentation": "The net amount of operating interest income (expense)." } } }, "auth_ref": [ "r86" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table]", "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r64" ] }, "us-gaap_SupplementalCashFlowInformationAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SupplementalCashFlowInformationAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL CASH FLOW INFORMATION:" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockholdersEquity", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance,\u00a0December 31, 2021", "periodEndLabel": "Balance,\u00a0June 30, 2022", "label": "Stockholders' Equity Attributable to Parent", "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity." } } }, "auth_ref": [ "r5", "r8", "r9", "r51", "r350", "r379", "r389", "r427" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://ammj/role/IntangiblesAssetsNeTables" ], "lang": { "en-us": { "role": { "label": "Schedule of Identified intangible asset", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r54", "r57" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://ammj/role/InventoryTables" ], "lang": { "en-us": { "role": { "label": "Schedule of inventory", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r2", "r11", "r12", "r13" ] }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounting for the Impairment of Long-Lived Assets", "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets." } } }, "auth_ref": [ "r60", "r65" ] }, "us-gaap_ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlock", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of operating lease liabilities", "documentation": "Tabular disclosure of future minimum payments required in the aggregate and for each of the five succeeding fiscal years for operating leases having initial or remaining noncancelable lease terms in excess of one year and the total minimum rentals to be received in the future under noncancelable subleases as of the balance sheet date." } } }, "auth_ref": [ "r103" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12bTitle", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r352" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right of Use Liabilities \u2013 LT", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r302" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://ammj/role/ShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Shareholders\u2019 Equity", "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income." } } }, "auth_ref": [ "r71", "r138", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r290" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "TradingSymbol", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r365" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right of Use Assets - Operating Leases, net", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r301" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityExchangeName", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r355" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r353" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "Security12gTitle", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r356" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SecurityReportingObligation", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r360" ] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table]", "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r54", "r57", "r317" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFileNumber", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_LitigationReserveNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LitigationReserveNoncurrent", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement", "documentation": "Carrying amount of estimated litigation liability for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r19", "r392" ] }, "us-gaap_NotesPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NotesPayableCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Note payables, current", "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer." } } }, "auth_ref": [ "r15" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r64" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "SolicitingMaterial", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r361" ] }, "us-gaap_InventoryPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory, Policy [Policy Text Block]", "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost." } } }, "auth_ref": [ "r110", "r120", "r161", "r189", "r190", "r191", "r312", "r341" ] }, "us-gaap_EquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "EquityAbstract", "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Net Loss Per Common Share", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r45", "r46" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Loss from Operations", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r172", "r174", "r178", "r180", "r346" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r359" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "Revenues", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Revenues", "label": "Revenues [Default Label]", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r129", "r139", "r168", "r169", "r173", "r176", "r177", "r181", "r182", "r183", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r294", "r321", "r394" ] }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentAbstract", "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetTables" ], "lang": { "en-us": { "role": { "label": "Schedule of property, plant and equipment, net", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r64" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r358" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentFlag", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipment", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment", "documentation": "Amount of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment, acquired at the acquisition date." } } }, "auth_ref": [ "r76" ] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r357" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "EarningsPerShareBasic", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic net loss per common share", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r130", "r146", "r147", "r148", "r149", "r150", "r154", "r155", "r157", "r158", "r159", "r160", "r292", "r293", "r320", "r324", "r344" ] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AmendmentDescription", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Inventory", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r121", "r338", "r350" ] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OperatingExpensesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Operating Expenses" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationSegmentAllocationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationSegmentAllocationTableTextBlock", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionTables" ], "lang": { "en-us": { "role": { "label": "Business Combination, Segment Allocation", "documentation": "Tabular disclosure of goodwill in a business combination." } } }, "auth_ref": [ "r78" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_InventoryFinishedGoods": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryFinishedGoods", "crdr": "debit", "presentation": [ "http://ammj/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished Goods - Cannabis Retail", "documentation": "Amount before valuation and LIFO reserves of completed merchandise or goods expected to be sold within one year or operating cycle, if longer." } } }, "auth_ref": [ "r372" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://ammj/role/SubsequentEvents" ], "lang": { "en-us": { "role": { "label": "Subsequent Events", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r310", "r311" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets", "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Goodwill", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r114", "r192", "r319", "r347", "r350", "r390", "r391" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Property and Equipment - Net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r64", "r96", "r322", "r350" ] }, "us-gaap_InventoryNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryNoncurrent", "crdr": "debit", "presentation": [ "http://ammj/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Total Inventory", "documentation": "Inventories not expected to be converted to cash, sold or exchanged within the normal operating cycle." } } }, "auth_ref": [ "r371" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Operating Expenses", "label": "Operating Expenses [Default Label]", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Property and Equipment, net", "label": "Property, Plant and Equipment, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r64", "r333", "r334" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "EquityComponentDomain", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r69", "r106", "r126", "r127", "r128", "r141", "r142", "r143", "r145", "r151", "r153", "r162", "r187", "r233", "r266", "r267", "r268", "r279", "r280", "r291", "r295", "r296", "r297", "r298", "r299", "r300", "r304", "r326", "r327", "r328" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SignificantAccountingPoliciesTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies", "documentation": "The entire disclosure for all significant accounting policies of the reporting entity." } } }, "auth_ref": [ "r43", "r136" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment, Gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r62", "r112" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncomeTaxPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Income Taxes", "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements." } } }, "auth_ref": [ "r125", "r272", "r273", "r275", "r276", "r277", "r278" ] }, "us-gaap_InventoryRawMaterials": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryRawMaterials", "crdr": "debit", "presentation": [ "http://ammj/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Raw Materials - Soil", "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r374" ] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://ammj/role/Inventory" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r191" ] }, "us-gaap_PropertyPlantAndEquipmentDisposals": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentDisposals", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchase of property and equipment", "label": "Property, Plant and Equipment, Disposals", "documentation": "Amount of divestiture of long-lived, physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment." } } }, "auth_ref": [] }, "us-gaap_NotesPayableToBankNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NotesPayableToBankNoncurrent", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LTD Note Payable", "documentation": "The total amount due within more than 12 month, or the operating cycle if longer, on all notes payable to banks paid on an installment. This can include the amount of any loans from the applicant firm. This does not, however, include any mortgage balances." } } }, "auth_ref": [ "r3", "r83", "r92" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "ammj_ScheduleOfStockPayableTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "ScheduleOfStockPayableTableTextBlock", "presentation": [ "http://ammj/role/StockPayableTables" ], "lang": { "en-us": { "role": { "label": "Schedule of stock payable" } } }, "auth_ref": [] }, "ammj_FiniteLivedIntangibleAssetsGrossAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsGrossAssets", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Total Intangible Assets" } } }, "auth_ref": [] }, "us-gaap_ProfitLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ProfitLoss", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "verboseLabel": "Net Loss", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest." } } }, "auth_ref": [ "r107", "r123", "r124", "r132", "r139", "r144", "r152", "r153", "r172", "r174", "r178", "r180", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r283", "r286", "r287", "r293", "r294", "r321", "r346", "r348", "r349", "r376", "r394" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r266", "r267", "r268", "r380", "r381", "r382", "r426" ] }, "ammj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLicenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLicenses", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Licenses" } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r368" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityShellCompany", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r353" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "ammj_BadDebtExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "BadDebtExpense", "crdr": "debit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bad Debt expense" } } }, "auth_ref": [] }, "ammj_SubscriptionReceivablePaid": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "SubscriptionReceivablePaid", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Subscription Receivable Paid" } } }, "auth_ref": [] }, "ammj_SubscriptionReceivableIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "SubscriptionReceivableIssued", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Subscription Receivable Issued" } } }, "auth_ref": [] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Income Tax Expense", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r140", "r152", "r153", "r171", "r274", "r281", "r282", "r325" ] }, "us-gaap_AssetAcquisitionContingentConsiderationLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetAcquisitionContingentConsiderationLiability", "crdr": "credit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Total Consideration", "documentation": "Amount of liability recognized from contingent consideration in asset acquisition." } } }, "auth_ref": [ "r425" ] }, "ammj_AdvancesFromClients": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "AdvancesFromClients", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Advances from Clients", "label": "AdvancesFromClients" } } }, "auth_ref": [] }, "ammj_StockbasedCompensationToEmployees": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockbasedCompensationToEmployees", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation to employees" } } }, "auth_ref": [] }, "us-gaap_InventoryDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Abstract]" } } }, "auth_ref": [] }, "ammj_StockbasedCompensationToThirdParty": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockbasedCompensationToThirdParty", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation to third party" } } }, "auth_ref": [] }, "ammj_IncreaseDecreaseRightToUseLeaseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "IncreaseDecreaseRightToUseLeaseAsset", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Right to Use Lease Asset", "label": "IncreaseDecreaseRightToUseLeaseAsset" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock-Based Compensation", "label": "Share-Based Payment Arrangement [Policy Text Block]", "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost." } } }, "auth_ref": [ "r239", "r258", "r259", "r260", "r261", "r264", "r269", "r270" ] }, "us-gaap_ShippingAndHandlingCostPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShippingAndHandlingCostPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Shipping and Handling Costs", "documentation": "Disclosure of accounting policy for the classification of shipping and handling costs, including whether the costs are included in cost of sales or included in other income statement accounts. If shipping and handling fees are significant and are not included in cost of sales, disclosure includes both the amounts of such costs and the line item on the income statement which includes such costs." } } }, "auth_ref": [] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r5" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://ammj/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r67", "r198", "r199", "r332", "r393" ] }, "ammj_IncreaseDecreaseInLitigationSettlementLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "IncreaseDecreaseInLitigationSettlementLiability", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement Liability" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "us-gaap_OfficeEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OfficeEquipmentMember", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Office Equipment [Member]", "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine." } } }, "auth_ref": [] }, "ammj_StockBasedCompensationThirdPartyOne": { "xbrltype": "sharesItemType", "nsuri": "http://ammj/20230930", "localname": "StockBasedCompensationThirdPartyOne", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Stock Based Compensation Third Party" } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FairValueMeasurementPolicyPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements", "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities." } } }, "auth_ref": [] }, "ammj_StockIssuedForReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockIssuedForReceivables", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Stock Issued for Receivables" } } }, "auth_ref": [] }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "crdr": "debit", "presentation": [ "http://ammj/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock", "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims." } } }, "auth_ref": [ "r36" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockValue", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Common stock, $0.00001 par value; 500,000,000 shares authorized; 171,402,938 and 92,152,938 shares issued and outstanding at September 30, 2023, and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r5", "r350" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://ammj/role/PropertyAndEquipmentNet" ], "lang": { "en-us": { "role": { "label": "Property and Equipment, net", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r66", "r333", "r334", "r335" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "ammj_StockIssuedForAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockIssuedForAcquisition", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Stock Issued for Acquisition" } } }, "auth_ref": [] }, "ammj_ScheduleOfAdvanceFromClientsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "ScheduleOfAdvanceFromClientsTableTextBlock", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of advances from clients" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_SellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SellingAndMarketingExpense", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Selling and Marketing", "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "ammj_DisclosureStockPayableAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ammj/20230930", "localname": "DisclosureStockPayableAbstract", "lang": { "en-us": { "role": { "label": "Stock Payable" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockSharesIssued", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r5" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockMember", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r380", "r381", "r426" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityFilerCategory", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r353" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "ammj_StockPayableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "StockPayableTextBlock", "presentation": [ "http://ammj/role/StockPayable" ], "lang": { "en-us": { "role": { "verboseLabel": "Stock Payable", "label": "StockPayableTextBlock" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressCountry", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "us-gaap_AdjustmentForAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdjustmentForAmortization", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNeDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Amortization expense", "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives." } } }, "auth_ref": [ "r36", "r59" ] }, "ammj_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedTradenamesAndTrademarks": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedTradenamesAndTrademarks", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Tradenames and Trademarks" } } }, "auth_ref": [] }, "ammj_ImpactOfCovid19PandemicPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "ImpactOfCovid19PandemicPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Impact of COVID-19 Pandemic" } } }, "auth_ref": [] }, "ammj_PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Prepaid Expenses and Other Current Assets", "label": "PrepaidExpensesAndOtherCurrentAssetsPolicyTextBlock" } } }, "auth_ref": [] }, "ammj_DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://ammj/20230930", "localname": "DisclosureOperatingLeaseRightofuseAssetoperatingLeaseLiabilityAbstract", "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-use Assetoperating Lease Liability" } } }, "auth_ref": [] }, "ammj_OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "OperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlockOperatingLeaseRightofuseAssetoperatingLeaseLiabilityTextBlock", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiability" ], "lang": { "en-us": { "role": { "label": "Operating Lease Right-of-Use Asset/Operating Lease Liability" } } }, "auth_ref": [] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SharesOutstanding", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning Balance, Shares", "periodEndLabel": "Ending Balance Shares", "label": "Shares, Outstanding", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "ammj_UnauditedInterimFinancialStatementsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "UnauditedInterimFinancialStatementsTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Unaudited Interim Financial Statements" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "ammj_StockbasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockbasedCompensationExpense", "crdr": "debit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Stock based compensation expense" } } }, "auth_ref": [] }, "ammj_ProductAndEquipmentSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "ProductAndEquipmentSalesPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Product and Equipment Sales" } } }, "auth_ref": [] }, "ammj_ConsultingServicesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "ConsultingServicesPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Consulting Services", "label": "ConsultingServicesPolicyTextBlock" } } }, "auth_ref": [] }, "ammj_CannabisSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "CannabisSalesPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cannabis Sales" } } }, "auth_ref": [] }, "ammj_SubscriptionReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "SubscriptionReceivableMember", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Subscription Receivable [Member]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r5" ] }, "us-gaap_PrepaidExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PrepaidExpenseAndOtherAssets", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Prepaid Expenses and Other Current Assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets." } } }, "auth_ref": [] }, "ammj_RelatedPartyTransactionsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "RelatedPartyTransactionsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Related Party Transactions", "label": "RelatedPartyTransactionsPolicyTextBlock" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "ammj_LoyaltyRewardProgramPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://ammj/20230930", "localname": "LoyaltyRewardProgramPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Loyalty Reward Program" } } }, "auth_ref": [] }, "us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "ammj_BrandMember": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "BrandMember", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "Brand [Member]" } } }, "auth_ref": [] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r14", "r350" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r35" ] }, "ammj_May2022ToApril2023Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "May2022ToApril2023Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "May 2022 To April 2023 [Member]" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RelatedPartyTransactionsAbstract", "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r5", "r69" ] }, "us-gaap_AccountsPayableAndOtherAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsPayableAndOtherAccruedLiabilities", "crdr": "credit", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued and other current liabilities", "label": "Accounts Payable and Other Accrued Liabilities", "documentation": "Amount of liabilities incurred and payable to vendors for goods and services received, and accrued liabilities classified as other." } } }, "auth_ref": [] }, "ammj_June2023ToJune2024Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "June2023ToJune2024Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "June 2023 To June 2024 [Member]" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r62" ] }, "us-gaap_InventoryWorkInProcess": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InventoryWorkInProcess", "crdr": "debit", "presentation": [ "http://ammj/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Work In Process - Cultivation", "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r373" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM FINANCING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://ammj/role/PrinciplesOfConsolidation." ], "lang": { "en-us": { "role": { "label": "Principles of Consolidation.", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r43", "r44", "r50", "r79" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInOperatingActivities", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used In) Operating Activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r32", "r34", "r37" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r353" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r20", "r69", "r106", "r126", "r127", "r128", "r141", "r142", "r143", "r145", "r151", "r153", "r162", "r187", "r233", "r266", "r267", "r268", "r279", "r280", "r291", "r295", "r296", "r297", "r298", "r299", "r300", "r304", "r326", "r327", "r328" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "Net Cash Used in Investing Activities", "label": "Net Cash Provided by (Used in) Investing Activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r133" ] }, "us-gaap_AccountsAndNotesReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsAndNotesReceivableNet", "crdr": "debit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, net", "documentation": "Amount, after allowance for credit loss, of accounts and financing receivable. Includes, but is not limited to, notes and loan receivable." } } }, "auth_ref": [ "r184", "r323" ] }, "us-gaap_AccountsPayableOtherCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsPayableOtherCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Other Accrued Expenses & Payables", "documentation": "Amount of obligations incurred classified as other, payable within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r14" ] }, "ammj_May2023ToApril2024Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "May2023ToApril2024Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "May 2023 To April 2024 [Member]" } } }, "auth_ref": [] }, "us-gaap_DepositContractsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DepositContractsPolicy", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Deposits", "label": "Deposit Contracts, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the treatment of funds received from or paid to insureds, insurers and reinsurers on contracts for which the criteria for transferring or assuming insurance risk has not been satisfied by the insurer or reinsurer." } } }, "auth_ref": [ "r99" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementLineItems", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Net Cash (Used) Provided by Financing Activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r133" ] }, "us-gaap_ReceivablesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ReceivablesAbstract", "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementTable", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r141", "r142", "r143", "r162", "r316" ] }, "ammj_May2024ToApril2025Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "May2024ToApril2025Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "May 2024 To April 2025 [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherSellingAndMarketingExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherSellingAndMarketingExpense", "crdr": "debit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "verboseLabel": "Advertising and Promotion Costs", "label": "Other Selling and Marketing Expense", "documentation": "Amount of selling and marketing expense classified as other." } } }, "auth_ref": [ "r25" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM INVESTING ACTIVITIES:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "CASH FLOWS FROM OPERATING ACTIVITIES" } } }, "auth_ref": [] }, "ammj_May2025ToApril2026Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "May2025ToApril2026Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "May 2025 To April 2026 [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ProceedsFromNotesPayable", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from note payable", "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r30" ] }, "us-gaap_RepaymentsOfNotesPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RepaymentsOfNotesPayable", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "verboseLabel": "LTD Note Payable", "label": "Repayments of Notes Payable", "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation." } } }, "auth_ref": [ "r31" ] }, "ammj_May2026ToApril2027Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "May2026ToApril2027Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "May 2026 To April 2027 [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Assets", "label": "Assets, Current", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r108", "r122", "r139", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r284", "r288", "r294", "r350", "r394", "r395", "r430" ] }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accrued and other current liabilities", "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses." } } }, "auth_ref": [] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization expense", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r36", "r170" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsPayableAndAccruedLiabilitiesCurrentAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Liabilities" } } }, "auth_ref": [] }, "us-gaap_ReceivablesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ReceivablesPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable", "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable." } } }, "auth_ref": [ "r383", "r386", "r387", "r388" ] }, "ammj_January2023Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "January2023Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "January 2023 [Member]" } } }, "auth_ref": [] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Proceeds from sale of common stock", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r29" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetsCurrentAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Current Assets" } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://ammj/role/RelatedPartyTransactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r305", "r306", "r307", "r308", "r309" ] }, "ammj_January2024Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "January2024Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "January 2024 [Member]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, net amortization", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r53", "r56" ] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StatementOfStockholdersEquityAbstract", "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r370" ] }, "us-gaap_DepositsAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DepositsAssetsCurrent", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter." } } }, "auth_ref": [ "r375" ] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "verboseLabel": "Accounts Payable", "label": "Increase (Decrease) in Accounts Payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r35" ] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NetIncomeLoss", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity", "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "NET LOSS", "label": "Net Loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r22", "r37", "r85", "r97", "r107", "r123", "r124", "r128", "r139", "r144", "r146", "r147", "r148", "r149", "r152", "r153", "r156", "r172", "r174", "r178", "r180", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r293", "r294", "r346", "r394" ] }, "ammj_January2025Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "January2025Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "January 2025 [Member]" } } }, "auth_ref": [] }, "us-gaap_AssetsNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetsNoncurrentAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Other Assets" } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsReceivableGross", "crdr": "debit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, before Allowance for Credit Loss", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r118", "r184" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "ammj_January2026Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "January2026Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "January 2026 [Member]" } } }, "auth_ref": [] }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IntangibleAssetsDisclosureTextBlock", "presentation": [ "http://ammj/role/IntangiblesAssetsNe" ], "lang": { "en-us": { "role": { "label": "Intangibles Assets, Ne", "documentation": "The entire disclosure for all or part of the information related to intangible assets." } } }, "auth_ref": [ "r197" ] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdditionalPaidInCapital", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r6", "r350" ] }, "ammj_January2027Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "January2027Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "January 2027 [Member]" } } }, "auth_ref": [] }, "us-gaap_RestrictedStockExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RestrictedStockExpense", "crdr": "debit", "presentation": [ "http://ammj/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Coomon stock", "documentation": "Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement." } } }, "auth_ref": [ "r36" ] }, "us-gaap_DepositsAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DepositsAssetsNoncurrent", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_OtherAssets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Long Term Deposits", "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer." } } }, "auth_ref": [ "r371" ] }, "us-gaap_AccountsReceivableNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsReceivableNet", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable, Net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business." } } }, "auth_ref": [ "r323", "r331" ] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r36", "r61" ] }, "us-gaap_TimeDepositLiabilityUninsured": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "TimeDepositLiabilityUninsured", "crdr": "credit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "FDIC-insured limits", "documentation": "Amount of uninsured time deposit liability. Excludes uninsured time deposit liability in excess of Federal Deposit Insurance Corporation (FDIC) insurance limit or similar state deposit insurance regime in United States of America (US)." } } }, "auth_ref": [ "r336" ] }, "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilities" ], "lang": { "en-us": { "role": { "verboseLabel": "Accrued and Other Current Liabilities", "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]", "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period." } } }, "auth_ref": [] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Accrued Interest", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r17" ] }, "ammj_June2022ToJune2023Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "June2022ToJune2023Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "June 2022 To June 2023 [Member]" } } }, "auth_ref": [] }, "us-gaap_AdvancesToAffiliate": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdvancesToAffiliate", "crdr": "debit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "lang": { "en-us": { "role": { "label": "Beginning Balance", "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients." } } }, "auth_ref": [ "r100" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "UseOfEstimates", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates in Financial Reporting", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r47", "r48", "r49", "r163", "r164", "r166", "r167" ] }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IntangibleAssetsFiniteLivedPolicy", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Intangible Assets, net", "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets." } } }, "auth_ref": [ "r57", "r313", "r314", "r315", "r317", "r340" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Current Liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r18", "r109", "r139", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r285", "r288", "r289", "r294", "r350", "r394", "r430", "r431" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r54", "r57" ] }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherNonoperatingIncomeExpenseAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other Income (Expense)" } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Recent Accounting Pronouncements", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "us-gaap_CostOfSalesPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CostOfSalesPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Costs of Revenues", "documentation": "Disclosure of accounting policy for cost of product sold and service rendered." } } }, "auth_ref": [ "r398" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r193", "r194", "r195", "r196", "r317", "r318" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsLineItems", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_SaleLeasebackTransactionRentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SaleLeasebackTransactionRentExpense", "crdr": "debit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Sale Leaseback Transaction, Rent Expense", "totalLabel": "Sale Leaseback Transaction, Rent Expense", "documentation": "The amount of the current period expense recorded for use of the property in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller." } } }, "auth_ref": [ "r102" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AdvertisingCostsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AdvertisingCostsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Advertising and Promotion Costs", "documentation": "Disclosure of accounting policy for advertising cost." } } }, "auth_ref": [ "r271" ] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r115", "r195" ] }, "us-gaap_BusinessDescriptionAndBasisOfPresentationTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessDescriptionAndBasisOfPresentationTextBlock", "presentation": [ "http://ammj/role/DescriptionOfBusiness." ], "lang": { "en-us": { "role": { "label": "Description of Business.", "documentation": "The entire disclosure for the business description and basis of presentation concepts. Business description describes the nature and type of organization including but not limited to organizational structure as may be applicable to holding companies, parent and subsidiary relationships, business divisions, business units, business segments, affiliates and information about significant ownership of the reporting entity. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r1", "r43", "r50" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross Profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r23", "r139", "r172", "r174", "r178", "r180", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r294", "r346", "r394" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Inventory", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r75", "r76" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Less: Accumulated Depreciation", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r63", "r113" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Gross Carrying amount", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r58", "r318" ] }, "us-gaap_CostOfRevenueAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CostOfRevenueAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Revenues" } } }, "auth_ref": [] }, "us-gaap_OtherLoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherLoansPayable", "crdr": "credit", "presentation": [ "http://ammj/role/StockPayableDetails" ], "lang": { "en-us": { "role": { "label": "Other loans ayable", "documentation": "Amount of long-term loans payable classified as other." } } }, "auth_ref": [ "r3", "r83", "r93" ] }, "us-gaap_OtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherAssets", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other Assets", "label": "Other Assets [Default Label]", "documentation": "Amount of assets classified as other." } } }, "auth_ref": [ "r81", "r90", "r116" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Carrying value", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r58", "r317" ] }, "us-gaap_SoftwareDevelopmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SoftwareDevelopmentMember", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Software Development [Member]", "documentation": "Internally developed software for sale, licensing or long-term internal use." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "WrittenCommunications", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r369" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "totalLabel": "NET INCREASE IN CASH", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r80" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed." } } }, "auth_ref": [ "r76" ] }, "us-gaap_GeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "GeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "General and Administrative", "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line." } } }, "auth_ref": [ "r25" ] }, "us-gaap_MachineryAndEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "MachineryAndEquipmentMember", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Machinery and Equipment [Member]", "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment." } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "periodStartLabel": "CASH AT BEGINNING OF PERIOD", "periodEndLabel": "CASH AT END OF PERIOD", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r32", "r38", "r42" ] }, "ammj_AdditionalDepositsReceived": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "AdditionalDepositsReceived", "crdr": "credit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "lang": { "en-us": { "role": { "label": "Additional deposits received" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Operating Lease Liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r377", "r428" ] }, "ammj_LessDepositsRecognizedAsRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "LessDepositsRecognizedAsRevenue", "crdr": "credit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "lang": { "en-us": { "role": { "label": "Less: Deposits recognized as revenue" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://ammj/role/StockPayableDetails" ], "lang": { "en-us": { "role": { "label": "Payments Upon Issuance of Shares", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r72" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://ammj/role/IntangiblesAssetsNeTables" ], "lang": { "en-us": { "role": { "label": "Schedule of estimated amortization expense", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r57" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "verboseLabel": "2023", "label": "Finance Lease, Liability, Payments, Due in Next Rolling 12 Months", "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease due in next rolling 12 months following current statement of financial position date. For interim and annual periods when interim period is reported on rolling approach." } } }, "auth_ref": [ "r429" ] }, "ammj_AdvancesFromClientOne": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "AdvancesFromClientOne", "crdr": "credit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails1" ], "lang": { "en-us": { "role": { "label": "Ending Balance" } } }, "auth_ref": [] }, "us-gaap_PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Present value of future minimum lease payments", "documentation": "Present value of minimum lease payments for sale-leaseback transactions accounted for using the deposit method or as a financing." } } }, "auth_ref": [ "r105" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock based compensation third party", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r265" ] }, "ammj_FinishedGoodsSoil": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FinishedGoodsSoil", "crdr": "debit", "presentation": [ "http://ammj/role/InventoryDetails" ], "lang": { "en-us": { "role": { "label": "Finished Goods - Soil" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts Receivable, Allowance for Credit Loss, Current", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r119", "r185", "r188" ] }, "ammj_BadDebtExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "BadDebtExpenses", "crdr": "debit", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Bad debt expenses" } } }, "auth_ref": [] }, "us-gaap_CapitalLeaseObligationsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CapitalLeaseObligationsCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Less: current obligations under leases", "documentation": "Amount of capital lease obligation due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r101", "r104", "r105" ] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonth": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonth", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "2023" } } }, "auth_ref": [] }, "us-gaap_OtherIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherIncome", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Other income", "documentation": "Amount of revenue and income classified as other." } } }, "auth_ref": [ "r98" ] }, "us-gaap_IncreaseDecreaseInIntangibleAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInIntangibleAssetsCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Intangible assets", "label": "Increase (Decrease) in Intangible Assets, Current", "documentation": "The increase (decrease) during the reporting period in intangible assets (for example patents and licenses)." } } }, "auth_ref": [ "r35" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accrued and Other Current Liabilities", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r17" ] }, "ammj_PropertyPlantAndEquipmentNetOther": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "PropertyPlantAndEquipmentNetOther", "crdr": "debit", "presentation": [ "http://ammj/role/PropertyAndEquipmentNetDetails" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net" } } }, "auth_ref": [] }, "ammj_FiniteLivedIntangibleAssetUsefulLifeOne": { "xbrltype": "stringItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetUsefulLifeOne", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Estimated useful life" } } }, "auth_ref": [] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseDuringPeriod", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "2022" } } }, "auth_ref": [] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockSharesIssued", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r4", "r220" ] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo1": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo1", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "2024" } } }, "auth_ref": [] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree1": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree1", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "2025" } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r4", "r220" ] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour1": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour1", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "2026" } } }, "auth_ref": [] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive1": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive1", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "Thereafter" } } }, "auth_ref": [] }, "us-gaap_PreferredStockNoParValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PreferredStockNoParValue", "presentation": [ "http://ammj/role/ShareholdersEquityDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, No Par Value", "documentation": "Face amount per share of no-par value preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r4", "r396" ] }, "ammj_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFiveTotal": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFiveTotal", "crdr": "debit", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "" } } }, "auth_ref": [] }, "ammj_AmountRepresentingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "AmountRepresentingInterest", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Less: amount representing interest" } } }, "auth_ref": [] }, "us-gaap_AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables", "crdr": "credit", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Allowance for Doubtful Accounts, Premiums and Other Receivables", "documentation": "The valuation allowance as of the balance sheet date to reduce the gross amount of receivables to estimated net realizable value, which would be presented in parentheses on the face of the balance sheet." } } }, "auth_ref": [ "r384" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfOtherOperatingCostAndExpenseByComponentTextBlock", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityTables" ], "lang": { "en-us": { "role": { "label": "Schedule of other operating cost and expense", "documentation": "Tabular disclosure of each detailed component of other operating costs and expenses that are applicable to sales and revenues, but not included in the cost of sales in the income statement." } } }, "auth_ref": [ "r24" ] }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "verboseLabel": "Goodwill", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets." } } }, "auth_ref": [ "r52", "r55" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CashAndCashEquivalentsPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents", "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value." } } }, "auth_ref": [ "r40" ] }, "ammj_LongtermLeaseObligations": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "LongtermLeaseObligations", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Long-term lease obligations" } } }, "auth_ref": [] }, "ammj_TemporaryEquityIssued": { "xbrltype": "sharesItemType", "nsuri": "http://ammj/20230930", "localname": "TemporaryEquityIssued", "presentation": [ "http://ammj/role/Stock-basedCompensationDetailsNarrative" ], "lang": { "en-us": { "role": { "label": "Common stock issued" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Stock Based Compensation Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r35" ] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Inventory", "label": "Increase (Decrease) in Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r35" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash paid for interest", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r131", "r134", "r135" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock issued for cash, Shares", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r4", "r5", "r69", "r70" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r364" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r367" ] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Acquisition of Assets", "label": "Payments to Acquire Property, Plant, and Equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r28" ] }, "us-gaap_PaymentsToAcquireNotesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PaymentsToAcquireNotesReceivable", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Payment of note payable", "label": "Payments to Acquire Notes Receivable", "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics." } } }, "auth_ref": [ "r27" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r351" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCentralIndexKey", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r353" ] }, "us-gaap_ConcentrationRiskCreditRisk": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ConcentrationRiskCreditRisk", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Significant Clients and Customers", "documentation": "Disclosure of accounting policy for credit risk." } } }, "auth_ref": [ "r88", "r165" ] }, "us-gaap_IncreaseDecreaseInDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInDeposits", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "verboseLabel": "Long Term Deposits", "label": "Increase (Decrease) in Deposits", "documentation": "The net cash inflow or outflow for the increase (decrease) in the beginning and end of period deposits balances." } } }, "auth_ref": [ "r39", "r87" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r10", "r84", "r95", "r350", "r379", "r389", "r427" ] }, "us-gaap_LoansPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LoansPayable", "crdr": "credit", "presentation": [ "http://ammj/role/StockPayableDetails" ], "lang": { "en-us": { "role": { "label": "Loans payable", "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer)." } } }, "auth_ref": [ "r3", "r83", "r89" ] }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock issued to service provider", "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_IncomeTaxesPaid": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncomeTaxesPaid", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Cash paid for income taxes", "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income." } } }, "auth_ref": [ "r33", "r41" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL LIABILITIES", "label": "Liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r16", "r139", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r285", "r288", "r289", "r294", "r345", "r394", "r430", "r431" ] }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockIssuedDuringPeriodValueIssuedForServices", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock-based compensation to service provider", "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders." } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock issued for cash", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r4", "r5", "r69", "r70" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r365" ] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r354" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentType", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RevenueRecognitionPolicyTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Revenue Recognition", "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources." } } }, "auth_ref": [ "r342", "r343" ] }, "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClients" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable and Advance from Clients", "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses." } } }, "auth_ref": [ "r385" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentAnnualReport", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r362", "r364", "r365" ] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "AnnualInformationForm", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r365" ] }, "us-gaap_PayablesAndAccrualsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PayablesAndAccrualsAbstract", "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r363" ] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r364" ] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LONG TERM LIABILITIES" } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentAccountingStandard", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r364" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "PatentsMember", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r77" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentTransitionReport", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r366" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RevenuesAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Revenues" } } }, "auth_ref": [] }, "us-gaap_AwardDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AwardDateAxis", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Award Date [Axis]", "documentation": "Information by date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424" ] }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Going Concern", "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern." } } }, "auth_ref": [ "r0" ] }, "ammj_DebtForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "DebtForgiveness", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "negatedLabel": "Debt Forgiveness", "label": "DebtForgiveness" } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityRegistrantName", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r353" ] }, "us-gaap_AwardDateDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AwardDateDomain", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "documentation": "Date or year award under share-based payment arrangement is granted." } } }, "auth_ref": [ "r399", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r420", "r421", "r422", "r423", "r424" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r364" ] }, "us-gaap_ResearchAndDevelopmentExpensePolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ResearchAndDevelopmentExpensePolicy", "presentation": [ "http://ammj/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "label": "Research and Development", "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process." } } }, "auth_ref": [ "r74" ] }, "ammj_June2024ToJune2025Member": { "xbrltype": "domainItemType", "nsuri": "http://ammj/20230930", "localname": "June2024ToJune2025Member", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "June 2024 To June 2025 [Member]" } } }, "auth_ref": [] }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "SalesAndExciseTaxPayableCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/AccruedAndOtherCurrentLiabilitiesDetails" ], "lang": { "en-us": { "role": { "label": "Sales Tax Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r14" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentAssets", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Other Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Assets", "documentation": "Amount of assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r76" ] }, "us-gaap_LitigationReserveCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LitigationReserveCurrent", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Litigation Settlement, current", "documentation": "Carrying amount of reserve for known or estimated probable loss from litigation, which may include attorneys' fees and other litigation costs, which is expected to be paid within one year of the date of the statement of financial position." } } }, "auth_ref": [ "r19", "r392" ] }, "ammj_StockBasedCompensationToEmployeesShares": { "xbrltype": "sharesItemType", "nsuri": "http://ammj/20230930", "localname": "StockBasedCompensationToEmployeesShares", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Stock based compensation to employees, shares", "label": "StockBasedCompensationToEmployeesShares" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r234", "r235", "r236", "r237", "r238", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r255", "r256", "r257", "r260", "r261", "r262", "r263", "r264" ] }, "ammj_StockholdersEquity1": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockholdersEquity1", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "periodStartLabel": "Balance,\u00a0December 31, 2022", "periodEndLabel": "Balance,\u00a0Sept. 30, 2023", "label": "StockholdersEquity1" } } }, "auth_ref": [] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetsAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit." } } }, "auth_ref": [ "r7", "r70", "r94", "r329", "r330", "r350" ] }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "EmployeeBenefitsAndShareBasedCompensation", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Stock based compensation to employees", "documentation": "Amount of expense for employee benefit and equity-based compensation." } } }, "auth_ref": [] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Cash and Equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r38", "r111", "r337" ] }, "ammj_AdvancesFromClient": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "AdvancesFromClient", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Advances from Clients" } } }, "auth_ref": [] }, "ammj_RightOfUseLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "RightOfUseLiabilitiesCurrent", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Right of Use Liabilities, current" } } }, "auth_ref": [] }, "ammj_StockPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "StockPayable", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "Stock payable" } } }, "auth_ref": [] }, "ammj_BasicAndDilutedWeightedAverageCommonSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://ammj/20230930", "localname": "BasicAndDilutedWeightedAverageCommonSharesOutstanding", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Basic and diluted weighted average common shares outstanding" } } }, "auth_ref": [] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "RetainedEarningsMember", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfChangesInShareholdersEquity" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit." } } }, "auth_ref": [ "r106", "r141", "r142", "r143", "r145", "r151", "r153", "r187", "r266", "r267", "r268", "r279", "r280", "r291", "r326", "r328" ] }, "ammj_TotalShareholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "TotalShareholdersEquity", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total Shareholders\u2019 Equity", "label": "TotalShareholdersEquity" } } }, "auth_ref": [] }, "us-gaap_DebtInstrumentDecreaseForgiveness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DebtInstrumentDecreaseForgiveness", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Debt Forgiveness", "documentation": "Decrease for amounts of indebtedness forgiven by the holder of the debt instrument." } } }, "auth_ref": [ "r378" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities:" } } }, "auth_ref": [] }, "ammj_ConsultingAndAdvisoryRevenues": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "ConsultingAndAdvisoryRevenues", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Consulting Services" } } }, "auth_ref": [] }, "us-gaap_AssetAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "AssetAcquisitionTextBlock", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisition" ], "lang": { "en-us": { "role": { "label": "Naturaleaf Asset Acquisition", "documentation": "The entire disclosure for asset acquisition." } } }, "auth_ref": [ "r425" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://ammj/role/AccountsReceivableAndAdvanceFromClientsTables" ], "lang": { "en-us": { "role": { "label": "Schedule of accounts receivable and advances from clients", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r21" ] }, "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock", "presentation": [ "http://ammj/role/Stock-basedCompensation" ], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation", "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)." } } }, "auth_ref": [ "r71", "r73" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "ammj_EquipmentSuppliesRevenues": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "EquipmentSuppliesRevenues", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Product & Equipment" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities", "crdr": "debit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "label": "Accrued and other current liabilities", "documentation": "The increase (decrease) during the reporting period in other obligations or expenses incurred but not yet paid." } } }, "auth_ref": [ "r35" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntitySmallBusiness", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r353" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "Assets", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "TOTAL ASSETS", "label": "Assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r82", "r91", "r117", "r139", "r172", "r175", "r179", "r186", "r200", "r201", "r202", "r203", "r204", "r205", "r206", "r207", "r208", "r284", "r288", "r294", "r350", "r394", "r395", "r430" ] }, "ammj_CannabisProducts": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "CannabisProducts", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cannabis Products" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfCashFlow" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r35" ] }, "ammj_NetLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "NetLoss", "crdr": "credit", "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net Loss", "label": "NetLoss" } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2022", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ammj/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "ammj_CostOfConsultingAndAdvisory": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "CostOfConsultingAndAdvisory", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "ammj_CostOfRevenuesNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Consulting Services" } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Other (Expense) Income", "label": "Nonoperating Income (Expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r26" ] }, "ammj_CostOfEquipmentSupplies": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "CostOfEquipmentSupplies", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "ammj_CostOfRevenuesNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Products and Equipment" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://ammj/role/LoansPayable" ], "lang": { "en-us": { "role": { "label": "Loans Payable", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r68", "r137", "r209", "r210", "r211", "r212", "r213", "r214", "r215", "r216", "r217", "r218", "r219" ] }, "ammj_CostOfCannabisProduct": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "CostOfCannabisProduct", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "ammj_CostOfRevenuesNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "label": "Cost of Cannabis Products" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Current Assets", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets", "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r76" ] }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "FinanceLeaseLiabilityPaymentsDue", "crdr": "credit", "presentation": [ "http://ammj/role/OperatingLeaseRight-of-useAssetoperatingLeaseLiabilityDetails1" ], "lang": { "en-us": { "role": { "label": "Total", "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease." } } }, "auth_ref": [ "r303" ] }, "ammj_CostOfRevenuesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://ammj/20230930", "localname": "CostOfRevenuesNet", "crdr": "debit", "calculation": { "http://ammj/role/CondensedConsolidatedStatementsOfOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://ammj/role/CondensedConsolidatedStatementsOfOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Total Cost of Revenues", "label": "CostOfRevenuesNet" } } }, "auth_ref": [] }, "us-gaap_LicenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LicenseMember", "presentation": [ "http://ammj/role/IntangiblesAssetsNetDetails", "http://ammj/role/IntangiblesAssetsNetDetails1" ], "lang": { "en-us": { "role": { "label": "License [Member]", "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark." } } }, "auth_ref": [ "r397" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://ammj/role/CondensedConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "label": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2022", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "crdr": "debit", "presentation": [ "http://ammj/role/NaturaleafAssetAcquisitionDetails" ], "lang": { "en-us": { "role": { "label": "Total Tangible Assets", "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date." } } }, "auth_ref": [ "r76" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "40", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19,20)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.3,4)", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "8", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3095-108585" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "8", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "URI": "https://asc.fasb.org/topic&trid=2122394" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "05", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.CC)", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "730", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "38", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5504-128473" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "230", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10))", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(16))", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04.10)", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "230", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123398031&loc=d3e60009-112784" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "825", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(10))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(16))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04.4)", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "825", "Section": "05", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6487483&loc=d3e32239-158577" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "946", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04.2)", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(19))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "840", "SubTopic": "20", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41499-112717" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "840", "SubTopic": "20", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=123406913&loc=d3e41502-112717" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "840", "SubTopic": "30", "Section": "45", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=123406127&loc=d3e45023-112735" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "840", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123386454&loc=d3e45280-112737" }, "r106": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "105", "SubTopic": "10", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r107": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "205", "SubTopic": "20", "Section": "50", "Paragraph": "7", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r108": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r109": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "5", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r110": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766" }, "r111": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r112": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r113": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r114": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r115": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r116": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r117": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r118": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(3)(a)(1))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r119": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(4))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r121": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r122": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r123": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r124": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r125": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r126": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r127": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "5", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r128": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r129": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r130": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r131": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "17", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r132": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r133": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r134": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(e)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r135": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r136": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r137": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(c))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r140": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "3", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "8", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "50", "Paragraph": "9", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "10", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "45", "Paragraph": "7", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "15", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "6", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126900757&loc=d3e543-108305" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "272", "SubTopic": "10", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "11", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "12", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "Subparagraph": "(h)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "22", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "40", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "42", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "45", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "323", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "326", "SubTopic": "10", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "326", "SubTopic": "20", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "330", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "330", "URI": "https://asc.fasb.org/topic&trid=2126998" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "440", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "440", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1B", "Subparagraph": "(g)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1B", "Subparagraph": "(h)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1B", "Subparagraph": "(i)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1B", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1C", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1C", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1C", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1E", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1I", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1I", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "20", "Section": "50", "Paragraph": "1I", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "35", "Paragraph": "1D", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "35", "Paragraph": "3", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "720", "SubTopic": "35", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "25", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "45", "Paragraph": "28", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "10", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "17", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "19", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "20", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "50", "Paragraph": "9", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB TOPIC 6.I.7)", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "740", "SubTopic": "20", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "19", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(a)(1)", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(1)", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "17", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "848", "SubTopic": "10", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "855", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "912", "SubTopic": "330", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6471895&loc=d3e55923-109411" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "920", "SubTopic": "350", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "920", "SubTopic": "350", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "920", "SubTopic": "350", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "924", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "926", "SubTopic": "20", "Section": "50", "Paragraph": "5", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "928", "SubTopic": "340", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "235", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "360", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(5))", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "220", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(9))", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "944", "SubTopic": "40", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "954", "SubTopic": "310", "Section": "45", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "954", "SubTopic": "440", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "958", "SubTopic": "360", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "958", "SubTopic": "360", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "958", "SubTopic": "360", "Section": "50", "Paragraph": "7", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Publisher": "SEC", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1406", "Paragraph": "(f)", "Subparagraph": "(2)" }, "r337": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r338": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r339": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "45", "Paragraph": "8", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r340": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r341": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r342": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(e)", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r343": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r344": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "55", "Paragraph": "52", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r345": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r346": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "280", "SubTopic": "10", "Section": "50", "Paragraph": "31", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r347": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "55", "Paragraph": "24", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r348": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4J", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r349": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "55", "Paragraph": "4K", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r350": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "55", "Paragraph": "10", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r351": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r352": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r353": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r354": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r355": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r356": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r357": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r358": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r359": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r360": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r361": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r362": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r363": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r364": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r365": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r366": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r367": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r368": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r369": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r370": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" }, "r371": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r372": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r373": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r374": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r375": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r376": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r377": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r378": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(f))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r379": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "235", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r380": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r381": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "24", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r382": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "250", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r383": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r384": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r385": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "10", "URI": "https://asc.fasb.org/subtopic&trid=2196772" }, "r386": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "20", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r387": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "20", "Section": "50", "Paragraph": "2", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534" }, "r388": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "310", "SubTopic": "20", "Section": "50", "Paragraph": "4", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534" }, "r389": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "323", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r390": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r391": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r392": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "450", "SubTopic": "20", "Section": "50", "Paragraph": "1", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r393": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r394": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r395": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r396": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "505", "SubTopic": "10", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r397": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "606", "SubTopic": "10", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r398": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "705", "URI": "https://asc.fasb.org/topic&trid=2122478" }, "r399": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r400": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r401": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r402": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r403": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r404": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r405": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r406": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r407": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r408": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r409": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r410": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r411": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r412": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r413": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r414": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r415": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r416": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r417": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r418": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r419": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r420": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r421": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r422": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r423": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r424": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r425": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "50", "Section": "15", "Paragraph": "3", "URI": "https://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492" }, "r426": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "815", "SubTopic": "40", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r427": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r428": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r429": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "842", "SubTopic": "20", "Section": "50", "Paragraph": "6", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r430": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r431": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Publisher": "FASB", "Name": "Accounting Standards Codification", "Topic": "852", "SubTopic": "10", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" } } } ZIP 65 0001903596-23-000879-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001903596-23-000879-xbrl.zip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�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